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ABSTRACT 
This work is focused on both targeted and comprehensive approaches of proteomic studies. 
The targeted proteomics brings information about protein presence and localization in a cell or 
tissue using luminescence labels based on quantum dots, while the comprehensive approach 
deals with the identification of changes in proteomes of two or more specimens of the same 
organism that have grown in various conditions. Since the proteomics requires high sensitive 
separation and identification techniques, various methods of sensitivity improvement in capillary 
electrophoresis - mass spectrometry were verified in this work. The use of a liquid junction 
interface as a hyphenation between these two techniques ensures a higher sensitivity of analyses. 
This was verified also by the analysis of ethanol and cocaine metabolites in human urine. 
The developed instrumentation and methodology are utilizable for the estimation of the influence 
of important environmental factors on living systems at the cellular as well as molecular levels. 
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ABSTRAKT 
Tato práce je zaměřena jak na cílený tak na přehledný přístup ve studiu proteomiky. Cílená 
proteomika přináší informace o přítomnosti proteinu a jeho lokalizaci v buňce či tkáni pomocí 
luminiscenčních značek na bázi kvantových teček, zatímco přehledná proteomika se zabývá 
identifikací změn v proteomu dvou nebo více jedinců stejného druhu vystavených různým 
podmínkám. Protože proteomika vyžaduje vysoce citlivé separační a identifikační techniky, byly 
v této práci ověřeny různé metody zlepšení citlivosti kapilární elektroforézy s hmotnostní 
detekcí. Použití rozhraní s kapalinovým spojem pro spojení těchto dvou technik, které zajišťuje 
vyšší citlivost analýz, bylo také ověřeno analýzou metabolitů etanolu a kokainu v lidské moči. 
Zavedené techniky instrumentace jsou využitelné při posouzení vlivu významných faktorů 
životního prostředí na živé systémy jak na buněčné tak na molekulární úrovni. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KLÍČOVÁ SLOVA 
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INTRODUCTION 
After the genome of many organisms including human was identified, proteome discovery is 
now in the focus of attention. The term proteome corresponds to the entire set of proteins 
expressed in organisms from DNA. Proteome can vary a lot with time, because of different 
changes of external conditions and the actual phase of cell life cycle. Transformation of 
proteome is very dynamic and thus the study of organisms´ protein content can show us the 
reaction in cells prior to changes in metabolome or apparent physiological modifications. 
Proteomics deals not only with the proteins identification and quantification, but also with the 
study of protein structures, functions, post translational modifications, metabolic pathways and 
biomarkers detection. Not only a proteomic background of human diseases, but also the effect of 
various environmental factors like traffic, industry or agriculture on organisms is nowadays 
studied by environmental science. 
 
Extremely complex effect of environment is displayed in microorganisms. The environment is a 
source of nutrients for microorganisms and also forms space for their growth. On the other hand, 
microbial cells are continuously exposed to a myriad of changes in environmental conditions. 
These conditions determine their metabolic activity, growth and survival. Basic knowledge of the 
influence of environmental factors on microorganisms on proteome level is important for 
understanding the ecology and biodiversity of microbial populations as well as for control of 
microbial physiology in order to enhance the utilization of microorganisms or to inhibit or stop 
their harmful activity. 
 
Two approaches for study of proteome are nowadays available, targeted and comprehensive. 
Targeted proteomics deals with selective identification and localization of a protein of interest 
within the cell or tissue using specific luminescence probes. The comprehensive proteomics is 
focused on systematic protein analysis, their identification and determination of their functions 
using high sensitive separation techniques. By combination of both approaches, the proteome of 
microorganisms or other part of biota can be studied in details. This leads to the understanding of 
the dependence of microbial metabolism on the changes in the environment.  
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1. THEORETICAL PART 
1.1 Targeted proteomics 
 
Targeted proteomics is focused on the selective identification and quantization of a protein of 
interest in cells or tissues. The cell signaling pathways, mitosis or processes at cell organelles can 
be studied using this approach. To understand the high complexity of the cell, not only molecular 
structure, but also mechanisms of cellular dynamics and cellular functions together with the 
connection between cells and higher levels of organization like tissues or organs have to be 
studied. The discovery of biomarkers is today in the focus of attention as well. Screening assays, 
where biomarkers can be quantified and statistically differentiated between healthy and diseased 
cells, are under development. Since biomarkers of diseases or specific proteins induced by an 
exposure to toxicological stressors in the environmental proteomics are often present at very low 
concentration, sensitive methods for their detection are required. Various analytical methods are 
used for studying protein localization or bimolecular interaction like atomic force microscopy [1, 
2], mass spectrometry imaging [3, 4], surface plasmon resonance biosensors [5], Raman 
spectroscopy [6], magnetic resonance or optical imaging [7] or fluorescence imaging [8, 9], 
which enable sensitive detection of visualized proteins.  
Targeted proteomics often take advantage of the unique selectivity of antibodies while binding to 
the antigen or other specific proteins, enzymes or small molecules. In such assays, the 
measurement of compounds in trace levels in the presence of potential structurally or chemically 
similar compounds at much higher concentration is possible. Antibody, which can be conjugated 
with fluorescence dye, forms stable immunocomplexes with antigen [10]. Various fluorophores 
are used for visualization of cells, cell organelles or biomolecules and their tracing. Different 
methods like size exclusion chromatography [11], enzyme/linked immunosorbent assay 
(ELISA),  polyacrylamide gel electrophoresis [12] or capillary electrophoresis [13, 14] have been 
used for characterization of immunocomplexes.  
In the next chapters, the possibilities of fluorescence probe selection and methods for 
conjugations of antibodies or other proteins with fluorescent probes will be discussed together 
with analytical methods for reaction products characterization and cell visualization. 
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1.1.1 Principles of luminescence 
Luminescence is a process of radiation emission during return of molecules or atoms from excite 
to ground electronic state. Luminescence can be divided by character of absorbed energy into 
some groups, for example: photoluminescence, where the molecule or atom is excited by photon, 
chemiluminescence, where the excitation is caused by chemical reaction, bioluminescence, with 
excitation by biological process and electroluminescence, where the energy of electric field is 
absorbed. In photoluminescence, the photon energy is absorbed by the molecule in ground state 
and the molecule is excited to the higher electronic state. At each of these electronic states the 
molecule can exist in several vibration and rotation energy levels. Then, the molecule 
deexcitation can take place in four basic processes: radiant photon emission and three types of 
radiationless transitions - vibration relaxation, internal or external conversion and intersystem 
crossing. The energy of emission radiation is usually lower than the absorption, because the 
molecule excited to different vibration energy levels, returns to the lowest vibration level prior to 
the regression to ground state. Fluorescence occurs, when the first excited state (S1) and ground 
state (S0) have the same spin. The time necessary for molecule deexcitation is called 
fluorescence emission lifetime and takes value for fluorescence in the range 10-7 - 10-10 s.  When 
the molecule undergoes spin conversion, it can convert to the triplet state (T1) by intersystem 
crossing. The emission from triplet electronic state is called phosphorescence and has much 
longer lifetime in the range 10-3 - 10 s in comparison with fluorescence. The scheme of radiation 
and radiationless transitions are depicted in Figure 1 of Jablonski diagram [15, 16].  
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Figure 1:  Jablonski diagram showing absorption and emission processes of fluorescence and 
phosphorescence. 
 
Due to the fact, that the energy of emission is typically lower than this of absorption, 
fluorescence occurs at lower energies (or longer wavelengths). This phenomenon is called Stokes 
shift. In many molecules the excitation and emission spectra are the mirror images of each 
others, because the molecules in ground and excited state are presented in similar vibration state. 
Some exceptions of the mirror-rule can occur. This could be caused by pKa changes in excited 
state like in the case of phenol or tyrosine or by formation of complexes with the same molecules 
(pyrene) or with other molecules (pyrene and amines). Another general property is that similar 
emission spectra are observed even when the excitation wavelength is different. When the 
excitation to higher energy levels occurs, the excess energy is quickly dissipated and the 
molecule remains in the basic S1 level [15]. 
The fluorescence is characterized by three basic properties, quantum yield, lifetime and intensity. 
Quantum yield (QY) is the ratio between number of photons emitted and number of photons 
absorbed and can be expressed as follows [17]: 
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Another definition tells that QY is the quantitative expression of the fluorescence efficiency and 
it is the fraction of excited molecules returning to the ground state by fluorescence.  
Fluorescence lifetime is an average time period that the molecule spends in excited state before 
the return to the ground state. It can be calculated as a time constant τ in the following equation: 
 
 = 

 , 
 
where I0 is the intensity at time 0 and I (t) is the intensity related to time t. The fluorescence 
intensity is the third of the characteristic properties. It is proportional to the power of the 
excitation source, quantum yield, molar absorptivity and concentration of the fluorescence 
molecule [18].  
Fluorescence resonance energy transfer (FRET or RET) is another process that occurs in the 
excited state. The energy transfer appears, when the emission spectrum of fluorophore (donor) 
overlaps with absorption spectrum of another molecule (acceptor). It is important to highlight 
here, that RET does not involve photon transport and it is the result of long range dipole-dipole 
interactions between the donor and acceptor. The rate of energy transfer depends on the rate of 
spectral overlap, quantum yield of the donor, relative orientation of transition dipoles and 
distance between donor and acceptor. The distance at which RET has 50 % efficiency is called 
Förster distance. The value of Förster distance is typically from 2 - 6 nm. The most common 
application of RET is the distance measurement between two molecules that can be placed, for 
example, on different sites of protein [15]. 
 
1.1.1.1 Fluorescence biomolecules 
There are many biomolecules with natural fluorescence like proteins, where the fluorescence is 
mainly determined by aromatic amino acids tryptophan, tyrosine and phenylalanine. Their 
emission lies in UV region of spectra. Tryptophan is a dominant fluorophore of proteins because 
of the presence of indol group in its structure. Its fluorescence is very sensitive to the external 
conditions and thus can be used to study conformation changes of proteins [19]. Green 
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Fluorescent Protein (GFP), discovered in 1962, is a specific protein present in jellyfish Aequorea 
victoria. It contains highly fluorescent group within a specific structure, a barrel β-sheet. Due to 
the covered structure of barrel β-sheet, GFP exhibit a high quantum yield and good 
photostability. The chromophore is formed spontaneously without the need of enzymatic 
synthesis. Nowadays, it is possible to incorporate the gene for GFP into various cells, and thus 
proteins with the same functions, but with additional green fluorescence are formed. Other 
fluorescence proteins with different emission wavelengths are now available like Yellow or Red 
Fluorescence Proteins [15]. Phytofluors are new fluorescence probes derived from 
phytochromes, light sensitive proteins present in photosynthetic organism. Phytofluors have a 
large molar absorption coefficients, fluorescence quantum yields greater than 0.7 and excellent 
photostability. Phycobiliproteins like phycoerithrin or phycocyanine are fluorescent proteins 
from blue-green and red algae. They absorb strongly in the range from 470 nm to 650 nm and 
their emission does not interfere with other biological molecules. They exhibit high quantum 
yields and high photostability. Another fluorescence biomolecules are enzyme cofactors like 
nicotinamide adenine dinucleotide (NADH) that emits at 460 nm, while its oxidized form NAD+ 
is not fluorescent at all. Also other cofactors like flavin adenine dinucleotide (FAD), flavin 
mononucleotide (FMN) and riboflavin have similar fluorescence properties [15, 19]. 
 
1.1.1.2 Fluorescence labels and probes 
Although the intrinsic nature of fluorescence occurs in some biomolecules, their application is 
strongly limited, because the intensity is usually weak, must be excited at UV region and, 
therefore, an external fluorophores are widely used for the labeling of biomolecules. 
Fluorescence dyes are frequently used in various applications in biology like in flow cytometry, 
cellular and molecular imaging, separation methods including electrophoresis or DNA 
sequencing, because of their high sensitivity and wide range of possible options for conjugation 
[15]. Fluorescence label is extrinsic fluorophore that is covalently bound to the targeted 
molecule. On the other hand, fluorescence probe is bound non-covalently to the targeted 
molecule and its fluorescent properties are usually changed after the conjugation. Additionally, 
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fluorescence sensor is a device that measures specific physical quantity and convert it to the 
fluorescence signal available for measurements.  
Fluorophores are available in several different forms with a variety of reactive groups capable to 
couple with specific functional groups on the target molecules like proteins or nucleic acids 
without any interacting molecule. The overview of the specific functional groups on the target 
molecule and specific groups on fluorophore are listed in Table 1. The table shows also the most 
common fluorophore structures that can be derivatized by specific functional group. Many of the 
fluorescence dyes are now commercially available in their trivial or brand names [15, 20]. 
 
Table 1: Overview of the most frequently used reactive groups of fluorophores suitable for 
conjugation with specific groups of linked molecules [20, 21]. 
Reactive group 
of the attached 
molecule 
Reactive group at fluorophore molecule 
Basic molecule of fluorophore 
name structure 
amine 
isothiocyanate – N = C = S 
Fluorescein, Rhodamine, 
Coumarine 
sulfonylchloride – SO2Cl 
Rhodamine, Coumarine, 
Cascade Blue 
azide – N3 
Fluorescein, Rhodamine, 
Coumarine, Cascade Blue 
carboxylic acid – COOH 
Fluorescein, Coumarine, 
BODIPY 
succinimide 
 
Fluorescein, Rhodamine, 
Coumarine, BODIPY, Cyanine 
dyes 
dichlorotriazine 
 
Fluorescein, Rhodamine 
aldehyde, 
ketone, 
hydrazide – NH – NH2 
Fluorescein, Coumarine, 
BODIPY,  Cascade Blue, 
18 
 
 
In following paragraphs, the overview of basic fluorophores is listed. Figure 2 shows the core 
structures of the most common organic fluorescence dyes. 
 
 
carboxylate Lucifer yellow, Cyanine dyes 
hydrazide derivates – NH – (CH2)x – NH2 
Rhodamine, BODIPY,  
Cascade Blue 
hydroxylamine – O – NH2 Rhodamine, Coumarine 
sulfonyl hydrazide – SO2 – NH – NH2 Rhodamine, Coumarine 
thiol 
iodoacetamide – NH – CO – CH2I 
Fluoresein, Rhodamine, 
Coumarine, BODIPY,  
Lucifer yellow 
maleinimide 
 
Fluorescein, Coumarine, 
Rhodamine, Cyanine dyes 
brom – Br 
Fluorescein, Coumarine, 
BODIPY 
hydroxyl 
azide – N3 
Fluorescein, Rhodamine, 
Coumarine, Cascade Blue 
dichlorotriazine 
 
Fluorescein, Rhodamine 
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Figure 2: Basic core structures of the most common fluorophores. 
 
Fluorescein 
Fluorescein is one of the most popular fluorescence dyes ever. Its fluorescence character is 
formed by the presence of the system of three condensed aromatic rings. Fluorescein could be 
derivatized by a number of functional groups, listed in Table 1, that are usually bound to the 
carbons at the isolated ring of fluorescein core structure. Its excitation wavelength lies in the 
range between 488 - 495 nm and emission maximum, depending on the selection derivatives, lies 
between 518 and 525 nm. Fluorescein exhibits QY of 0.9 under ideal conditions, which is the 
maximum found in the nature [20, 22]. 
 
Rhodamine 
Fluorescence character of rhodamine is given by the presence of a three ring aromatic structure 
as in the fluorescein molecule. Only the oxygen atoms are replaced by nitrogen in the outer rings. 
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Rhodamine molecule can be derivatized in the same manner as fluorescein molecule in the 
carbons of isolated ring. Additionally, its molecule is widely altered in the basic three ring 
structure to modulate its fluorescence character. The excitation wavelength is around 510 nm and 
emission maxima could be between 550 and 620 nm, depending on the derivatization. Quantum 
yield of rhodamine depends strongly on the molecular derivatization and solvent. It can vary 
from 0.25 to 0.95 [20]. 
 
Coumarine 
Coumarine is a naturally occurring compound with many possible derivatization possibilities on 
its basic two ring aromatic structure. It exhibits emission maxima from 400 - 550 nm and 
quantum yield around 0.7. 
 
BODIPY 
BODIPY fluorescence dyes create three ring aromatic structure that can be widely modified. The 
modification causes spectral shifts of excitation and emission wavelengths. Emission maxima are 
in the range from 550 nm to 665 nm. Emission spectra usually display narrow bandwidths and 
very small Stoke´s shift (10 - 20 nm), which can cause problems with excitation light filtering. 
BODIPY dyes exhibit very high quantum yield - greater than 0.8. The spectral characteristics are 
relatively stable toward pH changes  in comparison with other fluorophores [20].  
 
Cascade Blue 
Cascade Blue structure is derived from a trisulfonated pyrene backbone. Three negatively 
charged sulfonate groups ensure very good water solubility. The emission wavelengths lie in the 
blue region of visible spectra. Cascade Blue dyes exhibit QY around 0.54 and a relatively good 
photostability [20].  
 
Lucifer Yellow 
Lucifer Yellow fluorophores have excitation maximum between 426 - 428 nm and emission 
maximum between 530 - 535 nm in yellow region of visible spectra. Its structure is based on 
naphtalimide. Quantum yield is about 0.25 [20].  
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Cyanine dyes 
Cyanine dyes creates specific groups of fluorophores, because their structure is based on 
polymethine bridge that connects two cationic nitrogenous ring structures, where one ring must 
have positively charged quartenized nitrogen atom. The ring is usually substituted by sulfonate 
groups, which provide higher water solubility and also prevent dye to dye interactions. The name 
of cyanine dyes is derived from the number of carbon atoms in polymethine bridge; thus Cy3, 
Cy5 and Cy7 can be used for the labeling. The higher is the number of carbon atom, the higher 
are the excitation and emission wavelengths. Cy3 exhibits both excitation and emission maxima 
in the region around 500 nm, Cy5 around 600 nm and Cy7 around 700 nm [23].  
 
Py-dyes 
New class of fluorescent labels, so-called “Py-dyes”, has been reported in 2004. They contain 
pyrylium group that react with aromatic groups. When the dye is attached to a protein molecule, 
the color changes from blue to red and fluorescence quantum yield increases up 50 %. The most 
important advantage of this dye is no change of the charge of a protein after conjugation [24]. 
The scheme of reaction between a protein and Py-dye is presented in Figure 3. 
 
 
Figure 3: Reaction scheme of protein and Py-dye (R stands for respective fluorogenic group). 
 
The role of fluorophores in DNA sequencing 
The development of new fluorescence dyes contributed a lot to the acceleration of the 
development of DNA sequencing together with the new instrumentation of capillary 
electrophoresis with the LIF detection. In DNA sequencing, the single stranded chain of a 
genomic DNA is a template for synthesis of a new complementary chain. The synthesis runs by 
the addition of nucleotides in the direction from 5´ to 3´ end. The reaction starts at a specific 
priming site and terminates with the incorporation of appropriate fluorescently labeled 
+ 
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dideoxynucleotide terminator that disables the addition of a following nucleotide. The reaction 
mixture does not contain only dideoxynucleotides, but also deoxynucleotides in the ratio 1:100. 
Thus, other complementary chains are synthesized normally and the terminating occurs 
randomly at different positions. As a result, the mixture of new complementary chains with 
different lengths is synthesized according to the position of the terminator. Nowadays, two dyes 
based on the core structure of fluorescein (FAM, JOE) and two based on rhodamine (ROX, 
TAMRA) dominated in the nucleotide labeling. All these four dyes can be excited at single 
wavelength of argon ion laser - 488 nm, but emit at distinctly different wavelengths. Emission 
maximum is 520 nm, 548 nm, 576 nm and 601 nm for FAM, JOE, TAMRA and ROX, 
respectively [25]. The labeled DNA chains of different sizes are finally separated by capillary 
electrophoresis and detected by four photomultiplier tubes with specific filters [26].  
 
1.1.1.3 Nanoparticles and their luminescence 
Nanoparticles are nowadays in the focus of attention, because they have extraordinary optical 
and electrical properties that differ a lot from the bulk material. Among the most popular 
luminescence nanoparticles belong silica or gold nanoparticles, nanodiamonds and 
semiconductor nanoparticles called quantum dots. Diamond nanoparticles are formed by 
explosive reaction from a carbon source in a closed container. Usually the mixture of 
trinitrotoluene and hexogene is used to make small particle size nanodiamonds under appropriate 
pressure, temperature and reaction time. They can be modified with various surface ligands 
containing carboxylic or hydoxylic groups, lactones or ketones. Despite the relative difficulty of 
preparation, nanodiamonds are highly chemically and photo-stable and exhibit bright 
luminescence around 700 nm. The luminescence originates from the point defects of the crystal 
lattice and thus is independent on the surface structures. Nanodiamonds can find its application 
as a polishing material for the surfaces or as a composite material. Because of their 
biocompatibility and nontoxic nature, their use in biological and medical imaging is promising 
[27-29].  
Gold nanoparticles exhibit relatively low quantum yields, but their luminescence is million times 
higher in comparison with the bulk gold material [30]. The native luminescence is applicable 
only when high excitation power is used. Gold nanolayers are widely used in other analytical 
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fields due to their surface plasmon resonance band with a broad absorption around 520 nm that 
originate from collective oscillation of their conduction electrons in response to optical 
excitation. Gold nanoparticles can be prepared by two methods: preparation of colloidal gold 
from a solvent usually by simple citrate reduction and lithographic methods, where gold 
nanoparticles are formed from the thin layer gold films deposited over the soluble porous 
material. The surface of gold nanoparticles can be modified by various functional groups, but the 
most popular are thiol groups. The covalent bond between gold and thiol is the strongest one in 
comparison with other functional groups. Due to the very low photobleaching and excellent 
biocompatibility, gold nanoparticles found their application in DNA hybridization detection, 
immunoassay or drug delivery [31-33].  
 
1.1.1.4 Quantum dots 
Semiconductor properties arise from the periodic arrangements of atoms in crystalline lattice. 
The spatial overlapping of the atomic orbitals leads to the formation of conduction and valence 
bands, where electron and hole states are separated by a forbidden band gap. This gap is placed 
between valence and conduction energy levels and it is related to energy of an electron necessary 
for its release from the valence to the conduction band. Band gap energy is a main factor 
determining the conductivity of solids. The band gap with high energy belongs to the insulators, 
band gap with medium energy corresponds to semiconductors and very low energy or no band 
gap refers to conductive materials [34]. The major consequence of the quantum confinement 
effect in semiconductor is that their properties are size dependent, although this variable occurs 
at the size lower than 10 nm. There are two major effects responsible for the size variation of the 
properties. At first, the number of surface atoms is a large fraction of the total number of atoms 
in nanocrystals and second, the properties of nanocrystals are altered by quantum size effect. As 
the particle size decreases, the band gap energy increases, which can be observed as a blue shift 
to lower wavelengths in luminescence spectra [35]. When only one dimension is in nm scale, the 
structure is called quantum well. When two dimensions are in nanometers, it is a quantum wire. 
The term quantum dot is used, when all three dimensions are in nanometer scale. Quantum dots 
(QDs) are semiconductor nanocrystals whose size is usually in range from 1 nm to 10 nm. They 
can be made from different semiconductor materials from the elements of II - VI groups of 
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periodical table like various sulphide, telluride, selenide or phosphide of cadmium, lead, zinc, 
indium or gallium. Modification in chemical composition ensure different optical characteristics 
and different ranges of emission wavelengths tunability as it is shown in Figure 4 [36]. 
 
 
Figure 4: Examples of various types of QDs scaled as a function of their emission wavelengths. 
 
The colloidal synthesis of nanocrystals involves two consecutive stages. At first the nucleus is 
formed from homogenous solution usually by hot-injection technique, where precursors are 
rapidly injected into a hot solvent. Secondly, the nanocrystals nucleus is growing to the desired 
size, when the reaction is terminated and the quantum dots are separated from the reaction 
mixture [34]. Different ligands can be attached to the QD surface. The choice of appropriate 
ligand depends on required functional group and type of solubility. For organic soluble 
nanoparticles TOP/TOPO (trioctylphosphine/trioctylphosphine oxide), TOPO alone, stearic or 
oleic acid are widely used. The preparation of water soluble QDs is not an easy task, but in 1993 
Nozik et al. published the preparation of CdTe QDs with 3-mercapto-1,2-propanediol as a ligand 
on the nanoparticle surface [37]. Many other ligands were attached to make QDs water soluble 
like mercaptopropionic (MPA) or thioglycolic acid (TGA), which are attached to the 
nanoparticle surface by thiol-group and their carboxylic group remains free for further 
conjugation, mercaptoethylamine, polyethylene glycol (PEG), dihydrolipoic acid (DHLA) or 
lipids with their hydrophobic tails bind to the particle surface [23, 38]. The passivation of QD 
surface with an inorganic shell of a semiconductor with a wider band gap like ZnS is another 
step to produce highly luminescence QDs. Another possibility is silica coating with tetraethyl 
orthosilicate (TEOS). Passivated nanocrystals exhibit also higher chemical and photostability 
infra-red visible spectrum ultra-violet
PbSe/Te 
PbS 
CdTe
CdSe/Te CdHgTe alloys
CdSe
ZnSe
CdS
ZnS
400 nm700 nm 550 nm
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together with the decreased cytotoxicity, which is a drawback of QDs application in biological 
imaging.  
The main advantages of QDs, as compared with traditional fluorophores, are their unique optical 
properties. Their excitation spectra have much broader range than spectra of organic dyes; on the 
other hand, emission spectra are narrow and symmetrical; do not display the long-wavelength tail 
common to low molecular mass fluorophores [15, 39]. The advantage of broad excitation spectra 
is the possibility to use almost any available excitation light source. This is quite favorable in cell 
or tissue imaging, because several target proteins or organelles stained by different colors can be 
visualized using just a single excitation light source. Another advantage is the use of much 
shorter excitation than the emission wavelength. Thus, the scattered excitation light can easily be 
filtered out of the signal. Maximum emission wavelength tunable by particle size is a very 
important property as well. The maximum emission wavelength increases with the nanoparticle 
size. The CdTe QDs with the diameter of 2 nm emit at blue, 4 nm particles emit at red [37]. The 
CdTe QDs can be prepared easily by using reaction between cadmium chloride and natrium 
hydrogen telluride in the presence of 3-mercaptopropionic acid (MPA) with the molar ratio 
CdCl2 : NaHTe : HS - CH2 - CH2 - COOH = 2 : 1 : 4.8 according to procedure described by Li et 
al. [40]. The scheme of single CdTe QD with all the dimensions is shown in Figure 5. 
 
 
Figure 5: Scheme of CdTe quantum dot with face centered cubic crystal lattice in detail. 
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QDs display much longer luminescence lifetime than traditional fluorophores. The lifetimes of 
organic dyes are typically 1 – 10 ns and for QDs the lifetime increases up to 100 ns [39]. The 
longer luminescent lifetime ensures their use in time-resolved fluorescence as a detection 
method. Here, the emission is registered at a time, when excitation light source is already off and 
its light does not overlap the fluorescence emission [15, 41]. Good chemical stability and 
photostability is another advantage of using QDs in various applications, especially in 
fluorescence imaging microscopy. It was reported that QDs remain stable for at least 4 h, while 
the organic dyes bleach faster (from 20 s to 10 min) [41, 42]. Semiconductor nanoparticles have 
tendency to blink and the on/off switching can be observed from 1 ms to 1 s, which is relatively 
long and can cause problems in cell imaging or in flow cytometry. It is not such a problem for 
bulk measurements, because camera acquisition time could be longer than QD off time [23, 43]. 
QDs can exhibit cytotoxicity due to the toxic nature of their metallic composition. Under 
exposition to excitation light, they can release metal atoms like Cd or Te, generate free radicals 
that affected cell growth and viability or precipitate on the cell surface that also cause cell 
damage. To reduce this problem, QD surface can be passivated by the layer of non toxic 
material, for example ZnS or Si [23, 42, 44]. CdTe quantum dots of different sizes dissolved in 
water under UV light are depicted in Figure 6. 
 
 
Figure 6: CdTe quantum dots of different sizes under UV light. 
 
The sizes, size distributions and structures of nanoparticles and their bioconjugates have been 
characterized by various methods: transmission electron microscopy (TEM) [37, 45], atomic 
force microscopy [46], analytical ultracentrifugation [47],  X-ray photoelectron spectroscopy, X-
ray powder diffraction [37, 47] and dynamic light-scattering [48] or fluorescence correlation 
spectroscopy [40]. The electrophoretic methods, both in slab gel (SGE) or capillary (CE) format 
27 
 
have also been used for the analyses of nanocrystals and their functional coatings. Agarose SGE 
or SDS-PAGE are routinely used for the check of conjugation product [49, 50]. Capillary 
electrophoresis with laser-induced fluorescence detection (CE-LIF) has been used for the 
characterization of the surface modifications of QDs and evaluation of the particle charge [51-
53].  
 
Quantum dots find employment in a wide range of applications in electronics like in LEDs 
(Light Emitting Devices), photovoltaic cells, optical amplifier media for telecommunication 
networks or photonic crystals [34]. Bioconjugates based on QDs are also frequently applied as 
efficient fluorescence resonance energy transfer donors [36, 43, 54], pathogen like Escherichia 
coli or Salmonella Typhi detection, toxin detection, where cholera or Shigela-like toxin 1 were 
detected [42], gene localization within chromosomes [55] or specific labeling and identification 
of targeted DNA sequences [56]. QDs were used for imaging of proteins like F-actin fibres or 
mortalin that is important in tumor cells or to visualize and track movements of glycine receptors 
or GABA receptors [42]. Cell compartments of either live or fixed were labeled with QDs as 
mitochondria or nucleus [36]. QDs bioconjugates were used in single-molecule/cell tracking [57, 
58] and deep-tissue imaging [43, 59]. They are also widely applied in study of tumor and 
monitoring cancer cells during metastasis. In vivo studies in diseased mice showed that QD 
linked with specific antibodies were accumulated at the tumor sites [60]. Not only microscopy as 
a detection method used for the most of the previously mentioned assays, but also CE-LIF was 
used in QD based immunoassays. It was demonstrated that pH optimization of background 
electrolyte has significant effect on the separation of QD conjugate with antibody and 
immunocomplex [61, 62]. 
 
1.1.1.5 Determination of surface charge of quantum dots 
Since semiconductor nanoparticles can carry positive or negative charge due to the presence of 
ligands on the surface, electrophoretic methods play an important role in their characterization. 
Although they are primarily separation methods, they can be used for fractionation according to 
the different size or ζ-potential of nanoparticle. The theory reviewed by Pyell shows, that the 
determination of nanoparticle charge is not an easy task. Not only the charge of functional group 
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on the QD surface, but also a formation of a diffuse cloud on counterions compensating the 
charge of the particle have to be taken into account [63]. The ion cloud increases the solid 
nanoparticle radius by the distance that is in the same order of magnitude as solid radius. This 
layer is called the plane of shear and its electric potential is defined as a ζ-potential. The 
ζ-potential can be significantly lower than the surface potential because of counterion 
condensation. In the presence of external electric field during electrophoretic separation, the ion 
cloud is not symmetric due to the movement of the nanoparticle itself. The particle radius 
together with thickness of the double layer has to be taken into account. The electrophoretic 
mobility is than defined as: 
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where εr is relative permittivity of electrolyte, εo electric permittivity of vacuum, η dynamic 
viscosity and f (κa) is Henry´s function determined from κ (thickness of the double layer) and a 
(particle diameter) [63]. Thus, from experimental value of electrophoretic mobility, ζ-potential 
can be calculated. The value of ζ-potential is determinant for the calculation of charge number on 
QD surface according to the equation described elsewhere [64]. Additionally, when calculating a 
charge number, other parameters had to be taken into account like amount of ligands on the 
particles, pH and ionic strength of electrolytes, degree of dissociation, surface charge density as a 
function of pH and a maximum charge density [64].  
 
1.1.2 Conjugation of antibody and fluorescent labels  
1.1.2.1 Structure of antibody molecule 
The basic immunoglobulin molecule (IgG) is composed of two light and two heavy chains that 
make “Y”- shaped structure and are held together by non-covalent interactions and disulfide 
bonds. Light chain contains one constant domain and one variable domain, while heavy chain 
contains three constant and one variable domain. Each domain is composed of approximately 
110 amino acids and is stabilized by disulphide bond. Two parts of both heavy chains are 
connected to each other in hinge region. This region is very important in antibody function, 
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because here the molecule can rotate and open its structure and thus adapt its spherical 
arrangement for linkage with antigen. The constant domains of antibody heavy chains are 
glycosylated. The level and type of glycosylation brings a considerable variability to the IgG 
molecules. The carbohydrates bound to the heavy chains could be used as a place for conjugation 
with other compounds by their oxidation to aldehydes and subsequent linkage with hydrazide-
containing molecule.  The molecular mass of whole IgG molecule is approximately 150 000 Da, 
each heavy chain has molecular mass approximately 50 000 Da and light chain approximately 
25 000 Da [20, 65]. The estimated molecular dimensions of an antibody is 15 × 7 × 3.5 nm, 
although the protein could be very flexible [66]. There are two antigen binding sites (paratopes) 
on each antibody in the variable domains of both heavy and light chains. The specificity of the 
antigen binding site does not strictly depend on linear amino acid sequence but also on unique 
orientation in three-dimensional space in this region. The part of antigen molecule that is 
recognized by antibody is called epitope. Epitope interacts with antigen binding site due to the 
structural compatibility and combination of hydrogen bonds, electrostatic interactions, van der 
Waals interactions and hydrophobic binding forces. These weak binding interactions have effect 
to very short distances. The system of antibody - antigen interaction is very flexible, because 
weak interactions easily arise and wear off [20, 65].  The scheme of an antibody molecule 
structure is shown in Figure 7.  
 
Figure 7: IgG structure. 
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To reduce the antibody size and variability its molecule could be cleave by various compounds. 
Dithiotreitol (DTT) or 2-mercaptoethylamine (MEA) can be used for reduction of disulphide 
bonds between the heavy chains of antibody molecule. Appropriate concentration of DTT or 
MEA ensure the separation of molecule into two equal parts each containing one antigen binding 
site, while higher concentration of DTT with the presence of detergents reduce all disulphide 
bonds and cleave the molecule completely. When two equal parts, each containing one antigen 
binding site, are formed, they can be used for the conjugation with sulfhydryl-reactive 
cross-linking reagents, because a thiol functional group remain preserved in hinge region [20]. 
IgG molecule can be also digested by enzymes. Enzyme papain cleaves the molecule under the 
disulphide bonds and thus two Fab fragments (Fragment antigen binding) are formed together 
with one Fc fragment (Fragment crystalizable). On the other hand, enzyme pepsin cleaves the 
molecule below the disulphide bonds and one large F(ab)´ fragment containing both antigen 
binding sites and is formed. Fc fragment is digested in this procedure into several subunits [20, 
65]. The scheme of antibody molecule enzymatic digestion is presented in Figure 8.  
 
 
 Figure 8: Antibody molecule digestion with different enzymes. 
 
Fab fragments
Fc fragment
F(ab)' fragment
Digested
Fc fragment
31 
 
1.1.2.2 Conjugation techniques between antibodies and fluorophores 
Various methods of conjugation between antibody molecule and fluorophores were developed 
according to the type of fluorophore used for the reaction. In the case of quantum dots, the 
choice of conjugation technique depends on the type of ligand bound to the QD surface and on 
the type of functional group that remains free for further reactions. In this work, QDs with 
mercaptopropionic acid as a ligand with free carboxylic group were used for conjugation with 
antibody. The following sections describe the principles of selected conjugation reactions.  
 
1.1.2.3 Conjugation using zero-length cross linkers 
One of the simplest reagent systems for bioconjugation take advantage of compounds called 
zero-length cross-linkers. These compounds form a covalent bond between two functional 
groups without any intervening linker. Probably the most popular types of zero-length cross-
linkers are carbodiimides, which form peptide bond between carboxylic group and amine group. 
The reaction was preferentially developed for conjugation between two proteins, protein and 
peptide or two peptides, when this technique is applied to conjugation of protein and small 
molecule, further optimization is needed. 
 
EDC/sulfo-NHS system 
Carbodiimide molecule that is widely used for biological application is 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC). Water soluble EDC can be used for 
the reaction directly, but due to the instability of EDC in water, N-Hydroxysulfosuccinimide 
(sulfo-NHS) addition is used to stabilize the active intermediate formed during the reaction. The 
linker EDC reacts with carboxylic group containing molecule to form active ester O-acylisourea. 
After sulfo-NHS is added, another intermediate with higher stability is formed. Then, second 
molecule intended for conjugation containing amine group should be added and peptide bond 
between both molecules of interest is formed. The high stability of sulfo-NHS ester intermediate 
allows the later addition of molecules containing amino group and thus greater control over the 
conjugation [12, 20, 51]. The described conjugation scheme is depicted in Figure 9.  
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Figure 9: Scheme of conjugation between antibody and QD using zero-length cross-linkers 
EDC/sulfo-NHS. 
 
The presence of both amine and carboxylic groups in the molecules can cause a self-conjugation 
between the molecules of the same type. This can especially occur in protein and peptide 
molecules. Also some side reaction can decrease the reaction yield like EDC reaction with 
sulfhydryl groups or tyrosine residues [20]. This method has been successfully used for 
conjugations between quantum dot and specific antibodies [67, 68]. 
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Conjugation using CDI 
Another reactive agent, that is more specific than EDC, is N, N´-carbonyldiimidazol (CDI). CDI, 
in contrast to EDC, reacts just with carboxyl or hydroxyl groups and it links them to the amine 
group to form peptide bond [20, 69]. The conjugation scheme of QD with free carboxylic group 
and antibody containing primary amine group is depicted in Figure 10. CDI is more stable in 
water than EDC, and thus used widely for biological conjugation as well [57, 70]. 
 
 
Figure 10: Scheme of conjugation between antibody and QD using zero-length cross-linker CDI. 
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1.1.2.4 Conjugation via oxidized glycans 
The disadvantage of previously described method of conjugation via zero-length cross-linkers is 
the danger of peptide bond formation directly at the antigen binding site of antibody molecule. 
The antibody inactivation can be caused not only by a direct occupation of the paratope, but also 
by the conformational changes of antigen binding site induced by a linkage of other molecules 
close to this site. To ensure that the paratope remain active a site-directed chemical reaction may 
be used. One of these methods take advantage of the carbohydrates attached to the heavy chain 
on Fc fragment of antibody far from the antigen binding site. Antibodies of polyclonal origin are 
usually glycosylated, but other preparation methods may not provide the glycosylation. Antibody 
containing polysaccharides residues is gently oxidized using NaIO4 to form aldehyde groups, 
while QD with free carboxylic groups is modified by adipic acid dihydrazide in the presence of 
EDC to form a stable imide bond with free terminal hydrazide groups. Aldehyde containing 
molecules react spontaneously with hydrazide groups and form hydrazone linkages [20, 71, 72]. 
The scheme of conjugation via oxidized saccharides in depicted in Figure 11. 
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Figure 11: Scheme of conjugation between oxidized antibody and modified QD. 
 
1.1.3 Capillary electrophoresis immunoassay 
CE-LIF has been used for the characterization of immunocomplex labeled with quantum dots 
several times [61, 62, 73]. CE-LIF provides high selectivity, short analysis time, high separation 
efficiency, reduces sample and reagent requirements and low detection limits [61].  
Capillary electrophoresis immunoassay (CEIA) can be performed in non-competitive or 
competitive form. Non-competitive CEIA is based on the separation of antibody - antigen 
(Ab-Ag) complexes from free Ab or Ag. One of these reactants is labeled and the excess of this 
labeled reactant is added into the system. Then the immunocomplex and unreacted analyte can 
be registered as a luminescence signal. 
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Ab*(excess) + Ag  →  Ag-Ab* + Ab*(excess) 
 
In competitive CEIA a labeled reagent (Ag*) competes with the unlabeled one (Ag) to form 
complex with a limited amount of Ab.  
 
Ag + Ag* + Ab (limited)  →  Ab-Ag + Ab-Ag* + Ag + Ag* 
 
After the separation, there will be two different peaks corresponding to the free Ag* and Ab-Ag* 
complex, which determine the desired quantity of Ag [10]. 
 
1.1.4 Microscopy in cell imaging 
Fluorescence microscopy is used in biological sciences in different modes. Most fluorescence 
microscopes in use are epifluorescence microscopes, i.e., excitation and excitation light is 
focused and collected by the same objective, respectively Fluorescence imaging can reveal the 
localization of intracellular molecules sometimes at the level of single-molecule detection [15]. 
Various fluorophores together with QDs can be used for cell, cell organelles or biomolecules 
visualization [15, 39]. In the epifluorescence mode, the excitation light passes from above 
through the objective and then on the sample. The fluorescence of the sample is focused to the 
detector or eyepieces by the same objective that is used for the excitation. There are usually two 
filters in this setting; an emission filter between the objective and the detector and excitation 
filter between light source and objective. The scheme of this type of microscope is depicted in 
Figure 12. 
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Figure 12:  The scheme of epifluorescence microscope. 
 
More advanced microscope design is based on the total internal reflection fluorescence (TIRF), 
which can visualize a thin region of a sample, usually less than 200 nm. Total internal reflection 
mode takes advantage of an evanescent wave for the sample excitation. The evanescent wave is 
generated only when the light is totally reflected at the interface between a high-refractive index 
of the prism and a low-refractive index sample. The main advantage of the evanescent wave 
based techniques is associated with the preferable excitation of surface objects. This leads to a 
significant reduction of the background noise resulting from the emission of molecules which are 
not attached to the surface [74]. TIRF microscopy provides also a less bleaching and light stress 
for living cells in addition to the high contrast. 
In Figure 13, there is a scheme of two types of TIRF microscope, the red line shows the 
excitation beam that corresponds to the so-called prism-type TIRF, where the evanescent wave is 
generated at the slide/sample interface and the image is collected by the objective at the bottom 
[36]. The the green line corresponds to excitation beam of the objective-type TIRF, where the 
sample can be illuminated through the modern type of objectives with high numerical aperture. 
The emitted fluorescence is then collected by the same objective [75].  
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Figure 13: The scheme of TIRF microscope; the red line shows the evanescence wave 
generation in prism-type microscope and green line shows the same situation in objective-type 
microscope. 
 
1.2 Comprehensive proteomics 
 
Proteomics deals with the systematic analysis of proteins, their identification and determination 
of their amounts and functions. The aim of proteomics is the characterization and explanation of 
the protein role in organisms, protein interactions with other compounds and the qualitative and 
quantitative changes during biological processes [76]. The proteome refers to the full number of 
proteins encoded by the genome, but the further functions of individual proteins are strongly 
influenced by post-translational modifications and interaction with other proteins, DNA, RNA or 
small-molecule metabolites. Proteome is constantly modified as a response to environmental 
changes and drug treatment together with growth or disease processes [77]. The comparison of 
proteomes from the two or more specimens of the same organism that have grown under various 
conditions together with the searching and identifying of different expressed proteins is the aim 
of the comprehensive proteomics.  
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Proteomics can find its applications in various fields like medicine, where the disease causes and 
biomarkers are searched; pharmacy, where new drugs are sought; food industry; agriculture, 
where new more resistant species are cultivated or in the environmental protection. 
Environmental proteomics is a relatively new field that studies the responses of organisms to the 
changes in the environment. Nowadays, many chemicals are released to the environment by 
traffic, industry or agriculture. These compounds themselves or their mixtures are accumulated 
in aquatic environment, soils and biota that include not only microorganisms, but also plants and 
higher animals. The study of organisms´ proteomes allows the detection of changes of proteins 
amounts and functions, and thus can lead to a discovery of biomarkers of toxicity [78]. 
Environmental proteomics is presently focused on the bacterial physiology, metabolism and 
ecology. Bacteria are able to provide many degradation reactions like dehalogenation, 
methanogenesis, denitrification or sulfate reduction, where proteomics helps to find the specific 
metabolic pathways behind these cellular processes. This new proteomic topic that cover both 
the studies in laboratory or in the natural environmenl is still limited by the low number of 
microorganisms presented in the sequence databases and high genetic variability of organisms 
participated in the process of degradation of chemicals in the environment [79].  
The complexity and wide dynamic range of protein content in cells, tissues or body fluids 
stimulated an intensive development of highly resolved separation methods together with mass 
spectrometry, which is the most frequently used technique in protein identification. As an 
example, human serum contains up to 20 000 proteins with a concentration dynamic range of ten 
orders of magnitude [80]. Comprehensive protein analysis involves both the most abundant 
proteins like albumin or immunoglobulins that cover up to 90 % of human serum [81] and low 
abundance proteins, e.g., biomarkers or regulatory proteins, that are nowadays in the focus of 
attention. The scheme of dynamic range of human plasma proteins is depicted in Figure 14 [82]. 
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Figure 14: Dynamic range of human plasma proteins. 
 
1.2.1 An overview of methods for proteome analysis  
There are two main analytical strategies in comprehensive proteomics, “bottom-up” and “top-
down” approaches. 
 
„Bottom-up“ strategy 
 
In “bottom-up” proteomics, protein is isolated from the mixture; afterwards it is enzymaticly 
cleaved into peptides, which are characterized by mass spectrometry (MS). A protein can be 
identified by mass measurements of a set of peptides (peptide mass fingerprinting - PMF) [83]. 
In PMF, the protein is identified by matching its constituent peptide masses to the theoretical 
peptide masses generated from a protein or DNA database. The premise of PMF is that every 
unique protein will have a unique set of peptides, and hence unique peptide masses. Other 
possibility of protein identification is through MS fragmentation of one or more selected 
peptides. In MS fragmentation the peptide ion is isolated in the mass analyser and subjected to 
fragmentation to produce product ions and neutral fragments. The types of fragment ions depend 
on peptide primary sequence and the amount of internal energy. The nomenclature for fragment 
ions was first proposed by Roepstorff in 1984 [84]. Fragments will only be detected, if they carry 
at least one charge. If this charge is retained on the N terminal fragment, the ion is classed as 
either a, b or c. If the charge is retained on the C terminal, the ion type is either x, y or z. A 
subscript indicates the number of residues in the fragment. The scheme of peptide bond 
fragmentation is depicted in Figure 15. In low energy CID (collision induced dissociation in a 
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triple quadrupole or an ion trap) predominantly a, b and y ions are generated [85]. To indentify a 
protein, the results from MS/MS spectra are compared with the databases as well.  
 
 
Figure 15: The scheme of ion fragmentation of peptide backbone. 
 
An alternative approach to the “bottom-up” strategy is the “shotgun” method first reported by 
Yates et al. Here, the complete protein mixture from an organism is enzymaticly cleaved into 
peptides without a prior separation, separated and analysed by MS/MS fragmentation [86]. 
 
 „Top-down“ strategy 
 
In „top-down” approach the protein is analysed by MS fragmentation without prior enzymatic 
digestion. The main advantage of this approach is the potential access to the complete protein 
sequence. Also the possibility to locate and characterize posttranslational modifications is 
favorable. Using the “top-down” proteomics, a time-consuming protein digestion is eliminated as 
well. On the other hand several limitations occur with this approach. The requirements to the 
resolution of mass spectrometry are much higher and the mechanism of protein dissociation 
behavior is less understood than those of peptide dissociation. Fourier transform ion cyclotron 
resonance mass spectrometr (FT-ICR-MS) with very high resolution around 106 is used for this 
type of analyses. Additionally the bioinformatics’ tools for “top-down” approach is not well 
elaborated as for “bottom-up” approach [87, 88]. 
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1.2.1.1 Sample preparation 
Various techniques have been developed to simplify and clean the complex mixture of clinical 
samples. Interfering compounds like lipids, polysaccharides, nucleic acids or salts should be 
removed in the first step. Most of these substances are eliminated by protein precipitation or 
other techniques specific for each compound like dialysis for salt removal or extraction with 
organic solvent for lipid separation [89]. Then, high abundant proteins should be removed to 
decrease the concentration dynamic range [81]. Various non-specific methods are used for the 
high abundant protein elimination like organic solvent extraction [90], centrifugal ultrafiltration 
[91, 92] or solid phase extraction based on ion exchange [93-95] or dye-ligands columns [81, 96, 
97]. Among the most selective methods belongs affinity chromatography [98, 99] for specific 
protein type or removal of immunoglobulins G (IgG) by Protein A or Protein G, that are 
specifically bind to the Fc region of IgG [95, 100]. The most selective techniques for protein 
elimination are immunoaffinity methods, where monoclonal or polyclonal antibody is bound to 
the column. These techniques have been successfully used to reduce the number of high 
abundant proteins in human serum [101-103]. 
Another technology called Protein Equalizer takes advantage of different mechanism of high 
abundant protein removal and low abundant proteins enrichment at the same time. The solid-
phase beads are covered with hexapeptides with various amino acid sequences. These ligands are 
able to interact with complementary sequences in proteins structure. Due to the fact that all 
proteins are captured with the same probability, the amount of high abundant proteins is reduced 
and the quantity of low abundant proteins is enlarged [104]. All the techniques mentioned above 
serve to reduce the number of contaminants and/or sample complexity elimination. This leads to 
a better resolution of selected analytical methods, higher sensitivity and better accuracy in 
quantification.  
 
1.2.1.2 Multidimensional separation techniques used in proteomics studies 
In “bottom-up” approach, proteins are digested to peptides and their consecutive successful 
separation ensures the protein identification. Many techniques for effective peptide separation 
have been developed during the past years. Methods based mainly on different modes and 
different combinations of HPLC techniques (ion exchange, size-exclusion or reversed phase 
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chromatography) together with various CE modes (capillary zone, isoelectric focusing or 
isotachophoresis) has been applied for multidimensional separation. The combination of strong 
cation exchange chromatography (SCX) in the first dimension and reversed phase 
chromatography in the second dimension is the dominant procedure for the separation of protein 
digests. The technology of SCX and RP stationary phases packed in one column subsequently 
has been used in on-line multidimensional protein identification technology [105-107]. Other 
methods are combinations of size exclusion chromatography (SEC) [108], hydrophilic 
interaction liquid chromatography (HILIC) [109], affinity chromatography [110], metal affinity 
chromatography [111] or isoelectric focusing (IEF) [112] with RP-LC. Combinations of capillary 
electrophoresis (CE) and liquid chromatography [113, 114] or isoelectric focusing (IEF) [115, 
116] have been used for peptide separation as well. Within the past years, also some three 
dimensional approaches has been introduced, like combination of affinity 
chromatography/SCX/RP-LC [117, 118] or SEC/RP/RP-LC [119].  
Nevertheless, the most common process for proteins identification today involve extraction of 
proteins from the sample, protein separation by two-dimensional gel electrophoresis (2D 
electrophoresis that combines isoelectric focusing in first dimension and sodium dodecyl 
sulphate polyacrylamide gel electrophoresis in the second dimension), analysis of protein spot 
patterns on the gel and the enzyme digestion of each protein of interest. Although 2D 
electrophoresis is a very popular technique due to the ability to separate thousands of proteins 
[120], it has its limitations like worse detection limits of low-abundant proteins, problems with 
analyses of insoluble membrane proteins and generally incompatibility with an on-line 
arrangement [121, 122]. After the proteins are digested to peptides, the samples are separated by 
high performance liquid chromatography (HPLC) coupled to mass spectrometry. Soft ionization 
methods that have been developed for protein analysis, matrix-assisted laser 
desorption/ionization or electrospray mass spectrometry, are usually combined with mass 
analysers like time of flight or ion trap. 
 
HPLC in the process of protein identification 
The most commonly used HPLC mode is reversed-phase liquid chromatography (RP-LC), where 
peptides are separated on the basis of their different hydrophobicity. To increase the separation 
efficiency and sensitivity, separation columns of smaller inner diameter (ID) are used. With 
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decreasing the column diameter also the volumetric flow rates have to be reduced. Lower flow 
rates require a new instrumental design and new approaches to the flow delivery [121, 123, 124]. 
Not only inner diameter of the column, but also particle diameter of the packing was decreased 
to achieve a better resolution. New types of columns for HPLC are nowadays in progress, like 
monolithic columns and open tubular columns. Monolithic columns consist of a single porous 
piece of stationary phase instead of a cluster of individual packed particles. These columns can 
be divided into two groups according to the type of a stationary phase: the organic monoliths 
(polystyrene-divinylbenzene or polymethacrylate) and the inorganic (silica based) monoliths. 
Monolithic columns are characterized by a high permeability, low mass transfer resistance and 
high sensitivity. Because of their low back pressure they can be used in longer column settings. 
Open tubular columns have a stationary phase only on the inner wall of the capillary. It allows 
unrestricted path for the mobile phase, and thus very low backpressure. Open tubular columns 
have usually very small diameter (10 µm) and their length is generally around 4 m [123, 124]. 
Limits of detection (LOD) of peptides for both of these capillary columns have reached attomole 
levels [125, 126].  
 
1.2.2 Capillary electrophoresis and mass spectrometry  
Although the resolution up to 106 is attained in advanced MS instruments, the separation of 
proteins or peptides before MS is unavoidable, if complex samples are analysed. Otherwise the 
loss of sensitivity due to the ion suppression effects would significantly reduce the number of 
identifiable proteins. Capillary electrophoresis with mass detection (CE-MS) offers several 
advantages, like a fast separation, low sample and solvent consumption, high separation 
efficiency or different separation mechanism than LC [127]. On-line connection of CE and MS is 
implemented through electrospray ionization (ESI) that allows direct transfer of the analytes 
from CE to MS and provides a relatively easy way to close the electrical circuit that is necessary 
for CE operation. Although the selection of electrolyte system compatible with MS is highly 
limited, CE-MS has been successfully used in protein identification process [127-130]. The limit 
of detection of CE-MS usually reach nanomole or femtomole concentration level, but even 
attomole concentration had been achieved [131], that is comparable to LC-MS sensitivity.  
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1.2.2.1 Principles of capillary electrophoresis 
Electrophoresis is a separation method based on the migration of ions in electric field. It can take 
place in various carriers like gel, paper or in free solution that was first demonstrated by Hjertén 
[132]. He introduced the separation in quartz capillaries with inner diameter of 1 - 3 mm placed 
in rotating tube that stabilized the separated zones. Nowadays, capillaries with inner diameter of 
tens of µm are usually used for separations. The separation in such narrow capillaries provides 
lower sample consumption and higher efficiency caused by better Joule heat removal when a 
high voltage (up to 30 kV) is applied. Two forces have an effect on the migration of an ion 
through a viscous continuum in the electric field, the electric force F1 that moves the ion towards 
the electrode and the friction force of the medium, F2, that retards the ion movement. Both forces 
can be expressed as follows 
 
#$ = % ∙ & 
#' = ( ∙ ), 
 
where Q is the ion charge, E  intensity of the electric field, k friction coefficient and v is the 
velocity of the ion. When both electric and friction forces are balanced, the ion moves with 
constant steady state velocity: 
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where the friction coefficient k depends on the particle shape, size and on the media viscosity; 
for spherical particles is given by 
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where r is the particle radius and η is the medium viscosity. Thus the electrophoretic mobility of 
the ion can be expressed as: 
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The electrophoretic mobility of an ion in m2/(V·s) represents the speed of the ion in electric field 
of the intensity of 1 V/m. The value of the ionic electrophoretic mobility is characteristic for 
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each compound and can be found in the literature. In reality, the migration of an ionic compound 
in a given pH and background electrolyte (BGE) is controlled by the effective electrophoretic 
mobility, which takes into account various neutral and charged states of a specie. Electrophoresis 
is accompanied by different phenomena that influence the quality of separation, like Joule 
heating, interaction with capillary walls, diffusion and electroosmosis. Electroosmotic flow 
(EOF) is the flow of a solution of electrolytes due to the applied potential gradient, because of 
the electric double layer at the capillary inner wall. In silica capillaries, the surface of the inner 
wall is formed by silanol groups that are dissociated in medium with pH higher than pK. The pK 
of silanol groups is approximately 2 [133]. The silanol groups are dissociated as following: 
 
Si – O – H  ↔  Si – O
-
 + H+  
 
The negative charges on the capillary surface represent one part of the electric double layer; the 
second part is represented by the positive ions in the aqueous solution that are attracted to the 
negative capillary surface. The part of the electric double layer that is always fixed to the 
negative inner wall is called Stern layer. The rest of the cations form the mobile diffuse layer. 
The plane of shear is the plane behind which the ions in the liquid become mobile, and thus, in 
the electric field, they move. The electric potential of the double layer at this plane is called 
ζ-potential. For the practical reasons, the plane of shear is sometimes assumed to be identical 
with Stern layer [134]. The electrical double layer is formed not only at fused silica capillary 
wall, but also on the surface of charged colloidal particles, where a diffuse cloud compensating 
the charge of the particle is formed. Figure 16 shows the structure of electric double layer on the 
inner wall of silica capillary. 
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Figure 16: Scheme of the structure of electric double layer on the inner capillary wall. 
ζ1, ζ2- potentials correspond to the solvents with lower and higher ionic strengths, respectively.  
 
Electroosmotic flow mobility strongly depends on the pH of background electrolyte, because 
ζ-potential increases with the higher amount of dissociated silanol groups. In pH < 4, EOF is not 
significant, while in pH > 9, the EOF velocity is high, because the silanol groups are fully 
dissociated. The EOF velocity decreases with increasing ionic strength of BGE, because ζ-
potential is decreasing. The mobility of EOF can be expressed as: 
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where ε is the permittivity of BGE, ζ is ζ-potential and η is viscosity. When electroosmotic flow 
velocity is high enough, it carries to the detector not only cations, but also neutral compounds 
and anions. The EOF creates a piston-like profile that does not disperse the separated zones. The 
piston shape of the flow velocity profile can be disturbed by the molecules or particles absorbed 
on the capillary wall. Then the local ζ-potential is not constantalong the capillary and the local 
turbulences can occurr. The electroosmotic flow can be suppressed by capillary inner coatings 
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that neutralize the surface silanol groups like poly(vinyl alcohol) (PVA), poly(ethylene glycol) 
(PEG), poly(ethylene oxide) (PEO) or celluloseacetate (CA). Additionally EOF direction can be 
reversed by cationic surfactants like cetyltrimethylammonium bromide (CTAB), polybrene (PB) 
or poly(dimethyldiallylammonium chloride) (PDMAC) [133].  
Another phenomenon accompanying capillary electrophoresis is extensive production of Joule 
heating when high voltage is applied. The electrolyte overheating inside the capillary can cause 
bubble formation and collapse of the analysis. Thus, a concentration of background electrolyte, 
length and diameter of the separation capillary and applied voltage has to be taken into account 
in order to reduce the Joule heating [133].  
 
Nowadays, there are several simulation programs on the market that are widely used for the 
optimization of separation conditions in capillary electrophoresis, isotachophoresis or isoelectric 
focusing. Two of them has been introduced by Gaš et al., PeakMaster [135] and Simul 5 [136]. 
PeakMaster is a fast and simple software based on the acid-base equations and continuity 
equations that are necessary for description of the separation process in electrophoresis. These 
equations are nonlinear and thus can be solved preferably numerically than analytically. 
PeakMaster software takes advantage of the fact that the concentration of the injected sample is 
much smaller than the concentration of the background electrolyte, and thus the system does not 
change significantly only a little after sample injection. The system is thus considered to be 
linear what is reflected by the time required for the simulation. On the other hand, Simul 5 is 
more complex program that can be used for inspection of analytes behavior during separation, 
formation of system peaks, stacking of analytes etc. The model calculates the effect of ionic 
strengths of BGE and ionic activities of electrolytes on separation, and thus gives a complete 
view to dynamics of diffusion and electromigration. Thormann et al. compared Simul 5 with 
other computer simulation programs SPRESSO (Stanford Public Release Electrophoretic 
Separation Solver) [137] and GENTRANS [138] on the simulation of migrating boundaries, 
isotachophoretic boundary and the capillary electrophoresis separation of ten anions [139]. 
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1.2.2.2 Electrospray and nanoelectrospray ionization 
Electrospray ionization is provided by applying a strong electric field to a liquid that is passing 
through a capillary tube. The liquid containing analyte is charged on the surface and create the 
Taylor cone from which the small charge droplets are emited. These droplets are then reduced by 
a series of Coulombic explosions until the electric field on their surface does not reach a certain 
level, when desorption of ions occurs. The liquid flow in ESI can reach even hundreds of µl/min 
[140]. The advantage of nanoelectrospray is the low liquid flow rate in tens of nl/min from a 
narrow capillary. Such a low flow affects the mechanism of ion formation. The charged droplets 
formed from a Taylor cone are smaller and the ion release occurs sooner than in the conventional 
ESI. This results in higher sensitivity, because the surface charge per molecule is higher in such a 
small droplets. Improved release effect also enables the ionization without using of additional 
nebulization gas. The ion suppression by salts or buffer molecules is also significantly eliminated 
with nanoelectrospray ionization in comparison with traditional ESI [141, 142]. 
 
1.2.2.3 CE-MS hyphenation 
In spite of CE-MS advantages, two problems have to be solved to successfully establish coupling 
of these two techniques. Firstly, it is necessary to keep the liquid flow coming from the capillary 
at optimum values for the stable spray formation (tens of nl/min). Secondly, high volatility of the 
compounds in background electrolyte is required to achieve good ionization. To solve these 
problems, some different CE-ESI-MS interfaces have been developed [61, 143].  
 
Sheath flow interface 
Sheath flow interface was firstly reported by Smith in 1988 and it is the most commonly used 
interfacing until now and the only one commercially available until last year [144]. It consists of 
three coaxial tubes that feed the analytes, the nebulization gas and the sheath liquid. The sheath 
liquid, that consist of certain amount of organic phase, has two different functions. It plays the 
role as an additional liquid to improve spray and it closes the electric circuit at the outlet of the 
capillary acting as a second electrode. The sheath liquid flow also significantly dilutes the 
analytes before they enter the MS orifice. The dilution differs according to the flow from 
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separation capillary and flow of sheath liquid and can dissolve the analytes up to 300 times 
[145].  
 
Sheathless interface 
In sheathless interface, no additional liquid is required. The end of the separation capillary itself 
serves as a spray tip. The electrical contact is ensured via either metal coating of capillary outer 
tip – with gold [146], silver [147], graphite [148, 149] or via a wire serving as an electrode 
inserted to the capillary [150, 151]. The sheathless interface provides high sensitivity up to low 
femtomole [152] or attomole level [153], but can cause spray instability or turbulences of 
electrolyte around the wire [154]. 
 
Liquid junction interface 
Another possible type of CE-MS hyphenation is the liquid junction interface. It is based on the 
use of an additional liquid reservoir that provides the electrical connection. Different types of 
this interface was developed in recent years like junction-at-the-tip interface [155], interface, 
where separation and spray capillaries are connected via Tee connection [156], interface using 
subatmospheric chamber [157], two part low-flow interface that is able to reduce the ion 
suppression of commonly used electrolytes like borate or phosphate buffer [158, 159] or 
interface with glass electrospray emitter, where LOD in attomole levels has been reached [160]. 
In our laboratory, the pressurized nanoelectrospray liquid junction interface, which was 
successfully used for peptide separation, was constructed [161]. It was demonstrated that this 
interface does not significantly dilute the analytes under optimum conditions [162]. This type of 
interface provides an independent control of both the CE separation and electrospray [143, 154]. 
 
Recently, the Beckmann Coulter company introduced the CESI 8000TM sprayer that is based on 
the design first published by Moini in 2007 [163]. The electrical contact is ensured via a porous 
tip at the capillary outlet. The porous part is created by removing the capillary coating and 
etching the silica surface by hydrofluoric acid. The capillary with a porous region is than inserted 
into the metal ESI needle filled with conductive liquid. This interface was used successfully in 
analysis of peptides, where subnanomolar limits of detection were achieved [164]. 
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1.2.2.4 Sensitivity improvement in CE-MS 
The sensitivity of CE-MS can be improved by various methods like using certain extraction for 
sample treatment prior to the analysis, by different techniques of online sample stacking or 
another interface that does not dilute the analytes.  
The method of solid phase extraction can increase the sensitivity by concentration of the sample 
by volume reduction and sample desalting. Various offline [129] and online [128, 165-167] 
methods of SPE-CE-MS have been developed for the peptide separation. The limits of detection 
in attomole concentrations have been achieved using this method [128].  
Stacking techniques can overcome the major sensitivity drawback of CE in comparison with LC, 
because a longer plug of sample can be injected than in the conventional CE. In LC-MS, the 
amount of injected sample is usually in µl quantities using capillary columns, but in CE-MS, the 
amount is only in the nl scale [168]. The easiest method of a sample stacking is based on the 
differences in the ionic strength of a sample and background electrolyte (BGE). A long plug of 
sample with low electric conductivity is injected into the capillary filled with highly conductive 
BGE. After the voltage is applied, the strong electric field is established in the sample zone; the 
analytes migrate quickly to the BGE boundary and create a narrow zone. Then, analytes are 
separated according to their electrophoretic mobilities [169, 170]. Both hydrodynamic and 
elektrokinetic injection can be applied in this stacking technique. By the method realized by 
elektrokinetic injection, up to 3000 – fold sensitivity improvement was reached [171]. 
In transient isotachophoresis (tITP) in CE-MS the sample is introduced between discrete zones 
of leading electrolyte (LE) with high conductivity and terminating electrolyte (TE) with low 
conductivity. The long sample plug up to 70 % of the capillary length can be injected [172]. The 
sample is than stacked into a narrow sharp zone. When the high-concentration zones of the 
leading and terminator ions disappear due to their high and low electrophoretic mobilities, 
respectively, separation procedure continues as a typical capillary electrophoresis [169, 173]. 
The scheme of tITP procedure is depicted in Figure 17. 
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 Figure 17: Scheme of tITP process; 1-injection, 2-stacking, 3-destacking and separation. 
 
Mainly formic or acetic acid are used as a terminating electrolyte that usually serves also as a 
BGE in tITP. In the positive electrospray mode, ammonium acetate or formate is usually used as 
a leading electrolyte that can be injected before the sample plug or together with the sample 
[174, 175]. Using tITP-CE-MS the sensitivity of peptide analysis can be improved by two orders 
of magnitude, when 30 mM or 50 mM (pH = 4.8) ammonium acetate serves as a leading 
electrolyte and 10 mM or 50 mM acetic acid serves as a terminating electrolyte [172, 174, 176]. 
 
1.2.3 The proteomic study of carotenogenic yeast under stress  
1.2.3.1 Carotenogenic yeasts 
Carotenogenic yeasts belong to phylum Basidiomycetes that are divided into two families 
Rhodotorulaceae and Sporobolomyceae. Rhodotorula, Rhodosporidium, Sporobolomyces, 
Phaffia and Cystofilobasidium are the genera with a large production of carotenoid pigments 
[177]. The composition of produced carotenoids is individual for each strain; it depends also on 
the environment and conditions. Carotenogenic yeasts are strictly aerobic, so they are not able to 
ferment glucose. On the other hand, their pentose cycle is strongly developed to utilize glucose. 
All these strains produce lipids, which are stored in cytoplasm [178]. In some strains lipids can 
make up to 60 % of dry yeast mass. The cell wall of carotenigenic yeast is extremly rigid, and 
thus the isolation of proteins or metabolites can cause problems. As carotenoids are insoluble in 
water, they are localized within the cytoplasmatic membrane. The acceptor of light, that is 
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necessary for production of carotenoids, is flavin or flavoprotein. Due to the high content of 
double bonds in molecule, carotenoids are sensitive to oxidation, and thus they behave as 
antioxidants. They are able to quench singlet oxygen and can inhibit the peroxidation in lipidic 
part of membranes [177, 179]. Carotenogenic yeasts are suitable for industrial production of β-
carotene. Rhodotorula glutinis can reach up to 10 mg of β-carotene in 1 g of dry yeast mass. 
Yeast biomass can be used directly as a feed after fermentation without additional β-carotene 
isolation [180].  
 
   
Figure 18:  Photograph of carotenogenic yeast Rhodotorula glutinis. Cells morphology (A) and 
agar streak (B). 
 
Since carotenogenic pigments are widely used as food supplements or pigments, new methods 
for increasing their microbial production have been developed. One approach to achieve 
enhanced production involves methods of genetic engineering, like mutagenesis [181]. The 
second approach uses the changes of cultivation conditions or application of some external 
factors as additions of metal ions, salts or organic solvents into the cultivation media [182]. 
Several studies have already been published on the stimulation of carotenoid production using 
various stress factors [183-188]. 
 
1.2.3.2 The influence of environmental stress on microorganisms 
One of the most important stresses, that are able to change structures and functions of cells, is 
oxidative stress. A primary destructive aspect of this stress is the production of reactive oxygen 
species (ROS), which include oxygen molecules in different redox or excitation states, oxygen 
compounds coupled with hydrogen, nitrogen or chlorine. ROS are natural products of oxygen 
A B 
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metabolism and play an important role as second messengers in intracellular signaling cascades. 
On the other hand, they induce cellular ageing and apoptosis [189].  The main source of ROS is 
respiration, but they are also produced by β-oxidation of fatty acids, agrinine metabolism or 
metabolism of xenobiotic compounds. In Table 2 some of the primary and secondary oxidants 
are listed.  
 
Table 2: Reactive oxygen species originated from oxygen metabolism in organisms [190]. 
oxidant name properties 
•O2- superoxide anion 
- primary ROS, formed in many autooxidation reactions, 
unreactive 
•OH hydroxyl radical - primary ROS, extremely reactive 
RO•, 
ROO• 
alkoxy and peroxy 
radicals 
- formed in lipid peroxidation, secondary ROS 
ROOH 
organic 
hydroperoxide 
- formed by radical reactions with lipids and nucleobases 
H2O2 hydrogen peroxide 
- primary ROS,  formed by dismutation of •O2- or by direct 
reduction of  O2, lipid soluble, can penetrate through 
membranes 
HOCl hypochlorous acid - formed from H2O2, lipid soluble 
ONOO- peroxynitrite - formed in a reaction between •O2- and NO•, lipid soluble 
 
ROS can cause damage of enzymes and cell organelles. They attack DNA, lipids and proteins as 
well. In DNA, long chains can be cut into shorter ones and the bases can be replaced. This can 
cause DNA mutation, which might contribute to tumor formation. Lipids undergo peroxidation 
and fatty acids degrade. The fluidity of membranes changes and cells are not able to control their 
permeability. The ROS also modify protein molecules, change their conformation, inactivate 
them or denature [190].  
 
Antioxidant defense in cells involves several strategies. One of the mechanisms is to produce 
several enzymes like catalase and superoxide dismutase, isoenzymes, peroxiredoxin, 
cytochrome c, peroxidase and glutathione synthesis enzymes. Other mechanism of cell defense is 
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the production of non-enzymatic antioxidants like tocopherols and carotenes in lipid phase or 
ascorbate and glutathione in aqueous phase [191]. Superoxide dismutase (SOD) is an enzyme 
that catalyzes dismutation of superoxide anion to hydrogen peroxide and oxygen. Superoxide 
dismutase occurs in different form depends on the organism. The human enzyme is a tetrameric 
glycoprotein with Cu-Zn or Mg ions [192], the E.coli SOD occurs as a dimeric glycoprotein 
containing Mg or Fe ion [193]. 
 
The important part of stress response is the induction of a group of proteins called in general heat 
shock proteins (HSP), which were named due to their first discovery in cells exposed to high 
temperature. They are present in all cells, all life forms and are induced in various types of 
applied stresses. In S.cerevisiae at least 52 different proteins are induced by temperature shift 
from 25 °C to 38 °C. HSP are presented in cells growing under normal conditions as well. They 
help new proteins to be fold into right shape and move other proteins between organelles [194]. 
Individual HSPs are named according to their molecular mass that varies from 10 up to 
approximately 110 kDa. Major role of these proteins is cytoprotection and supporting the cell 
under the stress condition. Nevertheless, each HSP have other functions in organisms. For 
example HSP 27 has been reported to interact with actin and intermediate filaments in human 
muscles and prevents filaments from fragmentation [195]. HSP 70 occurs in an ATP bound state 
and prevents protein folding during post-translational import into the mitochondria or 
chloroplast. The HSP 90 is strongly connected with steroid receptors [196]. 
 
Another type of stress, that is used to change the cell function, is salt stress. The increase of salt 
concentration in surrounding media causes changes in the cell inner osmotic pressure, loss of 
cytoplasmic water and inhibition of many cellular functions, because of the increased Na+ 
intracellular concentration. An important part of the stress response against salt stress is the 
production of osmotic active compound glycerol that is able to equalize osmotic pressure and 
adapt membrane transport systems to remove Na+ from cells. One of the key enzymes in glycerol 
production is glycerol-3-phosphate encoded by the GPD 1 gene [194, 197]. 
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1.2.3.3 The state of the art of yeast proteome under stress study 
Protein databases are very important tools for studying proteins, their functions in various 
organisms and their up- or down-regulation under various conditions. Protein databases are 
based not only on the mass spectrometry results, but also on the known DNA sequences. In 
NCBI database (National Center for Biotechnology Information) there is a list of yeasts whose 
genomes were already sequenced or whose genome project is in progress. Subgroup 
Ascomycetes is mostly representative in this database. Saccharomyces cerevisiae was the first 
yeast with sequenced genome, which was accomplished in 1997 [198]. The second yeast with 
known genome was fission yeast Schizosaccharomyces pombe [199]. After that, other yeast 
genomes were sequenced with focus on yeast that are important in industry (Kluyveromyces 
lactis) or are possible pathogens (Candida albicans). Only one yeast´s genome sequence from 
subphylum Basidiomycetes is completed (Cryptococcus neoformans). Genome projects of other 
Basidiomycetes (Rhodosporidium babjevae, Malassezia globosa) are in progress [200]. 
 
The comparative proteomic analysis of the effects of various stresses in Saccharomyces 
cerevisiae at the protein level has already been carried out several times. The response to 
herbicide-related stress in this yeast has been studied. Protein carbonylation was evaluated as a 
biomarker of oxidative stress in this work [201]. The differential expressions of eight oxidative 
response proteins and heat shock proteins were identified also in the batch or fed-batch industrial 
fermentation when producing ethanol [202]. In other work, the possible role of mitochondrial 
enzyme F1F0-ATPase in stress tolerance was studied in transgenic Saccharomyces cerevisiae 
[203]. The exposure to cadmium was studied and it was found out that this yeast has developed 
several mechanisms to manage cadmium stress, which leads to a significant increase in the 
synthesis of sulfur compound, glutathione [204].  
The nutrition stress response was studied in pathogenic yeast Candida albicans in exponential 
and stationary phase of its growth. During the exponential growth, proteins required for the 
synthesis of RNA, DNA and proteins were over-expressed. In the stationary phase, the metabolic 
networks undergo complex reprogramming, where glyoxylate cycle or gluconeogenesis were up-
regulated. The presence of proteins involved in the defense against oxidative stress indicates a 
change in redox balance and ROS production [205]. The study of the stress response in C. 
albicans after treatment with hydrogen peroxide and the thiol oxidizing agent, diamide, was 
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reported by the same group. Among 21 up-regulated proteins the enzymes with previously 
known antioxidants functions like catalase, thioredoxin reductase and a set of oxidoreductases 
were found [206]. Proteomic analysis of acidic or alkaline stress response in the Candida 
glabrata was studied in another report. Under alkaline conditions, C. glabrata produces more 
proteins involved in stress responses than under acidic conditions. This is in contrast with other 
pathogen, Candida albicans [207]. The proteomic analyses of stress response in carotenogenic 
yeast like genuses Rhodotorula or Sporobolomyces are in progress [208, 209].   
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2. OBJECTIVES OF THE STUDY 
There are three objectives of this doctoral thesis: 
 
The development of selective fluorescent molecular probes synthesized via conjugation of 
quantum dots with antibodies or other specific ligands. The probes will be designed for high 
sensitivity analyses of chosen analytes by capillary electrophoresis with laser-induced 
fluorescence detection or fluorescence microscopy imaging of individual cells and tissues 
potentially exposed to external stress. 
 
The optimization of laboratory procedures for the identification of protein changes in 
carotenogenic yeast Rhodotorula glutinis cultivated under normal conditions and under 
environmental stress. The instrumentation methods will comprise two-dimensional gel 
electrophoresis followed by liquid chromatography or capillary electrophoresis with mass 
spectrometry identifications. 
 
The design and testing of a new interface between capillary electrophoresis and mass 
spectrometry; the interface will ensure high sensitivity analyses of proteins and their peptides as 
well as small molecules of clinically important metabolites in complex matrices of human urine 
samples. 
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3. EXPERIMENTAL PART  
3.1 Targeted proteomic analysis 
3.1.1.1 Preparation of quantum dots (QDs)  
CdTe water soluble quantum dots were prepared using modified two step reaction published 
elsewhere [40]. At first natrium hydrogen telluride was prepared by the reaction of natrium 
borohydride with tellurium powder according to the following equation: 
 
4 NaBH4 + 2 Te + 7 H20 → 2 NaHTe + Na2B4O7 + 14 H2 
 
The shots of 84.85 mg NaBH4 and 126.97 mg Te-powder were transferred into small flask with 
2 ml of deionized water. The flask was covered with a lid perforate by a needle to delivery 
hydrogen that was generated during the reaction. The reaction flask was cooled by the water with 
ice cubes and it was kept stirring in a closed box for approximately 8 hours. Figure 19 shows the 
first reaction mixture.  
 
Figure 19: Violet solution of NaHTe produced in the first reaction step. 
 
The violet solution of NaHTe from the first reaction step was transferred into the second reaction 
flask filled with 80 ml of degassed solution of 366.7 mg cadmuim chloride and 418 µl 
(509.47 mg) 3-mercaptopropionic acid (MPA) in water. The molar ratio of all these chemical 
was CdCl2 : NaHTe : MPA = 2 : 1 : 4.8. pH of the created red solution was adjusted to 9.5 - 10 
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using 0.1 mol/l NaOH and MPA. The second reaction mixture was heated under the reflux 
condenser for a certain time to reach the appropriate nanocrystal size. Water soluble quantum 
dots prepared in the two-step reaction were precipitated from the reaction mixture by 
isopropanol, centrifuged and dissolved in water again. 
 
 
Figure 20: Solution of freshly prepared CdTe quantum dots illuminated by UV light. 
3.1.1.2 Optical properties measurements  
Spectral properties 
The luminescence spectra were collected by spectrograph MS 125 1/8 77400 (Oriel) equipped 
with 600 lines/mm diffraction grating. The spectra were recorded by an intensified CCD camera 
IntraSpec V DH 501 (Oriel). A spit (50 µm × 3 mm) and notch filter for 488 nm (Oriel) were 
placed in front of the spectrograph. 
 
Lifetime measurements 
Time-resolved photoluminescence was measured on a laboratory-made instrument that consist of 
a pulsed solid state frequency-quadrupled Nd:YAG laser (LCS-DTL-382QT, Laser-compact, 
Russia) with an output power of 6 mW (at 2.5 – 3 kHz, emitting at 266 nm). The 
photoluminescence decay was registered by a photomultiplier module (model H5783-03, 
Hamamatsu Photonics K.K., Iwata City, Japan) with a rise time of 780 ps connected to digital 
storage oscilloscope (model WaveRunner 6050, LeCroy, NY, USA) with sampling rate 5 GS/s. 
The laser pulse time profile was determined using a solution of Rose Bengal with a constant 
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luminescence lifetime around 100 ps [210], which is a sufficiently short delay for the registration 
of nanosecond laser pulses. 
3.1.1.3 CE-LIF device and measurement 
A laboratory-made CE-LIF was used in this work. A high voltage power supply by Spellman 
CZE 1000R was used for applying desired voltage to the system. The detection system consists 
of the Ar ion laser (LGR 7801 M5, Lassos, Germany) emitting at 488 nm. The fluorescence 
emission was collected by a microscope objective 40 × 0.65 (Oriel, Stratford, CT) and then 
detected by a photomultiplier tube R 647-01 (Hamamatsu, Japan). To separate the scattered light 
of the laser from the QDs emission, two optical filters were used; the blocking filter 488 nm 
(Oriel) and the band-pass interference filter 610 ± 10 nm (Oriel). The data were recorded by the 
acquisition and evaluation system CSW 1.6 (Data Apex, Prague, Czech Republic).  
The separations were realized at fused silica capillary (Polymicro Technologies, Phoenix, USA) 
with ID of 75 µm and a different length. The capillary was rinsed by a 0.1 mol/l NaOH for 
10 min, deionized water for 5 min and BGE for 5 min prior a set of analyses. Samples were 
injected electrokinetically for a different time and voltage. 50 or 100 mmol/l TRIS/TAPS (1:1) at 
pH = 8.3 were used as a BGE. Appropriate conditions are listed in the figures captions. The high 
mobility of electroosmotic flow (EOF) that transports the analytes from the injection part of the 
capillary to the detection window at the positive voltage mode was determined using coumarin 
(1,2-benzopyrone) which plays role of  a neutral marker in wide range of pH. 
 
Figure 21: Laboratory-made instrumentation for CE-LIF analysis. 
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3.1.1.4 Separation of QDs by slab gel electrophoresis 
1% agarose gel (Sea Plaque Agarose, FMC BioProducts, USA) was prepared in 0.09 mmol/l 
TRIS/borate buffer, pH = 8.5. 10 µl of the samples were injected into the sample hole after the 
gel become solid. Whole system was poured by 0.09 mmol/l TRIS/borate buffer with 0.1% of 
SDS, pH = 8.5. Horizontal electrophoresis (Thermo Scientific Owl Microgel System, USA) have 
been running for 2 hours by applying 70 V (power supply MP-300N, Major Science, Taiwan). 
3.1.1.5 Quantum dots desalting by Sephadex column 
The glass tube (diameter 0.25 cm, length 13 cm, volume 0.64 ml) was filled by a suspension of 
stationary phase for Size Exclusion Chromatography Sephadex G-15 (Sigma-Aldrich, USA) in 
water. This stationary phase is able to catch molecules bigger than 15 000 Da. 3 µl of crude 
reaction mixture was injected on the surface of Sephadex in the column and a syringe has been 
connected to the system. A constant flow of 2 ml/h were applied to the system from the pump 
(kdScientific, USA). The separation was detected by contactless conductivity detector 
(TraceDec, Austria). 
3.1.1.6 Conjugation techniques 
Different conjugation techniques between quantum dots and proteins (antibodies or antigens) 
have been used in this work. Following paragraphs describes the optimized protocols of 
conjugations. 
 
Conjugation via EDC/sulfo-NHS 
1.5 mg of solid EDC ((1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, Sigma-
Aldrich, USA) and 0.5 mg of solid sulfo-NHS (N-Hydroxysulfosuccinimide, Sigma-Aldrich, 
USA) have been added to 100 µl of 0.01 mmol/l QDs in 0.1 mol/l phosphate buffer at pH = 7.4. 
3 µl of modified QDs were immediately added to 8 µl of 0.0667 mmol/l anti-ovalbumin (Sigma-
Aldrich, USA) solution. The molar ratio was 1:1 (QDs : Ab). The mixture was incubated at room 
temperature for 1 h. Ovalbumin as an antigen has been added to the conjugate in molar ratio 1:1 
(antigen : antibody).  
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Conjugation via CDI (Carbonyldiimidazole) 
To 100 µl of 0.01 mmol/l QDs solution 1 µl of 0.01 mol/l CDI was added. The mixture was kept 
at room temperature for 30 minutes. Then 30 µl of modified QDs were mixed with 10 µl of anti-
ovalbumin and incubated another hour at room temperature. The molar ratio was 1:1.2 
(QDs : Ab). Whole conjugation was realized in 50 mmol/l borate buffer, pH = 8.9. 
 
Conjugation via oxidized antibody glycans 
20 µl of antibody was oxidized by 10 µl of 1 mol/l NaIO4 for 30 minutes at room temperature. 
1 ml of 0.01 mmol/l QDs were modified by 5 µl of 0.06 mol/l EDC and 10 µl of 0.03 mol/l 
adipic acid dihydrazide (Sigma-Aldrich, USA). The mixture of 20 µl oxidized antibody and 10 µl 
of modified QDs (molar ratio 1:6 ~ Ab:QDs) was kept at 0.1 mol/l phosphate buffer (pH = 7)  
overnight at 4 °C.  
3.1.1.7 Preparation of F(ab´)
2
 fragments of antibody 
An antibody anti-hemagglutinin was cleaved using commercially available kit FabRICATOR® 
(GENOVIS AB, Lund, Sweden) that is able to enzymatically cleave the antibody in the hinge 
region into F(ab´)2 and Fc fragments. The antibody was mixed with FabRICATOR enzyme in a 
molar ratio 1:1 and incubated at 37°C for 40 minutes. The Fc fragments, that do not contain the 
active site, were separated from the reaction mixture by modified magnetic particles included in 
the kit. After the separation of Fc fragments, F(ab´)2 fragments were conjugated to QDs via 
EDC/sulfo-NHS method in phosphate buffer according to the previously mentioned protocol. 
3.1.1.8 Separation of conjugation products by polyacrylamide gel electrophoresis 
To prepare polyacrylamide gel, 2 ml of distilled water and 1.65 ml of acrylamide (AA) and 
N,N´- bis-methylenakrylamid (BIS)  (in ratio 29:1 of 40 % AA and 3.3 % BIS) was mixed with 
1.25 ml of 1.5 mol/l Tris-HCl buffer, pH = 8.8. Then 0.05 ml of 10 % Sodium dodecyl sulphate 
(SDS) and 0.05 ml of 10 % ammonium persulphate were added. Finally 0.002 ml of N,N´-
tetrametylendiamin (TEMED) was added to the solution. The created gel was poured between 2 
glasses and a comb for making sample holes was put on the gel. The gel was kept to polymerize 
approximately 30 minutes. The samples were prepared by the following procedure: 15 µl of each 
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sample was boiled with 15 µl of sample buffer (a mixture of 0.1 mol/l Tris-HCl buffer, pH = 6.8, 
4% SDS, 20% glycerol, 0.2% bromofenol blue and 5% β-mercaptoethanol) for 2 minutes.  
The gel with the glasses was transferred into the electrode vessel and 15 µl of each sample was 
put into the hole created on the gel after the electrode buffer was added. The electrode buffer 
consisted of 0.025 mol/l Tris, 0.192 mol/l glycin and 0.1 % SDS. Electrode buffer was poured 
also into the inner area of the electrode vessel. After the box was closed, the voltage of 180 V 
was applied until the blue line of bromofenol blue does not reach the down part of the gel. 
Electrophoresis was performed on Mini-PROTEAN 3 Cell (Bio-Rad, Hercules, CA, USA). 
After the separation was finished, the gel was washed in distilled water and its picture under UV 
light was taken. The gel was poured into the staining solution (1 g Coomassie Brilliant blue, 
200 ml methanol and 100 ml of acetic acid) for 20 - 30 minutes and then it was destained in other 
solution (100 ml methanol, 70 ml acetic acid and 530 ml distilled water) for 2 hours. 
3.1.1.9 Separation of conjugation products by native PAGE  
Polyacrylamide gel was prepared equally as in previous section except of addition of SDS. The 
sample buffer consisted of 0.1 mol/l Tris-HCl buffer, pH = 8.8, 20% glycerol and 0.2% 
bromofenol blue, neither SDS nor ME was added to avoid the antibody denaturation. Samples 
were also only mixed with sample buffer, not boiled as in previous section. The electrode buffer 
consisted of 0.025 mol/l Tris, 0.192 mol/l glycin, SDS was excluded as well. The gel separation 
run at 180 V until the blue line does not reach the bottom of the gel. When the separation was 
finished, the gel was stained with Coomassie Brilliant Blue according to the standard protocol 
described in previous section. 
3.1.1.10 Cell imaging using quantum dots 
A suspension of human lymphocytes and baker´s yeasts Saccharomyces cerevisiae in phosphate 
buffer, pH = 7.4 were stained by quantum dots with MPA. After approximately 10 minutes, the 
cell has been visualized under epifluorescence microscope (FLIM, Intraco Micro, Czech 
Republic) with camera Moticam 5000 C (Motic, China). Laboratory-fabricated TIRF microscope 
with camera EMCCD Luca, Andor (UK) was used for lymphocyte visualization as well. The 
TIRF instrumentation was described elsewere [211].  
65 
 
3.1.1.11 Cell imaging using quantum dots conjugates 
After the QDs were conjugated to appropriate antibodies (anti - FAS, anti - FADD or anti - CD3) 
using EDC/sulfo-NHS method described in previous paragraph, the prepared conjugate was 
added to a suspension of human lymphocytes in phosphate buffer, pH = 7.4. After 10 minutes, 
lymphocytes was transferred to the microscope glass and observed under epifluorescence 
microscope. 
3.1.1.12 Tissue imaging using quantum dots conjugate to annexin V 
Quantum dot conjugate was prepared using EDC/sulfo-NHS method described in previous 
paragraph. The molar ration between QDs and annexin V was 1:1.  
A piece from a mouse duodenum tissue was added to 0.5 ml of enzyme biotase (Biochron L 
2197 09/09) dissolved in phosphate buffer, pH = 7.4. After 30 min in 37 °C, the tissue was 
washed twice in 0.5 ml of phosphate buffer. 4 µl of QD conjugate with annexin V was added to 
this tissue and the mixture was kept at 25 °C for 10 minutes. A piece of the tissue with conjugate 
was transferred on a microscope glass slide and observed under epifluorescence microscope. 
3.1.1.13 Immunocomplex formation from luminescent ovalbumin and magnetic anti-
ovalbumin 
Oriented conjugation of anti-ovalbumin to magnetic particles 
100 µl of 0.0667 mmol/l anti-ovalbumin was oxidized with 10 µl of 0.2 M NaIO4 for 30 minutes.  
Magnetic particles SiMAG - Hydrazide (Ø 1 µm, concentration 1 mg/ml, Chemicell, Germany) 
were washed 5 times in 1.5 ml of 0.1 mol/l acetate buffer with 0.2 mol/l NaCl, pH = 4.6. Then, 
oxidized antibody was added and the mixture was incubated overnight at room temperature. The 
second day, the conjugate was washed 5 times with the same buffer and then the conjugate was 
incubated in 0.5 ml of 0.1 mol/l D - glyceraldehyde in acetate buffer for 1 hour. Finally the 
conjugate was washed 3 times with acetate buffer and 3 times in phosphate buffer, pH = 7.5. 
 
Conjugation of QDs and ovalbumin using EDC/sulfo-NHS method 
4 mg of solid EDC and 1 mg of solid Sulfo-NHS were added to 100 µl of 0.01 mmol/l QDs in 
0.1 mol/l phosphate buffer at pH = 7.5. To prepared mixture 10 µl of 0.12 mmol/l ovalbumin was 
added and the conjugate was incubated for 45 minutes at room temperature.  
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Immunocomplex formation from fluorescently labeled ovalbumin and magnetically labeled 
anti-ovalbumin 
To 100 µl of anti-ovalbumin conjugated to magnetic particles 40 µl of antiovalbumin conjugated 
to QDs was added. The mixture was incubated 15 minutes at 37°C. After the incubation, the 
mixture was washed 5 times with 100 µl of distilled water. Finally, the immunocomplex with 
fluorescent and magnetic properties was resuspended in 50 µl of distilled water and detected 
under epifluorescence microscope. 
 
3.2 Comprehensive proteomic analysis 
Cell cultures were prepared at the Institute of Food Science and Biotechnology, Faculty of 
Chemistry, Brno University of Technology. Sample preparation for 2D gel electrophoresis, gel 
electrophoresis with following separation on liquid chromatography tandem mass spectrometry 
and protein identification was performed at the Department of Functional Genomic and 
Proteomic at Faculty of Science, Masaryk University, Brno. 
3.2.1.1 Cell cultivation 
Rhodotorula glutinis CCY 20-2-26 was cultivated in three steps, two times in inoculation media 
for 24 hours and one time in production media for 80 hours. The inoculation media was prepared 
by dissolution of 40 g glucose, 5 g (NH4)2SO4, 5 g KH2PO4, 0.34 g MgSO4 and 7 g yeast 
autolysate in 1000 ml of distilled water. The production media was the same mixture of 
compounds except of yeast autolysate. After the media sterilization, the cells were cultivated at 
28°C, at permanent lighting and shaking at 120 rpm. The salt stress was induced by addition of 
2% NaCl into the production media. 
3.2.1.2 Protein sample preparation from Rhodotorula glutinis 
Cell culture from red yeast Rhodotorula glutinis was centrifuged, washed and lyophilized. Then, 
the cells was resuspended in lysis buffer (lysis buffer - 7 mol/l urea, 2 mol/l thiourea, 4% 
CHAPS, 60 mmol/l dithiothreitol, 0.8% ampholyte, 0.003% bromophenol blue) and glass pellets 
were added. Proteins were extracted by vortexing in low temperatures by combination of 
mechanical and chemical factors. After the separation, a sample buffer was added to the samples. 
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3.2.1.3 2D gel electrophoresis 
The first dimension, isoelectric focusing, was realized on IPG strips (Bio-Rad, USA) with linear 
pH gradient from 3 to 10. Strips were put into the IPG buffer for rehydration. After several 
hours, analysis was realized in Protean IEF Cell device (Bio-Rad) in following conditions: 
30 minutes at 150 V, to 3 h at 1500 V, then 1 h at 2500 V, approximately 3 h at 3500 V and to 8 
h at 500 V. The limiting current was set to 50 mA. The strips from the first dimension were 
equilibrated in buffer (equilibrate buffer - 6 mol/l urea, 0.375 mol/l tris/HCl, pH = 8.8, 2% SDS, 
20% glycerol), then in 2% DTT, 2.5% iodoacetamide and finally in electrode buffer. After that, 
the strips were transferred on the PAGE gel and the analysis was realized at Protean plus Dodeca 
Cell (Bio-Rad) The second dimension was realized on 12% polyacrylamide gel with SDS. The 
size of the gel was 20 × 20 cm. The separation had been running approximately 17 hours. After 
the analysis, gels were stained with silver and their images from stressed and control cell cultures 
were analysed by image analysis software PDQuest both qualitatively and quantitatively. 
3.2.1.4 Digestion of the gel spots 
The spots that were selected from the gels were cut off the gel by scalpel and destained by 
commercial destainer A and B (Bio-Rad). Then the gel pieces were washed by water and the 
following procedure for protein release from the gel was applied. Firstly, 50 mmol/l ammonium 
bicarbonate with acetonitrile (ACN) were added to the tube with a gel piece, after 15 minutes of 
stirring at 20 °C, the liquid part was removed and only acetonitrile was added. After removal of 
ACN, another portion of ammonium bicarbonate and ACN were added respectively for 5 
minutes stirring at 0 °C. The spots were dried at vacuum evaporator to remove all solvents. After 
this procedure, 25 µl of 5 ng/µl trypsin in ammonium bicarbonate, pH = 8 - 9 was added to every 
tube. The mixture was kept stirring at 40 °C for 2 hours. 
3.2.1.5 Analysis by liquid chromatography - mass spectrometry 
Samples were centrifuged and dissolved in 10 µl acetone/water (1:1). Analysis was realized at 
C 12 columns (Ø 0.32 × 150 mm) with stationary phase from Phenomenex at a gradient mode of 
acetonitrile/water with 1% of formic acid at flow of 4 µl/min. MS analysis was performed at 
Bruker Esquire HCT, ESI-TRAP (Bruker Daltonics, Germany). The voltage was set to + 4 kV, 
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nebulization gas flow was 15 psi, dry gas flow 6 l/min, temperature of inner capillary was 
300 °C. 
3.2.1.6 Identification of proteins in the database 
The data from MS/MS fragmentation of peptides were compared with the data in NCBI database 
(National Centre for Biotechnology Information) using software MASCOT (Matrix Science), 
both available online. The search was realized between all types of organisms; peptide tolerance 
was set to ± 1.0 Da, peptide charge to 2+ and 3+, MS/MS tolerance was set to ± 0.5 Da. 
Acetylation and oxidation of methionine were set as a variable modification. 
3.2.1.7 Cytochrome C tryptic digestion 
1 mg/ml of cytochrome C from horse heart was diluted in 50 mmol/l ammonium bicarbonate pH 
= 8 and mixed with trypsin from bovine pancreas (both Sigma-Aldrich, USA) in the ratio 50 : 1 
(protein : trypsin). The solution was kept mixing overnight at 37°C. The enzyme was inactivated 
by increasing the temperature to 90°C for 5 minutes. The final tryptic digest has been stored at 
- 20°C.  
3.2.1.8 CE-MS analysis using sheath flow interface 
Analysis were performed CE – MS system consist of capillary electrophoresis from Beckman – 
P/ACE System 5010 (USA), CE ESI sprayer from Agilent Technologies (USA) and mass 
spectrometer electrospray – ion trap Esquire 2000 from Bruker Daltonics (Germany). The 
separation was performed on 90 cm uncoated capillary from Polymicro (50 µm ID). The 
capillary was rinsed with BGE (1 mol/l formic acid) for 4 minutes prior to each analysis. Prior 
the set of analyses, the capillary was rinsed with distilled water (for 15 minutes) and BGE for 10 
minutes. Separation voltage was 25 kV; hydrodynamic injection was performed by the pressure 
of 0.5 psi for 10 s. The polyimide coating at the capillary end was removed to avoid the 
possibility of affecting the flow that comes out from the separation capillary. Sheath liquid 
consisted of the mixture of methanol and water (in ratio 1:1) and its flow was 0.24 ml/h. 
Nebulization gas was 4 psi, dry gas flow 4 l/min and the temperature was set to 250°C.  
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3.2.1.9 Solid Phase Microextraction 
The SPME was performed using commercially available tips with immobilized reversed 
stationary phase. The procedure of sample treatment with ZipTip C 18 (Milipore, USA) was as 
following: The tip was washed by wetting solution (70% acetonitrile + 0.1% trifluoracetic acid) 
5 times. Then it was equilibrated with equilibrate solution (0.1% trifluoracetic acid) 5 times as 
well. 20 µl of the sample (diluted 20 times in 1 % trifluoracetic acid, pH = 1.8) was deposited on 
C 18 stationary phase by rinsing it 10 times. Then the tip was washed with wash solution (0.1% 
trifluoracetic acid) 5 times again. In the end, peptides were eluted by 5 µl eluting solution (70% 
acetonitrile + 0.1% formic acid) 10 times. The peptides dissolved in 70% acetonitrile and 0.1% 
formic acid was directly injected (hydrodynamically at 0.5 psi for 10 s) to the CE-MS. 
3.2.1.10 CE-MS analysis using Liquid Junction interface 
Analysis were performed CE – MS system consist of laboratory - made capillary electrophoresis 
and liquid junction interface in one piece and mass spectrometer electrospray – ion trap esquire 
HCT from Bruker Daltonics (Germany). The device is described in detail in section 4.3.1.1. The 
separation was performed in coated capillary (Alcor Bioseparation, USA), 40 cm long, 50 µm 
ID. Power supply from Villa Labeco (Spisska Nova Ves, Slovakia) has been used to apply the 
separation voltage of 10 kV. The separation capillary was rinsed with water prior to each 
analysis. 1 % acetic acid served as a BGE and 50 % isopropanol with 1 % acetic acid served as a 
spray liquid. The uncoated capillary from Polymicro serves as a spray capillary. It was 6 cm long 
and the diameter was optimized in this work. The injection was performed by increasing the 
liquid level for 10 s. The flow of the spray liquid through the spray capillary has been induced by 
pressurized nitrogen. Thus the pressure, which had to be the same in the whole system, has been 
controlled by a compact electropneumatic regulator, ITV 0050-3N-Q SMC (Tokyo, Japan), to an 
optimum value in the range from 2 to 2.5 atm. The MS instrument was set to nanoelectrospray 
on-line mode, the dry gas flow was 0.5 l/min, the temperature was set to 130°C and the applied 
voltage was 4 kV. 
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3.3 CE-MS analysis of ethanol metabolites 
3.3.1.1 Separation of Ethylglucuronide and Ethylsulphate in coated capillaries 
For the separation, laboratory-made liquid junction interface was used. The interface was placed 
in front of mass spectrometer (HCT Esquire, Bruker Daltonics, Germany), that was set to nano-
electrospray online and negative ion mode. Other parameter has been optimized automatically. 
Separation takes place in coated capillary (Alcor Bioseparation), 15 cm long, 50 µm i.d. The 
capillary was rinsed with water and BGE prior to every analysis. The spray capillary tip was 
sharpened by a fine abrasive paper placed on a motor-driven rotating disk.  The tip was approx. 6 
cm long, i.d. was 10 µm. 30 mmol/l ammonium acetate at pH = 9 served as a BGE and 50% 
isopropanol with 1% ammonium served as a spray liquid. Both of these liquids were filtered 
through the 0.1 µm filter. Standard samples of Sodium ethyl sulphate (TCI Europe nv, Belgium) 
and Ethylglucuronide (Medichem, Germany) were injected hydrodynamically (by increasing the 
water level) or electrokinetically at 10 kV usually for 10 s. The separation voltage was usually 10 
kV as well. The pressure applied to the spray liquid in order to achieve stable spray was between 
2 and 3 atmospheres.  
3.3.1.2 Analysis of spiked urine 
The urine was diluted 10 or 50 times. Then, the diluted urine was spiked with 10, 5 and 1 µg/ml 
EtS and EtG. The limits of detection for all experiments have been calculated from extracted ion 
electropherograms.  
3.3.1.3 Separation of Ethylglucuronide and Ethylsulphate in uncoated capillaries 
Separations were realized at the same liquid-junction device and mass spectrometer as in 
previous paragraph. Uncoated capillary (Polymicro), 15 cm, i.d. 75 µm was washed with 
0.1 mol/l NaOH, 0.1 mol/l HCl, water and BGE prior to a set of analysis, between each run, the 
capillary was rinsed by water and BGE. 10 mmol/l ammonium acetate, pH = 9, served as a BGE. 
Sheath liquid composition was optimized in this part of work. Separation voltage was set to 
10 kV, samples were injected hydrodynamically by increasing the liquid level for 10 s.  
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Prior to CE-MS analysis, the electroosmotic flow velocity was optimized using laboratory-made 
CE-UV instrument (UV detector - Jasco, 875 - UV, Tokio, Japan) at 200 nm. Dimethyl sulfoxide 
served as an EOF marker. 
 
3.4 CE-MS analysis of cocaine and its metabolites 
3.4.1.1 Simulation in Peak Mater 5.2  
The separation has been simulated in Peak Master 5.2 software [135] for the following 
conditions: capillary length - 40 cm; positive polarity at injection site; separation voltage - 
10 kV;  electroosmotic flow mobility - 30·10-9 m2/(V·s); BGE - 30 mmol/l ammonium formate, 
pH = 8.5 – 9.5. The pKa values were set according to the data obtained from the literature. Since 
the ionic mobilities of cocaine metabolites are not available, the only value of 24·10-9 m2/(V·s) 
found for cocaine was used for all analytes. 
3.4.1.2 Sample preparation 
Cocaine (C) and its metabolites cocaethylene (CE), norcocaine (NC), ecgonine methylester (E) 
and benzoylecgonine (BE) (1.0 mg/mL in MeOH) were purchased from Cerilliant Corporation 
(Round Rock, TX, USA). Standards were stored at – 20°C. The standard mixture, dissolved in 
water containing 10% MeOH and 0.1% v/v of formic acid, was diluted at a concentration of 
5 µg/ml for E, 0.5 µg/ml for C, CE and NC, and 2 µg/ml for BE.  
3.4.1.3 CE–MS analysis in uncoated capillaries 
A laboratory-made liquid junction interface, which integrates CE separation and electrospray, 
has been fixed on a microposition table in front of the mass spectrometer Esquire, HCT Bruker 
Daltonics (Bremen, Germany). This interface is described in details in section 4.3.1.1. The spray 
capillary tip (6 cm × 10 µm id) has been sharpened by a fine abrasive paper placed on a motor-
driven rotating disk and polished using a fibre-optic polishing foil. The separation have been 
performed in 40 cm fused silica capillary (Polymicro) with an inner diameter of 50 µm. The 
capillary has been rinsed with 0.1 mol/l NaOH for 5 minutes, 0.1 mol/l HCl for 5 minutes and 
distilled water for 10 minutes prior the series of analyses. Between individual runs the capillary 
has been rinsed with distilled water and BGE. A 30 mmol/l solution of ammonium formate, pH 
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9.5, has served as a BGE. A spray liquid has consisted of a mixture of 50 % isopropanol, 50 % 
water and 0.1 % formic acid. Power supply from Villa Labeco (Spisska Nova Ves, Slovakia) has 
been used to control a separation voltage of 10 kV. The sample has been injected 
electrokinetically at the same voltage for 10 s. The MS instrument has been set to 
nanoelectrospray on-line positive ion mode with the dry gas flow of 0.5 l/min, the temperature 
130°C and the applied voltage 1.8 kV at the inlet. 
3.4.1.4 CE–MS analysis in coated capillaries 
Analyses have been performed on CE system, Agilent Technologies (Waldbronn, Germany) and 
ion trap electrospray mass spectrometry, Thermo Finnigan (San Jose, CA, USA). Both 
instruments were connected via laboratory-made hydrostatically pressurized liquid junction 
interface [212] - Figures 22 and 23. The interface was made of polymethyl methacrylate 
(PMMA) resin (Repsol Glass®, Repsol Bronderslev, Denmark). A PEEK tube was inserted in the 
device to guarantee the self alignment of the separation capillary with the emitter tip. A fused 
silica capillary (4 cm × 50 µm id) was used as ESI emitter. Hydrostatic pressure was applied to 
the liquid junction to induce the flow of the spray liquid. The CE inlet port was also pressurized 
to counterbalance the backpressure inside the capillary. The inlet and outlet pressures were 
selected at 3 kPa and 1.3 kPa, respectively. The interface was positioned on a translation stage, in 
order to align the emitter tip with the MS orifice (distance 3 mm). PVA coated capillaries 
(Agilent Technologies) with an inner diameter of 75 µm and effective length of 48.5 cm coated 
with poly(vinylalcohol) have been used for the separations. Before analyses, the capillary has 
been rinsed with distilled water and BGE for 15 and 10 minutes, respectively. Between each run, 
the capillary has been rinsed with water and BGE for 1 and 2 minutes, respectively. A 15 mmol/l 
solution of ammonium formate, pH 9.5, has served as a BGE. Samples have been injected 
electrokinetically by applying 10 kV for different injection times. The separation voltage was 
15 kV. The sheath liquid has consisted of 80% methanol, 20% water and 0.1% formic acid. 
Spray voltage was set at 1.8 kV at the positive ion mode. The heated capillary temperature was 
selected at 200°C. No nebulizing gas was necessary. Mass spectra of cocaine and its metabolites 
were acquired by full scan in the range 190 – 350 m/z.  
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Figure 22: Laboratory-made liquid junction interface with hydrostatic pressure control 
 
 
Figure 23: Liquid junction interface in front of mass spectrometer 
 
3.4.1.5 Sample collection and extraction 
Urine samples obtained from non-addicted volunteers were collected in test tubes and maintained 
at –20°C. Before analysis, urine samples were centrifuged at 4000 rpm for 10 min and the 
supernatant subjected to an SPE procedure.  
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Oasis HLB cartridges 
The SPE process was run according to the protocol developed by producer for cocaine and its 
metabolites [213]. Oasis HLB (hydrophilic-lipophilic balance) cartridges (30 mg, 1 ml) from 
Waters Corporation (USA) were conditioned with a mixture of 1 ml methanol and 1 ml distilled 
water. 1 ml of urine sample was spiked with the standard mixture at the concentration reported in 
section 2.4.2 and mixed with 20 µl phosphoric acid (concentrated). The cartridges were washed 
with 1 ml of 5% methanol in water and the samples were then eluted with 1 ml of methanol. The 
eluate was evaporate under stream of nitrogen at 40°C and reconstitute in 250 µl of water : 
methanol, 80:20 (v/v). 
 
Supelclean cartridges 
The SPE process was previously published for the extraction of several drugs of abuse including 
cocaine [214]. The extraction was performed using SCX Supelclean (strong cation exchange) 
cartridges (500 mg, 3 ml) from Supelco, (Bellefonte, PA, USA). 500 µl of urine sample were 
diluted 1:1 (v/v) with water to a final volume of 1 ml and spiked with the standard mixture at the 
concentrations reported in section 2.4.2. A solution of 100 mmol/l phosphoric acid (100 µl) was 
added to urine sample. The cartridges were activated with 3 ml of methanol, and conditioned 
with 3 ml of double distilled water and 3 ml of phosphoric acid (10 mmol/l). Cartridges were 
loaded with urine samples and dried under a stream of nitrogen for 5 min. The cartridges were 
washed with phosphoric acid (10 mmol/l, 2 ml), acetic acid (100 mmol/l, 1 ml), and methanol 
(2 ml). Retained analytes were eluted with 4 ml of 3% ammonia solution in methanol. The eluate 
was brought to dryness in a rotary evaporator after addition of 50 µl of 1 mmol/l HCl to prevent 
volatile drug loss. The residue was re-constituted with 1 ml of methanol and stored at -20°C. The 
sample was diluted ten times with a mixture of 50% ACN containing 0.1% of formic acid and 
the resulting solution was injected into the CE apparatus.  
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4. RESULTS AND DISCUSSION 
4.1 Targeted proteomics 
 
The molecular interactions of proteins and their durability determine the functions of proteins in 
cells. Targeted proteomics is the method of choice to study proteins in their natural environment. 
The proteins in cells or tissues are usually visualized by fluorescence imaging that is 
advantageous, because of its high sensitivity and selectivity ensured by specific interaction 
between antibodies conjugated to fluorescence dye and targeted protein in the living cell. 
Quantum dots (QDs) promise many advantages in comparison with organic fluorescence dyes, 
typically used for protein imaging. They have narrow emission spectra, their color is tunable, 
they exhibit practically no photobleaching and are resistant to chemical and metabolic 
degradation [36]. Although QDs exhibit high level of cytotoxicity, because of toxic metals used 
for their preparation, their coating by non-toxic metal layer can minimize it. The stability of cells 
for more than week was proved after imaging with CdSe QDs coated by ZnS layer [215]. 
Immunofluorescent probes based on QDs were used for imaging of specific proteins in cells and 
in animals as well [38, 41, 216]. In this work I prepared quantum dots, characterized some of 
their unique optical properties, I conjugated them with various biomolecules by different 
methods and finally I verified their usage in fluorescence imaging of proteins in cells. The 
selected results are presented in following chapters. 
 
4.1.1 Quantum dots characterization 
For preparation of immunofluorescent probes CdTe quantum dots were chosen due to their 
simple preparation described in chapter 2.1.1 in experimental part.  As a ligand, that enables QDs 
solubility in water, 3 - mercaptopropionic acid (MPA) was used. MPA is covalently bound to 
cadmium atoms on QD surface via sulphur atom. Carboxylic groups of MPA give a negative 
charge to QD and remain free for linkage to the molecule of interest. At first, physical and 
chemical properties of quantum dots were characterized. 
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4.1.1.1 Physico-chemical properties of quantum dots 
The use of quantum dots in analytical chemistry becomes trendy due to their extraordinary 
optical properties. The excitation and emission spectra of prepared CdTe QDs were measured 
according to the protocol presented in section 3.1.1.2. The results are shown in Figure 24. 
 
 
Figure 24: Normalized excitation and emission spectra of CdTe QDs with diameter of 3.5 nm.  
 
Excitation spectrum shown in Figure 24 as a blue curve represents the luminescence of QDs 
registered at 610 nm and excited by a light in the range from 250 to 550 nm. The luminescence 
emission spectrum (red curve) is a result of the excitation by UV light at 350 nm. Wide range of 
excitation spectrum from 300 nm to at least 550 nm predestinates the possibility of using 
excitation sources of different wavelengths. On the other hand, emission spectrum exhibits 
narrow distribution with a maximum at 610 nm and full width of 58 nm at half maximum. The 
large distance of the emission and excitation maximum is useful for luminescence 
measurements, because the scattered light from excitation source can be easily removed by 
optical filters. 
Another extraordinary optical property is the tunability of emission maxima wavelengths. The 
maximum emission wavelength increases with increasing of nanoparticle size. This spectral 
tunability has already been published and I plotted the calibration curve for CdTe QDs according 
to the data from the literature [37]. The curve is shown in Figure 25. 
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Figure 25: Dependence of maximum emission wavelength on size of CdTe QDs (construction of 
calibration line is based on data adopted from literature [37]). 
 
All quantum dots diameters in following work were determined from their emission maxima 
wavelengths according to this calibration curve shown in Figure 25.  
The preparation of quantum dots of different diameters was simple; the dominant factor was the 
reflux time of QDs heating. In Figure 26, the dependence of emission spectra of quantum dots on 
reflux time and, therefore on different diameters are demonstrated. 
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Figure 26: Dependence of CdTe QDs emission spectra and sizes on reflux time. 
 
It can be seen from Figure 26, that the reflux time differs from 10 minutes, when the smallest 
dots were prepared, to 44 hours, when the biggest darkly red emitted QDs, were created. The 
first emission spectrum curve shows quite narrow peak, while the last two emission spectra from 
41 h and 44 h display broader peaks; because of the wider size distribution in the sample that was 
heated for a longer time. The luminescence spectra is Figure 26 were normalized, thus the 
luminescence intensity was not equal within the whole range of quantum dot sizes.  
 
CdTe quantum dots with MPA as a ligand exhibit a negative charge due to the carboxylic groups 
on the QD surface. I took advantage of their negative charges to characterize the sizes also by 
slab gel electrophoresis that is usually used for DNA analysis. I injected QDs of different sizes to 
the sample holes without any previous treatment as it is described in section 3.1.1.4. Figure 27 
shows the gel resulting from this separation. 
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Figure 27: Slab gel electrophoresis of QDs of different sizes:  
2.5 nm (line 1), 3.1 nm (2), 3.5 nm (3) and 3.7 nm (4) 
(1 % agarose gel, TRIS/borate buffer, pH = 8.5, 70 V, 2 h) 
 
As it is evident from Figure 27, QDs of different diameters exhibit different colors from light 
blue to yellow-orange. The colors do not correspond perfectly to the maximum emission 
wavelength, because of the influence of additional fluorescence of the separation buffer or 
agarose gel. The migration velocity of QDs of various diameters was different. The velocity of 
the smallest dots was the highest, while the largest ones with diameter of 3.7 nm migrates a little 
bit slower.  
The same method of slab gel electrophoresis was used also for size distribution determination of 
QDs with different ligands. I prepared two sets of quantum dots with mercaptopropionic acid 
(MPA) and thioglycolic acid (TGA) in the same way and analysed them by the gel 
electrophoresis. The results are shown in Figure 28. 
 
 
Figure 28: Slab gel electrophoresis of QDs with MPA (line 1) and with TGA (2) ligands;  
(1 % agarose gel, TRIS/borate buffer, pH = 8.5, 70 V, 2 h) 
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As you can see in Figure 28, QDs with MPA as a ligand are smaller and do not exhibit unique 
size; two types of QDs with different diameters (3.3 and 3.8 nm) were presented in the sample. 
On the other hand, QDs with TGA as a ligand displays unique QDs size (4 nm) with lower 
migration velocity.  
Although the migration velocities of QDs differ according to their sizes, this method was used 
just for a preliminary determination of size distribution of newly prepared dots. For more 
accurate determination of QDs sizes the emission spectra measurements were preferred.  
 
Luminescence lifetimes of prepared CdTe quantum dots were measured as well. QDs exhibits 
longer luminescence lifetimes than conventional fluorophores; for example lifetime of typical 
fluorescent dye - fluorescein isothiocyanate - is 3.8 ns. The long lifetime predestinates quantum 
dots for their application in methods based on time-resolved luminescence measurements. The 
luminescence lifetimes of QDs with different sizes were measured after a short pulse of laser as 
depicted in Figure 29 according to the protocol presented in section 3.1.1.2.  
 
 
Figure 29: Dependence of luminescence lifetime on QDs reflux time. 
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As it is evident from Figure 29, luminescence lifetime increases with increasing QD size. The 
characteristic constant of lifetime τ was calculated as a parameter of single-exponential decay 
curve for practical purposes, although the lifetime’s decays show multi-exponential 
characterization due to the size distribution especially in the samples with higher diameters. The 
following Table 3 shows the different luminescence lifetimes of various QD sizes and the reflux 
time of their preparation. 
 
Table 3: Luminescence lifetimes of QDs of different sizes. 
reflux time quantum dot size (nm) luminescence lifetime  - τ (ns) 
10 min 2.5 3.6 
1 h 2.7 6.7 
2.5 h 3.0 15.6 
13.5 h 4.1 33.2 
16 h 4.4 43.5 
 
The lifetimes differ from 3.6 ns for the smallest dots with diameter of 2.5 nm to 43.5 ns for the 
dots with diameter of 4.4 nm. The luminescence lifetime of the smallest dots is even shorter than 
for fluorescein (3.8 ns), but it increases with increasing particle size. The common analyses can 
be disturbed by fluorescence from buffer components, biological samples or from the excitation 
source noise, when using conventional organic dyes with short fluorescence lifetime. This should 
be avoided using longer lifetime fluorophore, where the detector can be switched on after 
approximately 30 ns after excitation pulse and no fluorescence noise is detectable. The bigger 
quantum dots with long lifetimes can be also used in time resolved luminescence measurements 
and as a donor in fluorescence resonance energy transfer (FRET). 
 
Crude CdTe quantum dots reaction mixture contains a lot of impurities that can cause problems 
in conjugation reactions and decrease the conjugation yield. One of the methods to clean 
quantum dots from their reaction mixture is QDs precipitation with isopropanol, consecutive 
centrifugation of solid material and dissolution in water. Quantum dots cleaned by isopropanol 
precipitation were used for conjugation reactions. Another possibility of crude QDs solvent 
cleaning is the desalting by size exclusion chromatography. For this experiment I used Sephadex 
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G - 15; a stationary phase that is able to retain molecules with 15 000 Da and smaller according 
to the protocol in section 3.1.1.5. Larger molecules do not enter the pores, of stationary phase 
and thus they are not retained in column at all. The record of QDs crude reaction mixture 
desalting detected via contactless conductivity detector is shown in Figure 30. 
 
  
Figure 30: Desalting of quantum dots from the reaction mixture by Size Exclusion 
Chromatography. 
 
Although QDs and the salts from the reaction mixture were not fully separated, I was able to 
collected clean QDs and used them for the measurement of luminescence quantum yield (QY) 
measurement. QY was determined by a secondary method, which assumes that the sample QY is 
related to the QY of standard in the same apparatus under the same conditions [217]. Fluorescein 
dissolved in ethanol with quantum yield of 90 % was used as a standard [22]. Quantum yield of 
MPA-coated quantum dots was 3.5 % before cleaning. After cleaning the QY increased to 8.4 %. 
Unfortunately, cleaned solution of QDs was not stable in water, they precipitated in several days.  
 
 4.1.1.2 Single quantum dot mass determination 
The determination of CdTe individual particle mass was one of the most important parameter for 
following conjugation reaction of quantum dots with biomolecules. Although different authors 
mention in their paper the molar concentrations of quantum dots, they have never published, how 
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they determine mass of a single quantum dot. Also the producers of QDs and their conjugates do 
not provide reliable information; for example PlasmaChem Company from Germany presents at 
their product of CdTe QDs molecular mass of 240 Da, which is simply a sum of cadmium and 
tellurium molecular masses. I determined the mass from the crystal structure that was visualized 
by High Resolution Transmission Electron Microscopy (HRTEM) [218]. The microphotograph 
is depicted in Figure 31. 
 
 
Figure 31: The HRTEM image of CdTe quantum dots. 
 
The HRTEM image shows several quantum dots with distinguishable atomic clusters. By 
comparing the scale of 5 nm, the size CdTe QDs was determined to be 3.5 nm, which confirms 
the size obtained from spectroscopic data (Figure 24). Another parameter confirmed by 
transmission microscopy was the lattice type - cubic face-centered crystal lattice with a lattice 
parameter of 0.648 nm and 8 atoms in every cube. The scheme of single QD is depicted in 
Figure 4. From the single quantum dot size and lattice parameter I was able to calculate the 
number of atoms that create quantum dot. The volume of sphere with diameter of 3.5 nm is 2.24 
× 10-26 m3, while the volume of cube with edge of 0.648 nm is 2.72 × 10-28 m3. Thus by dividing 
these two numbers I got the number of approximately 82.5 that corresponds to the number of 
crystal elements that create a single dot. There are 4 atoms of cadmium and 4 atoms of tellurium 
in every element, so there are 330 atoms of Cd and the same number of Te in sphere. By 
multiplying the number of atoms by their molecular masses, I obtained the single QD mass to be 
QD - 3.5 nm
5 nm
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approximately 79 kDa. This value was used for the calculation of molar concentration of QDs in 
all following experiments. The number of MPA molecules attached to the QD surface was 
evaluated from the ζ-potential that was calculated from the electrophoretic mobilities of QDs in 
different buffer pH and concentrations according to the theory mentioned in section 1.1.1.3. It 
was established that 12 molecules of MPA are covalently bound to the QD with diameter of 
3.5 nm. 
 
4.1.2 Synthesis of immunoluminescence probes 
Extraordinary optical properties together with tunable size distribution make quantum dots 
perfect candidates for the synthesis of immunofluorescence probes. Also the high sensitivity of 
immunochemical reactions and the possibility of detection trace amounts of targeted molecule 
make this combination of techniques attractive for analytical chemistry. I used three types of 
conjugation methods between quantum dots and antibody in this work. Their principles were 
mentioned in theoretical part and their protocols are presented in experimental part in section 
3.1.1.6. The results of various conjugation reactions determined by CE-LIF described in chapter 
3.1.1.3 or polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate (SDS-
PAGE) mentioned in section 3.1.1.8 are presented in following chapters. 
 
4.1.2.1 Conjugation of QDs with antibodies using EDC/sulfo-NHS 
Conjugation using zero-length cross-linkers EDC ((1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride) and sulfo-NHS (N-Hydroxysulfosuccinimide) is the most popular 
method for biomolecules labeling with QDs. These linkers are able to form a covalent bond 
between carboxylic group on the QD surface and amino group of a protein. This method is non-
selective; for example, when conjugating antibody with QD, it can be linked to each part of its 
molecule containing NH2 group, even to the antigen binding site. Thus following 
immunochemical interaction with an appropriate antigen is disabled. The conjugation efficiency 
is then just a question of probability.  
I optimized the conjugation conditions, because the protocols for a conjugation reaction between 
two proteins published in literature were not suitable for a conjugation between antibody and 
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QDs. I found out that it is more suitable to add both cross linkers, EDC and sulfo-NHS to the 
QDs solution directly in a solid state than as a solution, as it is usually recommended in the 
available protocols. When I added linkers as a liquid, QDs created linkage with each other and 
precipitated quickly. Also the time interval needed for an intermediate formation after addition of 
linkers to QD solvent was shortened to minimum. I did not observe any enhancement of reaction 
yield by increasing the temperature to 37°C. Thus, the reaction temperature was maintained at 
room temperature. The pH of reaction solvent was kept at 7.4 by phosphate buffer as was 
recommended in the protocol. At this pH carboxylic groups carry negative charge and amino 
groups are protonated as NH3
+ that is ideal for an effective peptide bond creation. 
 
The products of conjugation reaction were analysed by polyacrylamide gel electrophoresis in the 
presence of sodium dodecyl sulphate (SDS - PAGE), where non-labeled antibodies or their 
fragments can be visualized by Coomassie Blue. I expected that the positions of antibodies 
unlabeled and labeled by QD will be the same. Similarly, the positions of labeled and unlabeled 
immunocomplexes should be the same. In Figure 32 free quantum dots, both labeled and non-
labeled anti-ovalbumins, both labeled and non-labeled ovalbumins together with both types of 
immunocomplexes were separated by gel electrophoresis. Free anti-ovalbumin has molecular 
mass 150 kDa, ovalbumin 45 kDa and their immunocomplex should have either 195 kDa or 240 
kDa, depends if one or two antigen binding site are occupied by antigen. The sample was 
prepared by a standard procedure, where sample is boiled with sample buffer containing SDS 
and β-mercaptoethanol. 
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Line number  sample type 
1  quantum dots  
2  labeled anti-OVA with 
QDs  
3  complex of ovalbumin 
and labeled anti-OVA  
6  anti - OVA  
7  ovalbumin 
8  complex of anti - OVA 
and ovalbumin  
 
Figure 32: SDS - PAGE of QDs conjugate with anti-ovalbumin using EDC/sulfo-NHS method 
and its complex with ovalbumin as an antigen stained with Coomasie Blue. Analysis conditions: 
9% gel, separation voltage - 180 V, separation time - 70 min, sample prepared in the presence of 
SDS and β-mercaptoethanol. 
 
In Figure 34 there is no picture of the gel under UV light because no apparent luminescence was 
visible except of the first line of free QDs that exhibit slight luminescence on the bottom of the 
gel. Free anti - ovalbumin in the line 6 shows at least 9 lines; four of them in the region between 
approximately 120 kDa and 150 kDa. One of the two lines closest to the top of the gel can 
correspond to whole antibody molecule. Other five darker lines are apparent in the bottom part of 
the gel in the molecular mass range from 45 kDa to approximately 85 kDa. The most apparent 
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dark area around 60 kDa probably does not correspond to antibody heavy chain, but to the 
antibody solvent impurities. There are a lot of protein impurities in the antibody solvent, because 
monoclonal anti-ovalbumin is available only as mouse ascetic liquid, where also other proteins 
and antibodies are presented. Free ovalbumin at line 7 shows single dark blue line at 45 kDa that 
corresponds to its molecular mass. The mixture of anti-ovalbumin and ovalbumin at line 8 do not 
show any of the two predicted lines at 195 kDa and 240 kDa. Although these lines would not be 
perfectly apparent at the top of the gel, there is even no line apparent at the start position in 
comparison with molecular mass standard of 200 kDa that remained at the start position. Labeled 
anti-ovalbumin and immunocomplex at lines 2 and 3 shows exactly the same characteristic as 
non-labeled samples. Thus either the conjugation procedure was not successful or the conjugate 
was destroyed by the sample preparation conditions, because both SDS and β-mercaptoethanol 
took part in sample buffer. SDS is a surfactant, which is able to disrupt non-covalent linkages in 
the proteins structure, and thus change their conformation or the linkage between antigen and 
antibody. β-mercaptoethanol is able to cleave disulfide bonds of proteins, and thus their tertiary 
and quaternary structure or “Y”- shaped structure of antibody molecule linked by disulfide 
bonds. 
I prepared a native PAGE without using SDS and of β-mercaptoethanol in the sample buffer to 
avoid the antibody or immunocomplex cleavage. No SDS was also added to the polyacrylamide 
gel and electrode buffer as it is described in section 3.1.1.9. The analysis of non-labeled samples 
together with labeled conjugates of anti-ovalbumin with QDs with two different ligands, 
mercaptopropionic acid (MPA) or with thioglycolic acid (TGA), is shown in Figure 33. 
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Line number  sample  
1 quantum dots  
2 ovalbumin (OVA) 
3 anti-OVA and ovalbumin 
4 anti - OVA 
7 QD - MPA conjugate of anti-OVA 
8 QD - MPA complex of anti-OVA and ovalbumin 
9 QD - TGA conjugate of anti-OVA 
10 QD - TGA complex of anti-OVA and ovalbumin 
 
 
Figure 33: Native PAGE of QDs conjugate with anti-ovalbumin using EDC/sulfo-NHS method 
and its complex with ovalbumin as an antigen stained with Coomassie Blue - A and under UV 
light - B. Analysis conditions: 10% gel, separation voltage - 180 V, separation time - 60 min, 
sample prepared in non-denaturing conditions. 
 
Quantum dots exhibit in Figure 33 A a black line at the bottom of the gel that corresponds to the 
red luminescence line under UV light in Figure 33 B. Line 2 of free ovalbumin does not show 
any apparent single line, only two blue areas in the middle and at the bottom part of the gel. Free 
anti-ovalbumin at line 4 has nine apparent lines as it exhibits in the previous gel as well. The 
immunocomplex at line 3 does not show any new band; only the concentration of the sample was 
higher. The others four lines 7 - 10 of QDs conjugates and immunocomplexes does not show any 
1         2        3     4        7       8       9       10 1    9   10
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additional peak in the lines of immunocomplexes in comparison with lines of conjugates. 
Although anti-ovalbumin and immunocomplex labeled with QDs with MPA at line 7 and 8 do 
not exhibit any luminescence, anti-ovalbumin and immunocomplex labeled with QDs with TGA 
at line 9 and 10 exhibit apparent red luminescence under UV light in Figure 33 B. These broad 
zones could be mixtures of antibodies and immunocomplexes labeled at different positions or 
conjugates with multiple labeles or two protein molecules can be linked by a QD. Also unknown 
impurities can be the reason of unresolved broad zones. However, polyacrylamide gel 
electrophoresis did not certainly confirmed either the creation of labeled antibody conjugated 
using EDC/sulfo-NHS method or the immunocomplex formation after addition of ovalbumin.  
 
For the next analyses, CE-LIF was used. In Figure 34, there is a result of a CE-LIF analysis of 
crude reaction mixture after the conjugation of monoclonal anti-ovalbumin with CdTe QDs. 
Here, two electropherograms, the reaction mixture of labeled monoclonal anti-ovalbumin (black) 
and the same mixture after the addition of free QDs (red) are compared.   
 
 
Figure 34: CE-LIF analysis of anti-ovalbumin conjugated with QDs using EDC/sulfo-NHS 
method and free QDs. Analysis conditions: uncoated capillary 12/20 cm, BGE: 0.1 mol/l 
TRIS/TAPS pH = 8.3, separation voltage 6 kV, injection 5 s. 
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As can be seen in Figure 34, black line of labeled anti-ovalbumin forms a broad single peak at 
2.4 min. If free QDs solution is added to labeled antibody, another broad peak is created at 3.2 
min. The breadth of the QDs peak can be caused by size distribution. The absence of the free 
QDs peak at the black line of labeled antibody confirmed that QDs were conjugated completely. 
The labeled antibody peak is quite wide as well; this can be caused by the heterogeneity of 
antibody molecules, which results not only in the size differences, but also in various pI values of 
the molecule. Also the facts that antibody solution contains many impurities and that QD should 
bind to different parts of antibody molecule can contribute to the peak breadth. CE-LIF was also 
used for the immunocomplex formation verification. The anti-ovalbumin was conjugated to QDs 
in the same way like it is described in experimental part. Afterwards, ovalbumin as an antigen 
was added to the labeled antibody and the formation of labeled immunocomplex was detected. 
The records of labeled anti-ovalbumin in black, immunocomplex formation after ovalbumin 
addition in red and the same record after free QDs addition in blue are presented in Figure 35. 
 
 
 
Figure 35: CE-LIF separation of labeled anti-ovalbumin using EDC/Sulfo-NHS method (black 
line), its immunocomplex with ovalbumin (red line) and immunocomplex after addition of free 
QDs (blue line). Analysis conditions: uncoated capillary 15/25 cm, BGE: 0.1 mol/l TRIS/TAPS 
pH = 8.3, separation voltage 6 kV, injection 5 s. 
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Figure 35 shows the clear resolution of three zones. A broad peak presented in all 
electropherograms belongs to labeled antiovalbumin, narrow peak in red and blue records belong 
to peak of immunocomplex and a broad peak in blue electropherogram is the peak of free QDs. 
The absence of the third peak of free QDs in the first black electropherogram of labeled antibody 
signifies that the conjugation was complete as shown in previous Figure 32. I was not able to 
detect the immunocomplex immediately after antigen addition; the immunocomplex in Figure 35 
was detected after 2 days, when the sample was stored in the fridge. The peak of 
immunocomplex is much narrower than the one of labeled antibody. This phenomenon has 
already been described in literature [62]. The peak narrowing can be caused by the fact, that only 
a limited number of labeled antiovalbumin is able to create the immunocomplex with antigen. 
Some antigen binding sites of labeled antibodies should be occupied by QD.  
 
Not only antibodies but also specific proteins can be conjugated to QDs as selectors for certain 
molecules in the cell. The proteins usually do not have such a complex structure like antibody 
and thus the problems with antibody heterogeneity can be avoided. Annexin V, protein consisted 
of 320 amino acids with molecular mass of 33 kDa [219], was selected due to its possible 
application in apoptotic cell detection. Annexin V is able to form a complex with 
phosphatidylserine translocated from the interior to the exterior part of cell membrane during 
apoptosis [220]. I conjugated annexin V to QDs using EDC/sulfo-NHS method and analysed the 
conjugation product by CE-LIF as it is depicted in the following Figure 36. 
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Figure 36: CE-LIF of coumarin as an EOF marker, QDs conjugated with annexin V using 
EDC/Sulfo-NHS method and free quantum dots. Analysis conditions: uncoated capillary 
15/25 cm, BGE: 0.1 mol/l TRIS/TAPS pH = 8.3, separation voltage 6 kV, injection 15 s. 
 
Black line in Figure 36 corresponds to the electroosmotic flow marker - coumarin, blue line 
corresponds to labeled annexin V and red line shows the position of free QDs. Also here, the 
conjugation reaction run completely and no free QDs remain in reaction mixture. The labeled 
antigen formed three narrow peaks that belong probably to the multiple labeled annexin V. I used 
the conjugate of annexin V as a selector for apoptotic cells of mouse duodenum. The results of 
this assay are presented in Figures 55 and 56 in section 4.1.4.2. 
 
Although the method of zero-length cross-linkers EDC/sulfo-NHS is widely used for conjugation 
of peptides and proteins, its successful application for conjugation of quantum dots with proteins 
and antibodies needed optimization. Even though no labeled antibody was detected using 
polyacrylamide gel electrophoresis, by analysis of conjugation product using capillary 
electrophoresis with laser induced fluorescence I was able to detect labeled anti-ovalbumin 
(Figure 34), selector protein (Figure 36) and labeled immunocomplex as well (Figure 35).  
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4.1.2.2 Conjugation of QDs with antibodies using CDI 
Except of zero-length cross-linkers used in previous chapter, carbonyldiimidazole (CDI) have 
similar conjugation properties and is able to create a peptide bond between amino and carboxyl 
groups. Additionally CDI is able to conjugate also amino and hydroxyl group to form carbamate 
linkage. This could be used for multiple labeling of QDs with different ligands on the surface. I 
conjugated the same antibody as in previous section - anti-ovalbumin with quantum dots and I 
analysed the conjugation product by CE-LIF as it is shown in Figure 37. 
 
Figure 37: CE-LIF separation of labeled anti-ovalbumin using CDI method and free QDs. 
Analysis conditions: uncoated capillary 12/20 cm, BGE: 0.1 mol/l TRIS/TAPS pH = 8.3, 
separation voltage 6 kV, injection 5 s. 
 
In Figure 37 only single electropherogram with two peaks is presented. The first peak 
corresponds to the labeled antibody and the second to QDs that did not participate in conjugation 
reaction and thus remained free in the solvent.  
 
4.1.2.4 Oriented conjugation via oxidized glycans 
The best method to avoid the possibility of blocking the antigen binding site on antibody 
molecule, is using an oriented conjugation technique, described in section 1.1.2.4. This technique 
is advantageous, because of the presence of glycans on antibody heavy chain in Fc region that 
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are placed far away from the antigen binding sites. The hydroxyl groups of these glycans are 
oxidized to form aldehyde groups. The originated aldehyde groups are highly reactive towards 
the hydrazides at QD surface modified previously with adipic acid dihydrazide. The products of 
conjugation anti-ovalbumin with QDs using the oriented method were analysed by CE-LIF as it 
is shown in Figure 38.  
 
 
Figure 38: CE-LIF of free QDs (black line) and anti-ovalbumin conjugated with QDs using 
oriented method with excess of free QDs (blue line). Analysis conditions: uncoated capillary 
12/20 cm, BGE: 0.05 mol/l TRIS/TAPS pH = 8.3, separation voltage 6 kV, injection 5 s. 
 
In Figure 38 the electropherogram of labeled anti-ovalbumin is depicted in red. It shows three 
peaks, where the first correspond to the coumarin as an EOF marker, second to labeled antibody 
and third to free QDs. The electropherogram of free QDs is presented in black; two peaks 
observed in this record correspond to EOF marker and free QDs. This confirms the position of 
the third peak as peak of free QDs. I also conjugated antibody to CD3 protein with QDs using 
the oriented technique. The results of this conjugation are shown in Figure 39. 
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Figure 39: CE-LIF of antibody to CD3 protein conjugated using oriented method (black line) 
and the same conjugate after addition of free QDs (red line). Analysis conditions: uncoated 
capillary 12/20 cm, BGE: 0.05 mol/l CAPS pH = 11.2, separation voltage 6 kV, injection 5. 
 
Labeled anti - CD3 is shown in Figure 39 as a red electropherogram with three peaks of EOF 
marker, labeled antibody and free QDs again. The black electropherogram shows the labeled 
anti-CD3 after QD addition; where the increase of the third peak confirms the position of free 
QDs. Both records presented in Figures 38 and 39 of conjugated antibodies with QDs keep 
similar characterization although the migration times are different due to the different conditions 
used during CE-LIF analysis. 
 
The products of conjugation via oriented glycans were analysed also by SDS - PAGE. The same 
labeled antibodies, anti-ovalbumin and anti - CD3, analysed by CE-LIF were used in following 
analysis by gel electrophoresis. Samples were shortly boiled with sample buffer in different 
ratios (1:1 or 2:1 ~ sample : sample buffer). There was no β- mercaptoethanol in this sample 
buffer. The results are shown after Coomassie Blue staining and under UV light in Figure 40. 
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Line number  sample  
5 
conjugate of anti-CD3 (2:1, 
sample:sample buffer) 
6 conjugate of anti-CD3 (1:1) 
7 conjugate of anti-OVA (1:1) 
8 conjugate of anti-OVA (2:1) 
9  molecular mass marker  
 
Figure 40: SDS - PAGE of QDs conjugates with different antibodies using oriented method 
stained with Coomassie Blue - A, under UV light - B. Analysis conditions: 10% gel, separation 
voltage - 180 V, separation time - 30 min, samples prepared in the presence of SDS. 
 
The separation of anti-CD3 conjugated with QDs using oriented method is presented in lines 5 
and 6, while anti-ovalbumin conjugated by the same method in lines 7 and 8 in Figure 40. There 
was an excess of QDs in all the samples; this fact signifies black bands in the bottom of the 
stained gel and highly luminescence bands in the gel illuminated by UV light. In lines 5 and 6 
there are two stained areas around 75 and 50 kDa in Figure 40 A. These areas could signify one-
half of antibody molecule (75 kDa) and heavy chain of antibody (50 kDa). In addition, the area 
at 75 kDa is also luminescent as it is shown in Figure 40 B. Thus anti-CD3 molecule was 
probably labeled successfully, but it was cleaved by boiling during the sample preparation 
process. In the lines 7 and 8 anti-ovalbumin exhibits different characterization. There are two 
BA
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bands around 50 kDa and one band again in 75 kDa that is luminescent as in previous case with 
anti-CD3. Another band is presented in 25 kDa close to the gel bottom. This value corresponds 
to antibody light chain. Unfortunately the luminescence of this band was not display, because 
this part of the gel is already higly luminescent due to the QDs excess in the sample.  
To avoid the possibility of destroying sample during the preparation process I analysed the 
samples using native PAGE without any boiling or SDS presence. The analysis of non-labeled 
samples together with labeled conjugates of QD with TGA as a ligand is shown in Figure 41. 
 
Line 
number  
sample  
1 quantum dots  
2 ovalbumin 
3 anti-OVA and ovalbumin 
4 anti - OVA 
5 QD - TGA conjugate of anti-OVA 
6 QD - TGA complex of anti-OVA and ovalbumin 
 
Figure 41: Native PAGE of QDs conjugate with anti-ovalbumin using oriented method and its 
immunocomplex with ovalbumin as an antigen stained with Coomassie Blue - A, under UV light 
- B. Analysis conditions: 10 % gel, separation voltage - 180 V, separation time - 60 min, samples 
prepared in non-denaturing conditions. 
1         2        3     4        5       6 1    5     6
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Lines 1 - 4 in Figure 40 correspond to the same lines in Figure 33. Free quantum dots show black 
band at the bottom of the gel in Figure 40 A and red luminescence band under UV light in Figure 
40 B. The lines of non-labeled antiovalbumin (4) and immunocomplex (5) exhibit the same 
characterization. In line 6, no additional band of immunocomplex is presented in comparison 
with line 5 of labeled antibody. In Figure 43 B, very slight red luminescence is apparent on the 
top of the gel in lines 5 and 6. These areas, that are much smaller than the luminescence areas in 
Figure 33 B, could signify higher selectivity of oriented method when compared with 
conjugation using EDC/sulfo-NHS, because only glycosylated proteins could be labeled using 
oriented method. 
 
Although I tried to analyse the immunocomplexes formed by addition of ovalbumin to anti-
ovalbumin labeled with quantum dots via oxidized glycans by both SDS-PAGE and CE-LIF, I 
was no able to detect the immunocomplex formation as in EDC/sulfo-NHS method presented in 
Figure 36. Thus, I made another experiment, where both magnetic and luminescence properties 
of immunocomplex were verified.  
 
4.1.2.5 Preparation of probes with combined luminescence and magnetic properties  
The promising application of quantum dots is the synthesis of combined probe with both 
luminescence and magnetic properties. Such probe can be visualized by fluorescence microscopy 
and simultaneously manipulated using permanent magnet.  
I verified the effectivity of conjugation procedures to both CdTe quantum dots and SiMAG 
magnetic particles. Magnetic particles used in this work are made from ferric oxide core and 
silica matrix with hydrazide ligands on the particle surface. I conjugated anti-ovalbumin with 
magnetic particles using oriented conjugation method. After the antibody glycans were oxidized 
to form aldehyde groups, the hydrazide groups from magnetic particles spontaneously reacted 
with them to form hydrazone linkages. Such conjugated antibody was mixed with ovalbumin 
conjugated to QDs using EDC/sulfo-NHS method. After the incubation, the suspension of 
immunocomplex labeled with both quantum dots and magnetic particles was formed and 
transferred to a sealed glass capillary and observed in white light and under epifluorescence 
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microscope as can be seen in following Figure 42. Whole protocol is described in section 
3.1.1.13. 
 
 
Figure 42: Attraction of immunocomplex:  anti-ovalbumin conjugated with magnetic particles 
and ovalbumin conjugated with QDs. Microphotograph in white light - A, under epifluorescent 
microscope with emission filter 590 nm - B. Magnification 25 x. 
 
SiMAG magnetic particles have diameter 1 µm and thus can be nicely visualized in white light 
by the magnification of 25 as seen in Figure 42 A. In Figure 42 B there is the same labeled 
immunocomplex in fluorescence mode. The pin-tip that is present in both parts of Figure 42 was 
magnetized using permanent magnet and stained by QD solution for tip visualization in 
epifluorescence microscope. Figure 43 shows the magnetic property of synthesized 
immunocomplex. The magnetized pin-tip was moved to the right and the magnetic particles 
changed their position in capillary according to the induced movement.  
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Figure 43: Immunocomplex of anti-ovalbumin conjugated with magnetic particles and 
ovalbumin conjugated with QDs follows magnetized pin-tip. Illumination in white light - A, 
under epifluorescence microscope with emission filter 590 nm - B. Magnification 25 x. 
 
As it is obvious from Figure 43 not only magnetic particles alone, but whole immunocomplex 
moved according to the magnetized pin-tip movement. This experiment was designed to verify, 
whether only free quantum dots were adsorbed on the magnetic particles. The sealed capillary 
was rinsed with distilled water to washed out nonspecifically bound quantum dots. Even when 
the flow rate reached relatively high value of 1 ml/min, the immunocomplex was held by 
magnetized pin-tip and its luminescence was preserved. 
 
In the previous chapters I used two separation methods to verify the effectivity of conjugation, 
PAGE and CE-LIF. Each of the previously mentioned methods has its advantages in this type of 
analysis. PAGE enables the precise characterization of antibody fragments or impurities by 
comparison with standard molecular mass marker after gel staining together with luminescence 
characterization after UV light exposition. On the other hand, CE-LIF enable very sensitive 
detection of luminescent analytes, while non-labeled impurities are not detected. I tested three 
different types of conjugation procedures: two with zero-length cross linkers (EDC/sulfo-NHS 
and CDI method) and one method of oriented conjugation. Using all these methods I was able to 
detect conjugation product - labeled antibody. The migration velocity of such product was 
always different than the velocity of free quantum dots. On the other hand the labeled 
immunocomplex was confirmed by CE-LIF only when I conjugate the anti-ovalbumin with QDs 
using EDC/sulfo-NHS method. The immunocomplex formation was also confirmed by synthesis 
pin-tip
sealed capillary
magnetic particles 
conjugated to anti-OVA
quantum dots 
conjugated to OVA
pin-tip
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of probe with fluorescence and magnetic properties, where antibody was conjugated with 
magnetic particles using oriented conjugation method and antigen was conjugated to quantum 
dots using EDC/sulfo-NHS method. Because of the successful immunocomplex formation and 
simple working procedure I used EDC/sulfo-NHS as a conjugation method for the following 
analysis of antibody fragments and specific cell imaging. 
 
4.1.2.6 Conjugation of an antibody fragment 
One of the possibilities for simplify antibody molecule while keep its binding side is the 
preparation of various antibody fragments [221]. For an antibody molecule cleavage to F(ab´)2 
fragment containing antigen binding side and Fc fragment, that usually carries more molecule 
modifications, I used commercially available FabRICATORTM kit presented in section 3.1.1.7. 
This kit includes proteolytic enzyme pepsin, which cleaves the antibody molecule at one specific 
site below the hinge region and magnetic particles with Protein A that serves for separation of Fc 
fragment and FabRICATOR enzyme from the reaction mixture. Since FabRICATOR is able to 
cleave all types of IgG except of mouse that I used in all previous experiments, for this single 
experiment, I chose rabbit anti-hemagglutinin. At first this antibody was analysed by ESI-MS. 
Result is depicted in Figure 44. 
 
Figure 44: MS spectra of anti-hemagglutinin without treatment. 
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As you can see in Figure 44, native antibody creates an envelope typical for proteins analysed by 
electrospray ionization, but not well distinguished. This is due to the fact, that IgG molecule is 
large (150 kDa) and heterogenic by different posttranslational modifications. To reduce the 
molecular mass and the heterogeneity I analysed F(ab´)2 fragment of the same antibody created 
by the FabRICATOR enzyme (Figure 45).  
 
 
Figure 45: MS spectra of F(ab´)2 fragment of anti-hemagglutinin after FabRICATOR treatment. 
 
Figure 45 shows ESI - MS analysis of F(ab´)2 fragment of anti-hemagglutinin. The fragment 
creates even worse distinguished envelope than whole molecule. Also the signal intensity was 
much lower when analysing this fragment probably due to the sample dilution during 
FabRICATOR treatment. It was not possible to interpret molecular masses from whole antibody 
or its fragment from both presented MS spectra. Beyond the problems with MS analysis, I 
conjugated native anti-hemagglutinin and its F(ab´)2 fragment with quantum dots using 
EDC/sulfo-NHS method and analysed these conjugates by CE-LIF as you can see in Figure 46. 
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Figure 46: CE-LIF of QDs conjugate with anti-hemagglutinin using EDC/sulfo-NHS method 
without any treatment (black line) and after treatment with FabRICATOR (red line). Analysis 
conditions: uncoated capillary 15/25 cm, BGE: 0.1 mol/l TRIS/TAPS pH = 8.3, separation 
voltage 6 kV, injection 40 s. 
 
The red line in Figure 46 corresponds to F(ab´)2 fragment conjugate analysis and black line to the 
analysis of native antibody. The red line electropherogram shows one intensive narrow peak and 
three low-intensity peaks. Although there is no direct evidence, three small peaks could be the 
result of twice or more labeled F(ab´)2 fragment. On the other hand the black line 
electropherogram of antibody conjugate exhibits at least eight not very well resolved peaks that 
indicate complex mixture of conjugation products. The differences in both electropherograms 
illustrate the increase in homogeneity when analysing F(ab´)2 fragment conjugate.  
 
4.1.4 Cell imaging  
QDs were used in fluorescence imaging of cells and tissues many times [58, 59, 185]. The 
tunability of QDs size, and thus emission wavelength together with QDs color is advantageous in 
multiply cell imaging. Various QDs of different colors can be conjugated with various antibodies 
and specific ligands to visualized proteins under a fluorescence microscope. At first, non-specific 
imaging of whole cells using free QDs and then specific protein imaging using luminescence 
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probes based on QDs was proved. The respective protocols are presented in sections 3.1.1.10 and 
3.1.1.11. 
 
4.1.4.1 Non-specific cell imaging using quantum dots 
As model experiments CdTe QDs without any selector on their surfaces were examined. These 
experiments allow testing and optimizing our optical detection systems and prove the 
compatibility of QDs with living systems for in vivo applications. It was proved that 
nanoparticles can penetrate to the cells by endocytosis [215]. Since QDs are compounds of toxic 
metals, in the case of this work cadmium and tellurium, they can cause cell death. To avoid this 
problem, QDs are usually coated layers of compounds of non-toxic metal, e.g. ZnS.  
I used two types of cells for testing non-specific cell imaging, yeast Saccharomyces cerevisiae 
that is used in food industry and human lymphocytes separated from the human blood in hospital 
laboratory. In Figure 47, the same yeast cells of Saccharomyces cerevisiae are visualized as a 
phase contrast in white light and in luminescence mode. 
 
 
Figure 47: Saccharomyces cerevisiae labeled with QDs illuminated in white light - A, under UV 
light of mercury lamp (excitation range from 420 - 485 nm) - B. Magnification 1000 x. 
 
While in Figure 47 A approximately 8 yeast cells are visible in white light, only 2 sells can be 
resolved in luminescence mode in Figure 47 B. They are labeled in red on the cell surface. The 
same visualization as was shown in yeast cell is presented also in Figure 48. There is the same 
human lymphocyte displayed under microscope in the white light and in luminescence mode.  
A B 
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Figure 48: Human lymphocyte labeled with QDs illuminated by white light - A, under laser light 
532 nm - B. Magnification 1000 x. 
 
The lymphocyte is labeled with QDs on the cell membrane as in the case of yeast cell. Human 
lymphocyte was also observed in Total Internal Reflection Fluorescence (TIRF) microscope, 
where very narrow layer of the sample (hundred nanometers) is excited by evanescent wave, 
which enables to visualize objects on cellular membranes. This method significantly increases 
contrast and resolution of obtained images as it is depicted in Figure 49. 
 
 
Figure 49: TIRF image of human lymphocyte non-selectively labeled by QD. 
 
To verify the endocytosis intake of QDs into the cell I left both cell types in the QDs solution for 
a certain time and observed the quantity of nanoparticles intake. In Figure 50, a human 
lymphocyte is presented at different periods of time after the QDs addition to the cell suspension. 
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Figure 50: Non-selective luminescent labeling of human lymphocyte with QDs. Magnification 
1000 x. 
 
As it is evident from Figure 50, luminescence intensity increases with the time. After one hour 
some parts of the cell are already visible, while after 2.5 hours whole cell is highlighted by QDs. 
I did the same test also with yeast cells of Saccharomyces cerevisiae, whose visualization is 
shown in Figure 51.  
 
 
Figure 51: Non-selective luminescent labeling of Saccharomyces cerevisiae with free QDs. 
Magnification 1000 x. 
 
The intake of QDs into the yeast cells took much longer time than this of lymphocytes. Some 
luminescence is apparent after three hours, while the steady state is reached after 22 hours. These 
results signify that specific cell imaging of selected compartments or proteins have to be realized 
within an hour for human lymphocytes or three hours for yeast cells to avoid the interferences 
with free QDs intake. Other possibility to avoid this problem is separation of free QDs from the 
labeled antibody prior to the mixing with cell suspension.  
1 h 2 h 2.5 h
3 h 5 h 22 h
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4.1.4.2 Specific cell imaging using immunoluminescent probes based on quantum dots 
Specific imaging has a greater biological importance in comparison with the non-specific. Not 
only cellular organelles or specific proteins can be visualized by differently colored QDs; they 
can be also used in flow cytometry instead of traditional fluorophores [222].  
At first I conjugated antibody against FAS protein using EDC/sulfo-NHS method and added the 
labeled antibody to the suspension of human lymphocytes. The FAS protein is a transmembrane 
protein that plays role in the programmed cell death (apoptosis) after binding with its specific 
receptor. The same abeled human lymphocytes illuminated by white light and in luminescence 
mode are presented in following Figure 52. 
 
  
Figure 52: Human lymphocyte in white light - A, labeled with QDs conjugated to FAS antibody, 
mercury lamp (excitation range from 420 - 485 nm, emission at 515 nm and more) - B, 
magnification 1000 x. 
 
As it is shown in Figure 52 B, the uneven intensity of luminescence reflects a veried density of 
some FAS proteins/receptors on the lymphocyte membrane. Next, I conjugated also antibody 
against FADD protein with QDs using the same method with EDC/sulfo-NHS. FADD (Fas 
Associated Death Domain) protein takes part in apoptosis as well; it makes the connection 
between FAS receptor and procaspase 8 during programmed cell death. Figure 53 shows the 
same human lymphocyte in white light and in luminescence mode. 
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Figure 53: Human lymphocyte in white light - A, labeled with QDs conjugated to FADD 
antibody, laser excitation at 532 nm, emission at 590 nm - B, magnification 1000 x. 
 
As it is evident from Figure 53 A, human lymphocyte is already not intact. The cell membrane 
had been broken and the inner content was poured out. The inner content outside the cell 
membrane is highlighted. Thus, either the programmed cell death has already started or the cell 
membrane was broken, because of differences in inner and outer osmotic pressure. The 
luminescence areas probably correspond to the positions of FADD proteins, although no labeled 
intact cell was found in the sample. This can signify that FADD protein, placed in cytoplasm, 
can be labeled only when the cell apoptosis already started and the cellular membrane is 
disturbed.  
 
To verify the conjugation efficiency I conjugated QDs to anti-CD3 protein using EDC/sulfo-
NHS method. CD3 protein complex is presented only at T-lymphocytes, while B-lymphocytes 
do not contain any CD3 protein. Thus, the suspension of human lymphocytes was separated to T- 
and B- types in density gradient and a solution of conjugated antibodies were added to both 
portions. The microscope images of both types of lymphocytes types are shown in Figure 54. 
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Figure 54: Selective imaging of human lymphocytes labeled with QDs conjugated to CD3 - 
antibody; T-lymphocyte (A), B-lymphocyte at longer exposition time (B). Magnification 1000 x. 
 
A T-lymphocyte shows red luminescence immediately after the mixing with QDs conjugate as it 
is shown in Figure 54 A, while B - lymphocytes remain unlabeled although the exposition time 
was increased 10 – 100 times (Figure 54 B). Thus, the B-lymphocyte is visualized as a black cell 
in the red field due to the collection of the background luminescence 
. 
QDs were conjugated also to annexin V using EDC/sulfo-NHS method. The CE-LIF separation 
is presented in Figure 36 in section 4.1.2.1. Here, the application in fluorescence microscopy is 
presented. I mixed the labeled annexin V, a small protein that is able to make a complex with 
phosphatidylserine in the membrane of apoptotic cells, with mouse duodenum tissue previously 
treated with enzyme biotase to induce apoptosis as it is described in section 3.1.1.12. Labeled 
tissue is shown in Figure 55.  
 
 
Figure 55: Mouse duodenum tissue in white light - A, labeled with QDs conjugated to annexin V 
and excited by laser light at 532 nm, emission 590 nm - B. Magnification 1000 x. 
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In Figure 55 A mouse duodenum tissue is depicted in white light, while Figure 55 B shows the 
same tissue under epifluorescence microscope, where some areas are highlighted by labeled 
annexin V conjugate. To avoid the nonspecific labeling, I mixed the mouse duodenum tissue also 
with free QDs. The result from epifluorescence microscope is shown in Figure 56. 
 
 
Figure 56: Control: Mouse duodenum tissue in white light - A, labeled with QDs alone excited 
by laser light at 532 nm, emission at 590 nm - B. Magnification 1000 x. 
 
Figure 56 A shows the duodenum tissue in white light and Figure 56 B in fluorescence mode. As 
it is evident the tissue was not labeled by free QDs, because no red luminescence is apparent in 
Figure 56 B, although the camera exposition time was prolonged to 13.5 s instead of 2 s used in 
previous experiment. The violet color in Figure 56 B is caused by the fluorescence of the 
background under the long time exposition.  
 
QDs conjugated with various antibodies (anti-FAS, anti-FADD, anti CD3) or proteins 
(annexin V) were used in specific cell imaging. The EDC/sulfo-NHS method was chosen for all 
of these successful conjugations, which were verified by epifluorescence microscopy. The 
adsorption of free QDs was avoided by different negative control measurements, e.g. in by 
comparison of T- and B-lymphocytes or in the test with mouse tissue. The method of the specific 
cell and tissue labeling, verified in several examples in this work, could be used for the detection 
of molecules of interest in single cells, even in multicolor imaging, when QDs of different sizes 
will be used for conjugation with different antibodies.  
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4.2 Comprehensive proteomics 
 
The aim of proteomics is the characterization and explanation of the protein role in organisms, 
protein interactions with other compounds and the characterization of qualitative and quantitative 
changes during biological processes. The comparison of proteomes from two or more specimen 
of the same organism that have grown in different conditions together with searching and 
identifying of different proteins is the aim of comprehensive proteomics. Proteome is constantly 
modified as a response to environmental changes and drug treatment together with growth or 
disease processes. 
Environmental proteomics is relatively new field that studies the response of organisms to the 
changes in the environment. The study of organism´s proteome allows the detection of changes 
of proteins amounts and functions. This new proteomic topic is still limited by the low number of 
microorganisms presented in the DNA sequence databases and high genetic variability of 
organisms participated in the degradation process in the environment. 
Comprehensive proteomic approach was applied to the red yeast system that was exposed to 
environmental salt stress in this thesis. The aim was the verification of application of new 
instrumentation techniques for studying the influences of the stress exposition to the living 
systems. Similar methodologies should be applied also in other fields of environmental and 
clinical proteomics. 
 
4.2.1 Analysis of proteins by 2D electrophoresis followed by LC - MS/MS 
(Identification of proteins from carotenogenic yeast Rhodotorula glutinis) 
Carotenogenic yeast is a general term that covers yeast species producing carotenogenic 
pigments in their membranes as a protection against UV radiation. These pigments work as 
protective factors against photo oxidation; they turn off the singlet oxygen and inhibit the 
peroxide radicals. In a human body they serve as an antioxidant and anticarcinogenic 
compounds. These pigments are generated in yeast secondary metabolism and their production 
can be increased by methods of genetic engineering or by modification of cultivation conditions 
that include the application of appropriate stress factors. One of the techniques with a great 
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influence to carotenoids production is the use of salt or oxidative stress applied to the yeast 
culture during growing. The effect of these two stresses on the pigments production in 
carotenogenic yeasts has been widely studied to find the maximal amount of stress factor 
addiction leading to higher production of carotenogenic pigments without restriction of other 
growing and metabolic properties [183, 184, 188, 223, 224].  
When a stress factor is added to the yeast culture, the production of pigments is changed together 
with the proteomic apparatus necessary for their metabolism. To study the differences in 
metabolic pathways of carotenogenic compounds production under stress, the knowledge of 
protein composition is useful. Together with enzymes that catalyze the metabolic pathway, the 
protein composition is changed due to the stress application. The stress response mechanism 
includes the synthesis of specific stress proteins that help other proteins to keep their structure 
and shape and thus their appropriate function.  
Rhodotorula glutinis (RG) is well studied representative of carotenogenic yeast [183, 188]. It 
produces mainly β-carotene that is generated in long secondary phase of well studied growth 
curve. To increase the β-carotene production, the salt stress was applied to the Rhodotorula 
glutinis culture by addition of 2 % NaCl to the production media (section 3.2.1.1). After the 
cultivation, proteins were extracted by glass beads and IPG buffer and than they were separated 
by 2D gel electrophoresis (section 3.2.1.3). In Figures 57 and 58 the pictures of 2D gels of the 
separation of both unstressed and stressed samples are presented. The gel photos were analyzed 
by Image Analysis Software after the separation and spots, which intensity differs by a factor of 
5 or higher were highlighted. In this case, 79 proteins, which production was down-regulated and 
89 proteins, which production was up-regulated after the stress application were found. Figure 57 
shows the protein separation of control sample. 
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Figure 57: 2D electropherogram of RG control sample, identified proteins down-regulated after 
stress application are highlighted in green. 
 
There are spots of the proteins highlighted in green of the control sample of Rhodotorula glutinis 
culture, to which no stress has been applied. Those 19 highlighted proteins correspond to 
proteins down-regulated after the stress application that were finally identified in the 
identification process. In Figure 58, the separation of proteins on 2D gel electrophoresis of yeast 
culture after application of salt stress is shown. 
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Figure 58: 2D electropherogram of RG sample stressed with 2 % of NaCl, identified proteins 
up-regulated after stress application are highlighted in red. 
 
Identified up-regulated proteins are highlighted in red in Figure 58. Only 9 of 89 proteins that 
have higher intensity after stress application were identified.  
When proteins were separated on 2D gel electrophoresis and induced proteins or repressed 
proteins were found by image analysis of the gels, the protein identification process continues. 
The spots were cut off from the gel and digested by enzyme trypsin. This enzyme cleaves the 
peptide backbone after C-term of Lysine (K) and Arginine (R).  
The process of protein identification is shown in the following set of pictures on the example of 
the spot of up-regulated protein number 6. In Figure 59, there are two pictures with this spot, the 
left one corresponds to control sample, where the protein has lower intensity and the right from 
stressed sample, which is 10 fold intensive, and thus was cut of the gel and used for the 
identification. 
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Figure 59: Comparison of the 10 - fold increased intensity of spot number 6 at control gel - A, at 
2% NaCl stressed gel - B. 
 
The protein corresponding to spot number 6 from Figure 59 was cut off and digested to specific 
peptides and analyzed by MALDI-MS/MS. Unfortunately, his technique does not provide any 
statistically important identification and thus the sample was analyzed by another technique, LC-
MS/MS. Since peptides are separated before MS fragmentation, this technique is usually more 
successful in protein identification. The total ion chromatogram of protein from spot number 6 is 
shown in Figure 60. 
 
 
Figure 60: Total Ion record of Liquid Chromatography of peptides extracted from spot 
number 6. 
 
The peptides from protein corresponding to the spot number 6 have been separated in 35 
minutes. For demonstration of further steps of protein identification process, the peptide that 
migrates at 25.5 minute was chosen. The MS spectrum of this peak is in Figure 61. 
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Figure 61: Mass spectra of peak eluted at 25.5 min. 
 
There are 2 intensive peaks in Figure 61 that correspond to specific peptides of a protein. The 
peak with m/z = 757.9 is charged once and the peak with m/z = 654.4 is charged twice. The mass 
spectrometer was set of fragmentation of two most intensive ions in each spectrum, and thus both 
previously mentioned peaks were fragmented. The data were submitted to NCBI (The National 
Center for Biotechnology Information) database search via software MASCOT that serves to 
compare MS/MS data with the database. 
Peptides are fragmented along the amino acid backbone according to the scheme shown in 
Figure 15, section 1.2.1. In collision induced dissociation (CID), that is typical for ion-trap 
instruments, positively charged peptides are usually fragmented to a, b and y ions. When the 
peptide of interest with m/z = 654.4 (2+) was fragmented, several a, b and y ions were formed as 
demonstrated in Figure 62. Software MASCOT marked the fragments according to their type.  
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Figure 62: Results from Mascot database search and evaluation of peptide fragments. 
 
As an example of the identification process, two fragment ions that were created during the 
fragmentation process were chosen. Those two fragments y 7 and b 5 are highlighted in 
Figure 62 together with their amino acid sequence predicted from the database search. In the 
following paragraph, two types of calculation of peptide molecular mass are compared. 
Fragment y 7 with m/z 807.4 is charged positively as well as fragment b 5 with m/z 501.2. They 
form together the peptide with molecular mass 1306.6, according to the calculation: 
Mw = ([M1 + H
+] - 1) + ([M2 + H
+] - 1) = (807.4 - 1) + (501.2 - 1) = 1306.6 
This molecular mass fits to peptide mass before fragmentation that was 1306.8 according to the 
calculation: 
Mw = [M + 2H
+] · 2 - 2 = 654.4 · 2 - 2 = 1306.8 
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The whole sequence of the peptide represented by double charged peak with m/z = 654.4 is 
SNVLSVTDGLFR. The inaccuracy of the calculation is probably caused by the insufficient 
precision of the MS instrument. According to this peptide that was statistically important and 
another peptide that was statistically insignificant, this protein has been identified as isocitrate 
dehydrogenase, according to the similarity with the same protein from a different organism. In 
Table 4, all 19 down-regulated proteins together with the organism of protein origin are listed. 
The spot numbers correspond to the green highlighted proteins in the 2D gel in Figure 57. 
 
Table 4: Identification of 19 down-regulated proteins together with the organism of proteins 
origin, identified proteins correspond to green highlighted spots on 2D gel of control sample. 
spot number  identified protein original protein organism 
1 ADP-ribosylation factor Arf1 Schizosaccharomyces pombe 
2 tRNA intron endonuclease Nitrosopumilus maritimus 
3 GTPase Cryptococcus neoformans 
4 protein synthesis elongation factor 1 - alpha Rhodotorula mucilaginosa 
5 hypothetical protein DDB_0191262 Dictyostelium discoideum 
6 YPT1-related protein Schizosaccharomyces pombe 
7 60S ribosomal protein L10 Botryotinia fuckeliana 
8 hypothetical protein UM05139.1 Ustilago maydis 
9 heat shock protein 90 Schizosaccharomyces pombe 
10 hypothetical protein CC1G_03927 Coprinopsis cinerea 
11 
cell division cycle related family member, 
heat shock protein of HSP70 family 
Caenorhabditis elegans,  
Coprinopsis cinerea 
12 chain 1, maltodextrin binding protein Escherichia coli 
13 regulator protein blaR1 Staphylococcus aureus 
14 subunit of the signal recognition particle Chlamydomonas reinhardtii 
15 ubiquitin-activating enzyme E1 Neurospora crassa 
16 hypothetical protein CC1G_10805 Coprinopsis cinerea 
17 chain 1, maltodextrin binding protein n.a. 
18 hypothetical protein CC1G_00516 Coprinopsis cinerea 
19 AER184Wp Ashbya gossypii 
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In Table 5, nine identified up-regulated proteins together with the organism of protein origin are 
listed. The spot numbers correspond to the red highlighted proteins in the 2D gel in Figure 58. 
 
Table 5: Identification of 9 up-regulated proteins together with the organism of proteins origin, 
identified proteins correspond to red highlighted spots on 2D gel of stressed sample. 
spot number identified protein original protein organism 
1 
binding-protein-dependent transport systems 
inner membrane component 
Paracoccus denitrificans 
2 ATP synthase beta subunit Bradyrhizobium japonicum 
3 hypothetical protein Reut_C6180 Ralstonia eutropha 
4 COG0553: Superfamily II DNA/RNA helicases Escherichia coli 
5 tetratricopeptide repeat domain protein Microscilla marina 
6 isocitrate dehydorgenase Cryptococcus neoformans 
7 mutant trpytophan synthase Neurospora crassa 
8 hypothetical protein CC1G_12439 Coprinopsis cinerea 
9 hypothetical protein MGL_3020 Malassezia globosa 
 
 
All proteins listed in Tables 4 and 5 have been identified according to the homology with 
proteins of different organisms. Unfortunately, the genome of yeast Rhodotorula glutinis has not 
been identified yet, so the NCBI database contains only 28 proteins that belong to this 
microorganism. None of those 28 proteins have been found between proteins identified in this 
work. Many of the proteins have been identified according to the homology with other Fungi in 
phylum Basidiomycota, like Coprinopsis cinerea, Cryptococcus neoformans, Rhodotorula 
mucilaginosa or Ustilago maydis. Other proteins belonged to the phylum Ascomycotina like 
Schizosaccharomyces pombe, Botryotinia fuckeliana, Neurospora crassa or Ashbya gossypii. 
Some of the proteins have also been identified because of the homology with Bacteria like 
Escherichia coli, Paracoccus denitrificans, Staphylococcus aureus or Bradyrhizobium 
japonicum.  
Many of the identified proteins have been established according to only one peptide in whole 
protein sequence. The sequence coverage has never got over 36 %, but it was usually in the 
range from 1 - 10 %. Such a low coverages do not provide precious results. However, there is no 
 possibility of increasing the percentage of 
microorganism with unknown genome.
 
Further experiments focused on the comprehensive proteomic analysis of yeasts were not 
accomplished due to the previously mentioned problems with
poorly characterized strain. Another issue, when working with carotenogenic yeasts, cause 
extremely rigid cell walls complicat
probably fully representative and many o
at all or were isolated only at insufficient amounts. The presented procedure of 2D 
electrophoretic separation combined with proteins identification using mass spectrometry is 
promising approach to the comprehensive evaluation of proteomic changes caused by activation 
of mechanisms of stress responses and characterization of metabolic pathways of 
microorganisms or other parts of biota. 
 
4.2.2 Analysis of proteins by 2D gel electrophoresis followed by 
interface 
Sheath flow interface is the most commonly used interface for capillary electrophoresis and mass 
spectrometry hyphenation. In principle, in this interface ty
separation capillary and serves to close the electrical circuit and to make background electrolyte 
compatible for electrospray ionization. Nebulization gas helps to decrease the droplet size
thus enable better ionization. The scheme of sheath flow interface is in 
 
Figure
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Cytochrome C was used as a model protein in following optimization of CE-MS. Cytochrome C 
plays the role as an electron-transporter in cellular respiration. Its main function is to transport 
electrons from Cytochrome C reductase to Cytochrome oxidase in crucial part of respiratory 
chain, where reactive oxygen species (ROS) are frequently formed.  
 
Cytochrome C tryptic digest has been chosen as a standard sample for the optimization of CE-
MS method. The primary structure of Cytochrome C from horse heart consists of 104 amino 
acids. The electropherogram of separated peptides by CE-MS using sheath liquid interface is in 
Figure 64. In Table 6, both identified specific and unspecific peptides are listed.  
 
 
Figure 64: Tryptic peptides of Cytochrome C and their m/z values separated in uncoated 
capillary by CE-MS with sheath flow interface. 
 
Table 6: Specific and nonspecific tryptic peptides from Cytochrome C. 
peak number m/z charge type of peptide amino acid sequence 
1 284.2 1 specific HK 
2 332.3 1 specific GKK 
3 147.1 1 specific K 
4 533.4 1 specific KTER 
4 261.1 1 specific GGK, NK 
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5 806.6 1 specific KYIPGTK 
6 405.2 1 specific TER 
7 617.4 1 unspecific VEKGGK 
8 562.4 1 specific KATNE 
8 604.5 1 specific GITWK 
9 634.5 1 specific IFVQK 
10 678.5 1 specific YIPGTK 
11 779.6 1 specific MIFAGIK 
12 955.7 1 unspecific TGPNLHGLF 
13 631.4 1 unspecific ANKNKG 
14 589.4 1 specific GDVEK 
15 723.5 1 unspecific EDLIAY 
 
As it is evident from Figure 64, all peptides presented in sufficient concentration have been 
separated in less than 30 minutes. I was able to identify 18 peptides, 14 specific and 4 unspecific. 
Specific peptides are products of specific tryptic digestion and thus are terminated by Lysin (K) 
or Arginine (R), unspecific peptides result probably from the digestion of enzyme chymotrypsin 
that always takes place in the trypsin standard. Specific peptides are highlighted by gray boxes in 
following Cytochrome C primary structure (Figure 65). These 14 peptides cover 51 amino acids 
from 104 amino acids of the protein that matches sequence coverage of 49 %. Together with 
unspecific peptides, those are highlighted in following sequence in bold and italic, the peptides 
cover 72 amino acids that correspond to 69.2 % of the Cytochrome C primary structure. 
 
GDVEKGKKI FVQKCAQCHT VEKGGKHKTG PNLHGLFGRK TGQAPGFTYT 
DANKNKGITW   KEETLMEYLE   NPKKYIPGTK   MIFAGIKKKT   EREDLIAYLK   
KATNE 
Figure 65: Amino acid sequence of Cytochrome C with highlighted specific (in grey frames) and 
unspecific (in bold and italic) peptides.  
 
I have determined the limit of detection (LOD) from extracted ion electropherogram of the most 
intensive peak of peptide with m/z = 589.4. The limit of detection, recounted to the previous 
amount of protein, was (3.21 ± 0.65) · 10-7 mol/l. The LOD was calculated as a triplicate of 
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relative standard deviations (RSD) of the noise. The electropherogram of separated peptides with 
the most intensive peak highlighted is in Figure 66.  
 
 
Figure 66: Base peak electropherogram of Cytochrome C tryptic digest with highlighted peak 
used for limit of detection calculation. 
 
The data about protein sequence, specific tryptic peptides and unspecific peptides has been 
downloaded from the Swiss Institute of Bioinformatics database [225]. 
Although sheath liquid interface is the most popular one, because it was the only one 
commercially available until recent year, it does not ensure high sensitivity, because sheath 
liquid dilutes the analytes before they enter the mass spectrometer. The level of dilution depends 
on the sheath liquid flow, e.g. when the sheath liquid flow was 0.24 ml/h, the peptide with m/z = 
589.4, that migrated in 25.4 minute and lasted for 0.4 min, was diluted approximately 50 times.   
Using CE-MS connected by sheath flow interface I analyzed also the samples from the 2D gels. 
Even though I increase the injection time from 10 s to 90 s and even 180 s, I was not able to 
detect any peptide peaks. Thus, in the next experiments I dealt with CE-MS optimization and 
sensitivity improvement of this method. 
 
4.2.3 Methods for sensitivity improvement in CE-MS  
4.2.3.1 Type of sample injection optimization 
Generally in CE, two types of injection are available - electrokinetic and hydrodynamic. By 
applying hydrodynamic injection, all components of the sample are injected equally. On the 
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other hand, by applying electrokinetic injection, only cations in positive mode (or anions in 
negative) are injected to the capillary. The S/N ratio from the comparison of both injection types 
(hydrodynamic injection at 0.5 psi for 10 s and electrokinetic injection at 10 kV for 10 s) was 
evaluated to be 451 and 173, respectively. Therefore, for all experiments, hydrodynamic 
injection at 0.5 psi for different injection time was applied. 
 
4.2.3.2 Sample solvent optimization 
An important parameter for optimization was the solvent, in which the peptides are dissolved. 
Samples are usually dissolved in background electrolyte, but when they are dissolved in a 
solvent with lower conductivity like water or some organic solvents, the ions from the sample 
migrate quickly to the BGE boundary and create a narrow zone, after the voltage is applied. 
When the conductivity is adjusted, analytes migrate normally according to their electrophoretic 
mobilities. In Table 7, the results from the different solvents are listed. The Cytochrome C tryptic 
digest has been dissolved 10 times in BGE (1 mol/l formic acid), water and 50 % acetonitrile to 
the concentration of 0.1 mg/ml recounted to the amount of protein prior to digestion. The 
samples were injected hydrodynamically at 0.5 psi for 10 seconds. Signal to noise ratio was 
evaluated from extracted ion electropherogram of the most intensive peak with m/z = 589.4 as in 
the previous experiments.  
 
Table 7: Sensitivity reached in different solvents for Cytochrome C tryptic digest. 
Type of solvent S/N LOD (mol/l) 
BGE (1 mol/l formic acid) 64.8 3.96 · 10-7 
Water 74.4 3.45 · 10-7 
50 % Acetonitrile 92.0 2.79 · 10-7 
 
As you can see in Table 7, the best signal to noise ratio was achieved when the sample was 
dissolved in the 50 % acetonitrile. The sample dissolved in water provide better limit of detection 
than the sample dissolved in BGE. Nonetheless, the differences in achieved limits of detection 
are not essential. Probably the injection time of 10 s was not sufficient for the completion of 
stacking procedure completion.  
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4.2.3.3 Sensitivity improvement by Solid Phase Microextraction 
Sensitivity can be improved also by sample desalting and concentration via reversed stationary 
phase prior to CE-MS analysis. For this procedure C 18 stationary phase immobilized inside the 
small pipette tips was used. These tips are commercially available as ZipTips. The peptides from 
tryptic-digested protein were bound to the stationary phase and after washing, they were eluted 
by appropriate volume of elution solvent. The procedure is described in details in experimental 
section 3.2.1.9.  
As the first experiment, the amount of acetonitrile needed for the peptide elution was optimized. 
20 µl of 20 times diluted Cytochrome C digest dissolved in 0.1 % trifluoracetic acid was treated 
with ZipTips and eluted with 20 µl of acetonitrile solution in concentration range of 
30 % - 70 %. The results from optimization of elution volume are depicted in Figure 67.  
 
Figure 67: Optimization of elution solvent composition. 
 
It is evident from Figure 67 that the 30 % acetonitrile solvent was not sufficient to elute the 
peptide with m/z 723.4 completely from the stationary phase. Using the solvent with the 
acetonitrile concentrations from 40 % to 70 %, peptide was eluted independently of the solvent 
concentration. Thus, for other experiments, 70 % acetonitrile was used as an elution solution in 
order to achieve good peptide coverage. The signal to noise ratios and limits of detection have 
been evaluated from the extracted ion electropherogram of the peptide with m/z = 723.4. This 
peak was the most intensive one after the sample treatment; the peptide with m/z = 589.4, that 
was used for the evaluation of limit of detection in the previous experiments, was too hydrophilic 
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to be bound to the stationary phase. Following Figures 68 A - C show the peptide composition of 
the original mixture before ZipTip treatment, bound portion and non-bound peptides that remain 
in the waste solution. 
 
 
 
 
Figure 68: Composition of peptides in original mixture (A) bound in ZipTip (B) and non-bound 
portion (C). 
 
As it is depicted in Figure 68 B, most of the peaks corresponding to the peptides of interest were 
bound to ZipTip except of the highest one - peak with m/z = 589.4. This peptide corresponds to 
amino acid sequence GDVEK that is too hydrophilic according to the Peptide property calculator 
from Innovagen [226] and thus was not bound to the stationary phase.  
 
In the next experiment the volume of the elution solvent was optimized. Again 20 µl of 
Cytochrome C digest dissolved in 0.1 % trifluoracetic acid has been treated with ZipTips, but in 
these experiments peptides has been eluted with different volumes of 70 % acetonitrile solution. 
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Figure 69: Sensitivity improvement with elution volume reduction
 
As it is evident from Figure 
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improvement by volume reduction is summarized.
 
Table 8: Sensitivity improvement with volume reduction
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The results in Table 8 show, that the lower the elution volume the higher is the sensitivity 
improvement. When the elution volume is equal to initial volume of the sample, the 
improvement is 1.4 times, due to the sample desalting. When the volume is reduced 4 times to 
5 µl, the sensitivity increased 20 times. The reason of this improvement is both sample desalting, 
volume reduction and the change of solvent from ammonium bicarbonate to 70 % acetonitrile 
with 0.1 % formic acid. This solvent ensures lower conductivity and thus sample stacking 
principle can take place at the beginning of the separation as well. In Figure 70, the base peak 
electropherograms of sample before and after ZipTip treatment is shown. 
 
 
Figure 70: Base peak electropherogram of 20 times diluted Cytochrome C tryptic digest; before 
(red) and after (black) ZipTip treatment. 
 
As it is evident from LOD values and from Figure 70, the Solid Phase Microextraction procedure 
is able to increase the limit of detection twenty times. Thus, other samples from the 2D gels were 
analyzed after their treatment with ZipTips.  
4.2.3.4 Analysis of peptides 
Samples from 2D gel electrophoresis of Rhodotorula glutinis were cut off the gel, digested to 
peptides by trypsin and directly injected to the capillary. Samples were dissolved in the optimum 
solvent for tryptic digestion - 50 mmol/l ammonium bicarbonate, pH = 9. The injection time of 
hydrodynamic injection was increased to 100 s. Afterwards samples were acidified with 1 % 
trifluoracetic acid and treated with ZipTips. The example of one sample analysis before and after 
treatment is shown in following Figure 71 together with m/z values of single peaks. 
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Figure 71: Base peak electropherogram of sample from 2D gel of yeasts stressed by 2% NaCl, 
before (A) and after (B) ZipTip treatment, injection 100 s. 
 
Figure 71 A of sample before ZipTip treatment shows only one peak, that is probably a polymer 
from eppendorf tubes. On the other hand, there are 5 peaks in Figure 71 B that could correspond 
to the peptides. Unfortunately, I observed peaks with similar m/z values in analysis of more 
samples. Thus, I checked whether the peaks are product of autodigestion of trypsin. The 
electropherogram of trypsin digested in the same conditions as samples is depicted in Figure 72. 
 
 
Figure 72: Base peak electropherogram of product of autodigestion of trypsin, after ZipTip 
treatment, injection 100 s. 
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The m/z values of four particular peaks presented in Figure 72 correspond to the peaks depicted 
in the previous figure. Thus, peaks identified as peptides did not correspond to the protein from 
the 2D gel, but to the enzyme trypsin used for their digestion. Probably the concentration of 
original peptides was very low. For the last experiments I chose the spots from 2D gels with the 
darker color that correspond to more concentrated proteins and I increased the injection time for 
300 s as well. The example of analysis of such a sample is shown in Figure 73. 
 
 
 
Figure 73: Base Peak Electropherogram of more intensive spot from 2D gel, before (A) and 
after (B) ZipTip treatment, injection 300 s. 
 
As it is depicted in Figure 73 A, when I used more concentrated sample and increased the 
injection time, some peaks, except of previously visible impurity, were detected. After the 
ZipTip treatment (Figure 73 B), I was able to distinguish twelve peaks, from which just two 
belong to the trypsin autodigestion. All of the peptides with m/z shown in Figure 73 were 
fragmented and the data were compared with the database. Although I did successfully MS/MS 
fragmentation of several samples from 2D gels, I was not able to identify any protein. 
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4.2.3.5 Sensitivity improvement by transient isotachophoresis (tITP) 
Sample concentration by isotachophoresis in capillary format occurs, when the sample is injected 
as a long plug between a leading electrolyte (LE) with higher and a terminating electrolyte (TE) 
with lower effective electrophoretic mobility. When transient isotachophoresis is to precede zone 
electrophoresis, LE and TE must be injected as relatively short zones in front and behind the 
sample zone, respectively. As an alternative, they can be mixed with the sample. In the following 
experiments, BGE serves as a TE and LE was added to the sample. Since the selection of 
electrolytes compatible with electrospray ionization is limited, 1 mol/l formic acid (pH = 1.8) 
was chosen as a BGE. At first, the injection time was increased from 2 to 300 s to find the 
optimum value of signal to noise ratio for peak with m/z = 723.5. The injection time of 2 s 
correspond to the 0.07 % of the capillary length, 10 s correspond then to 0.37 %, 100 s to 3.73 %, 
200 s to 7.46 % and 300 s correspond to 11.20 % of the total capillary length. The sample of 
Cytochrome C tryptic digest was dissolved twenty times in water (to 0.05 mg/ml recounted to the 
original concentration of protein before digestion). The dependence of S/N on injection time is 
depicted in Figure 74. 
 
Figure 74: Dependence of signal to noise ratio on injection time. 
 
As it is evident from Figure 74, the maximal S/N ratio was achieved when the sample was 
injected for 200 s. With longer injection, the peak shape was too broad and thus the S/N ratio 
was lower. In the following experiment, the sample of Cytochrome C tryptic digest was diluted 
twenty times to 0.05 mg/ml recounted to the protein concentration before digestion in 10 mmol/l 
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or 1 mol/l of ammonium formate at pH = 3, that serves here as a LE, because of its higher ionic 
mobility. The S/N ratios are presented in Figure 75. 
 
 
Figure 75: Dependence of signal to noise ratio on injection time for different concentrations of 
ammonium formate (pH = 3). 
 
As it is shown in Figure 75, the change of sample solvent did not induce any sensitivity 
improvement. The S/N ratios are even lower, in comparison with the analysis, where the sample 
was dissolved in water. The solution of 10 mmol/l ammonium formate displayed little bit better 
results, thus this concentration was selected for the next experiment, where Cytochrome C tryptic 
digest was twenty times diluted in 10 mmol/l ammonium formate at pH = 3 and pH = 9 to 
0.05 mg/ml of the original amount of protein.  
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Figure 76: Dependence of signal to noise ratio on injection time for different pH of ammonium 
formate. 
 
The analysis of the sample injected for 100 s and dissolved at pH = 9 shows a higher S/N ratio 
than this dissolved at pH = 3 (Figure 76). However, at the injection time of 200 s the opposite is 
true. The S/N ratio for peak 723.5 was only twelve times higher for injection time of 100 s than 
for injection time of 10 s for the sample dissolved in pH = 9. Thus, no sample stacking due to the 
tITP occurred in any of the previous mentioned experiments. The increase of S/N was caused 
only by the longer injection time. I was not able to introduce tITP process by any of the 
electrolytes added to the sample that should play the role of LE. With water as a sample solvent, 
the S/N ratios were always better, probably because of the lower conductivity in comparison 
with the conductivity of BGE. 
 
4.2.3.6 Simulation of transient ITP in Simul 5.0 
Because of the problems with transient isotachophoresis in CE-MS, I simulated this stacking 
phenomenon in software Simul 5.0 [136]. I used two amino acids instead of peptides, because 
the pK and ionic mobility values of peptides are not available in the Simul database. For the 
simulation of analysis, 10 mmol/l ammonium acetate at pH = 7 was used as a LE. This solvent 
was injected as a plug prior to the sample injection. The mixture of two amino acids (agrinine 
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and histidine) at very low concentration - 0.001 mmol/l was then injected as a long sample plug 
(blue line in Figure 77). The solution of 10 mmol/l acetic acid at pH = 4 served as a BGE and TE 
as well. Very short capillary (5 mm) and low voltage (260 V) was used for the simulation to 
decrease the calculation time. The whole procedure of simulation is presented in Figure 77. 
 
 
Figure 77: Injection of two amino acids (A), their concentration after stacking (250x) (B) 
destacking and separation (concentration 20x)(C) simulated by software Simul 5.0. 
 
Figure 77 A shows the injection of amino acids mixture. The mixture was injected as a long plug 
corresponding to the blue line in Figure 77 A. After the voltage was turned on, the samples were 
stacked at the sample - LE boundary. This stacking is shown in Figure 77 B. In this simulation 
experiment, the concentration of the samples increased during the stacking procedure 250 times. 
Figure 77 C corresponds to the separation that started after the leading electrolyte left the 
boundary. Two amino acids were separated successfully, but their concentration decreased in the 
separation part of the process a lot. Finally, the concentration was twenty times higher than the 
initial one. Although I optimized the simulation process and reached the higher concentration, 
this concentration was not maintain for longer time. Thus, the final concentration passing the 
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detector was much lower. Additionally, this system worked only for basic amino acids, neutral or 
acidic amino acids were not concentrated in the stacking process at all. Although the choice of 
leading and terminating electrolytes is limited, there is still a chance to find a system in which 
the breadths of stacked zones will be preserved till their complete separation.   
 
 
4.3 Development of Liquid Junction Interface for combination of CE-MS 
4.3.1.1 Liquid Junction Interface device 
Since the flow of sheath liquid in CE-MS connected via sheath flow interface significantly 
dilutes the analytes that comes out from the separation capillary, liquid junction interface was 
constructed in our laboratory. A laboratory-made liquid junction interface, which integrates CE 
separation and electrospray, is fixed on a microposition table in front of the mass spectrometer 
Esquire (Bruker Daltonics) with high-capacity ion trap. The interface consists of two parts. One 
part includes electrode chamber with two sealed inlets, one for pressurized nitrogen and two for 
injection end of the separation capillary together with the platinum CE electrode. The second 
part, connected to the electrode chamber via a three-port valve is a liquid junction chamber with 
four sealed inlets. Two for the outlet end of the separation capillary and the inlet of the spray 
capillary facing horizontally each other; third for the spray electrode; and fourth is a Luer lock 
for a Hamilton syringe, a reservoir of spray liquid. Both parts of the interface are made from 
polysulfone. All sealings are made of a silicon rubber compressed by the hollow screw. Thus, the 
separation capillary connects the electrode chamber and the liquid junction chamber. The scheme 
of the device with dimensions in millimeters is shown in Figure 78. 
 
 
 
 
 
 
 
 Figure 78: Scheme of laboratory
entire device, 
Both spray and separation capillaries are placed in the liquid j
was set up approximately to 70 µm and flooded by a spray liquid. The polyimide coating at the 
end of both capillaries was removed to avoid disturbing the flow between separation and spray 
capillaries. The spray tip is a 6 cm long uncoated capillary with 
µm. The tip was sharpened by laboratory
rotating disk with fine abrasive paper and the capillary holder. During the sharpening the 
capillary rotates around its longitudinal axis. Then, the capi
polishing foil instead of the abrasive paper.
Whole system was pressurized by nitrogen that forced the spray liquid to flow through the spray 
capillary. For the nitrogen pressure regulation, the system based on the com
electropneumatic regulator ITV 0050
was optimized according to the spray capillary diameter
in Figure 79.  
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Figure 79: Photograph of laboratory-made liquid junction interface: A - entire device, B - detail 
of the liquid junction gap in sheath liquid reservoir. 
  
4.3.1.2 The optimization of spray capillary diameter 
The laboratory-made liquid junction interface works in the nanoelectropray operation mode. For 
the nanoelectrospray mode, the spray tip diameter is fundamental. Generally, the lower the spray 
tip diameter, the better limit of detection should be reached. I have tested 4 spray capillary 
diameters 5, 10, 25, 50 µm. As a test mixture, 3 peptides (Angiotensin, Bradykinin and 
Neurotensin) dissolved in 50 % of isopropanol and 1 % of acetic acid in concentration 1.10-5 
mol/l were used. The limits of detection for every tip diameter are summarized in Figure 80.  
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Figure 80:  Limit of detections of standard peptides sprayed from capillaries of different 
diameters. 
 
The lowest limits of detection of all the peptides were obtained with 10 µm spray capillary. The 
limit of detection that I have reached with 5 µm spray capillary was worse than with 10 µm 
capillary. The reason is, that our system proved not be capable to reach the pressure for the 
optimum flow rate of the spray liquid through 5 µm capillary. The optimum liquid flow rate for 
various capillary diameters was calculated from Hagen - Poiseuille equation 
 
 
, where 
t
V
∆
∆
 is liquid flow; p∆ is the applied pressure; η is liquid viscosity, r and l are capillary 
radius and length, respectively. In Table 9, there are the optimum values of liquid flows for each 
capillary diameter calculated from Hagen - Poiseuille equation.  
 
Table 9: Optimum flow rates of spray liquid for the different spray capillary diameter. 
capillary 
diameter 
pressure 
(atm.) 
flow (nl/s) flow (nl/min) 
50 µm 0.17 44.02 2640.98 
25 µm 0.3 4.55 273.08 
10 µm 2.3 0.91 54.45 
5 µm 6 0.16 9.81 
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By using the capillary of 10 µm diameter, the best limits of detection were achieved, since the 
flow rate through the 5 µm capillary, limited by 6 atmospheres, was not sufficient for a stable 
spray. Therefore, for all the following analyses, the 10 µm spray capillaries were used. 
  
4.3.1.3 Peptide separation by CE-MS using Liquid Junction Interface 
It has been shown that liquid junction interface do not contribute to the dilution of analytes when 
working under optimum conditions [162]. The system was tested, similarly as sheath flow 
interface by the tryptic digest of Cytochrome C. For the separation of peptides using liquid 
junction interface, coated capillaries from Alcor BioSeparation were chosen. This producer 
ensures the electroosmotic flow mobility lower than 0.2 × 10-9 m2/(V·s). On the other hand, any 
information about coating type is not provided. In Figure 81, the separation of peptides in coated 
40 cm long capillary is shown. Table 10 provides the information about 13 specific and 2 
unspecific peptides that were identified in the separation.  
 
 
Figure 81: Cytochrome C tryptic peptides and their m/z values separated in coated capillary by 
CE-MS with liquid junction interface. 
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Table 10: Identified specific and nonspecific tryptic peptides from Cytochrome C. 
peak number m/z charge [M+H+] type of peptide amino acid sequence 
1 545.3 3 1633.9 specific IFVQKCAQCHTVEK 
2 390.3 3 1168.8 
specific TGPNLHGLFGR 
2 584.9 2 1168.8 
3 604.5 1 604.5 specific GITWK 
4 562.4 1 562.4 specific KATNE 
5 634.5 1 634.5 specific IFVQK 
6 339.6 2 678.1 
specific YIPGTK 
6 678.4 1 678.4 
7 533.6 3 1598.9 specific KTGQAPGFTYTDANK 
8 390.2 2 779.4 
specific MIFAGIK 
8 779.5 1 779.5 
9 542.0 3 1623.9 specific EETLMEYLENPKK 
10 478.4 2 955.7 unspecific TGPNLHGLF 
11 482.9 2 964.7 specific EDLIAYLK 
12 736.0 2 1471.0 specific TGQAPGFTYTDANK 
13 748.5 2 1496.0 trypsin/keratin 
 
14 434.2 1 434.2 specific ATNE 
15 589.4 1 589.4 specific GDVEK 
16 723.4 1 723.4 unspecific EDLIAY 
 
As it is shown in Figure 81, the separation of peptides was achieved in 30 minutes that 
corresponds to the results obtained in uncoated capillary with sheath flow interface. Also, more 
peptides occur here in higher charge states with 2 or 3 positive charges. This effect is probably 
because of the different conditions set to the interface. The sequence coverage in this case is 
86.5 % that correspond to 90 identified amino acids from 104 that form the Cytochrome C 
primary sequence. Two identified unspecific peptide sequences, highlighted in bold and italic, 
are shown in Figure 82 together with specific peptides highlighted in grey boxes. 
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GDVEKGKKI FVQKCAQCHT VEKGGKHKTG PNLHGLFGRK TGQAPGFTYT 
DANKNKGITW   KEETLMEYLE   NPKKYIPGTK   MIFAGIKKKT   EREDLIAYLK   
KATNE 
Figure 82: Cytochrome C amino acid sequence with highlighted specific (in gray frames) and 
unspecific (in bold and italic) peptides. 
 
By analyzing the sample using laboratory made liquid junction interface, I have determined the 
limit of detection from the extracted ion electropherogram of the most intensive peptide that has 
m/z = 478.1 to be (3.87 ± 0.75) · 10-9 mol/l recounted to the original amount of protein. The 
separation record with the most intensive peak highlighted is in Figure 83. The value of achieved 
limit of detection is approximately 80 times lower than the limit of detection that was evaluated 
for the sheath flow interface. 
 
 
Figure 83: Base peak electropherogram of Cytochrome C tryptic digest with highlighted peak 
used for limit of detection calculation. 
 
4.4 Analysis of metabolites in human urine by CE-MS 
 
Newly developed liquid junction interface presented in previous chapter was tested also for 
CE-MS analyses of ethanol and cocaine metabolites in complex matrices of human urine. 
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4.4.1 Application of developed instrumentation to separation of ethanol metabolites 
4.4.1.1 Ethanol metabolites in human body 
The determination of recent alcohol consumption is an important task in clinical and forensic 
applications. Ethanol itself can be detected in breath, blood or urine several hours after the 
alcohol intake. After the ethanol is metabolized in human body, other markers can be used for 
the determination of alcohol consumption like carbohydrate-deficient transferrin (CDT), enzyme 
γ-glutamyltransferase, fatty acid ethyl esters, phosphatidylethanol, ethylglucuronide (EtG) or 
ethylsulphate (EtS) [227, 228]. 
EtG and EtS reach the maximum level in serum or urine approximately 3 hours after alcohol 
consumption and can be detected after several hours or even days [229, 230]. Although urine and 
serum are the most frequent matrixes, where alcohols markers are analyzed, also hair [231, 232], 
vitreous humor [233] or tissues like muscle and liver were used for the detection of those 
markers [234]. Urine is very complex mixture, it contains many cations like ammonia, sodium, 
potassium calcium or magnesium, anions like chloride, carbonate and bicarbonate and other 
organic compounds like urea, creatinine, amino acids, glucose or proteins [235]. All of these 
compounds can involve the separation and thus urine can be treated by solid phase extraction 
[236]. On the other hand, the anion mode on MS together with high separation efficiency of CE 
enables the detection of both alcohol markers without complicated sample treatment. Usually, 
urine is just diluted and standardized according to the conductivity [229] or creatinine level 
measurement [230, 237]. 
Ethanol metabolites, EtS and EtG, have been analyzed by gas or liquid chromatography usually 
combined with mass spectrometry. The limit of detection 0.05 µg/ml was achieved for EtS in 
urine using LC/MS [230]. In other study, spiking level 0.1 µg/ml for both EtS and EtG in urine 
was used prior to analysis by LC/MS/MS. Capillary electrophoresis usually with indirect UV 
detection was used for detection of both metabolites in serum, where limit of detection of 0.1 
µg/ml was achieved [229, 238]. In urine, LOD 0.4 µg/ml was reached for EtS using CE with 
indirect detection. Recently, Thormann et al. published separation of these two metabolites using 
CE with mass spectrometry detection. Their method ensured the limit of detection 200 ng/ml in 
serum and urine for both metabolites. The reproducibility for detection times had very good RSD 
143 
 
values, 3.38 and 4.94 % for EtG and EtS, respectively, but for peak heights they declared poor 
RSD values 21.05 and 64.41 %, respectively [239]. 
Thus the aim of this work was to develop and optimize high sensitivity method for simultaneous 
analysis of two ethanol metabolites, EtS and EtG, in urine. CE connected with mass 
spectrometry via laboratory-made liquid junction interface was used for the analysis. Negative 
ion mode on MS used for the detection enabled the analysis of urine without previous sample 
treatment.  
The structures of both analyzed compounds are shown in Figure 84.  
 
Figure 84: Structures of analyzed compounds. 
 
Both EtS and EtG are derivates of ethanol and sulfuric or glucuronic acid, respectively. Their 
ionic mobilities and pKa are listed in the following Table 11.  
 
Table 11: Properties of analyzed compounds. 
 mobility (m2/(V · s) ) pKa molecular mass (g/mol) 
Ethylsulphate - 48.6 × 10-9 [227] - 3.14 [227] 126.13 
Ethylglucuronide - 23.5 × 10-9 [238] 3.21 [238] 222.19 
 
As it is evident from the Table 11, EtS is a strong acid with extremely low pKa value and with 
high ionic mobility. On the other hand, ionic mobility of EtG is twice lower in comparison with 
EtS. EtG is also partially dissociated approximately from pH = 1.2; thus these two compounds 
can be easily separated in a wide range of pH. 
  
At first, I sprayed EtG and EtS in concentration of 10 µg/ml dissolved in 50 % isopropanol by 
pressurized infusion from spray chamber of the laboratory-made liquid junction interface in 
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order to optimize the MS conditions. MS conditions were optimized automatically by settings 
various parameters and optimizing the MS response. The intensity of Total Ion Current of 3 · 106 
was achieved.  In Figure 85, the m/z spectra of EtS and EtG are shown. 
 
 
Figure 85: Infusion of Ethylsulphate and Ethylglucuronide (10 µg/ml in 50 % isopropanol). 
 
The m/z value of EtG is 221.1 that correspond to EtG molecular mass without cleaved proton as 
it is evident from the second peak in the spectra in Figure 85. The first peak of EtS does not 
exactly correspond to the expected m/z value (125.1). This was caused by non-precise calibration 
of MS in lower part of m/z axis.   
 
4.4.1.2 Separation of ethanol metabolites in coated capillary 
I dissolved standard solutions of EtS and EtG (10 µg/ml) in water and injected electrokinetically. 
The separation took place in coated capillary (15 cm long, 50 µm i.d.) filled with BGE 
(30 mmol/l ammonium acetate at pH = 9). After the application of voltage, analytes were 
separated as it is shown in Figure 86.  
 
Figure 86: Base peak electropherogram of CE-MS separation of EtS and EtG in coated 
capillary (BGE - 30 mmol/l ammonium acetate at pH = 9). 
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Both metabolites were fully separated in less than three minutes as it is shown in Figure 86. 
Since coated capillary should not exhibit any electroosmotic flow, effective electrophoretic 
mobilities of both analytes were evaluated directly from the migration times. Limits of detection 
were calculated from the signal to noise ratio as triplicate of relative standard deviations (RSD) 
of the noise. The limit of detection of each compound was evaluated from extracted ion 
electropherogram. Results are presented in Table 12. 
 
Table 12: Mobilities (evaluated from the analyses at 30 mmol/l ammonium acetate at pH = 9) 
and LOD of both ethanol metabolites separated in coated capillary. 
 Ethylsulphate Ethylglucuronide 
mobility (m2/(V.s)) 25 · 10-9 15 · 10-9 
LOD (µg/ml) 0.0064 ± 0.001 (28%) 0.065 ± 0.015 (23%) 
 
Contrary to Table 11, our results show much lower effective mobility of both metabolites. The 
reason is the difference in BGE composition. Limits of detection evaluated from the separation 
of standards are very low, 6.4 ng/ml for EtS and 65 ng/ml for EtG. Such values are promising for 
the following analysis in urine, where LODs are usually much worse than with the simple 
analysis of standards.  
 
4.4.1.3 Analysis of spiked human urine in coated capillary 
Prior to the spiking with the analytes of interest, urine without any additional compound was 
analyzed. I diluted the urine with water and injected electrokinetically for 5 s. The following 
Figure 87 shows base peak electropherogram of diluted urine together with two extracted ion 
electropherograms of both ethanol metabolites. 
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Figure 87: Base Peak Electropherogram of human urine 10 times diluted in water, injection 5 s 
- A. extracted ion electropherograms of EtS - B and EtG - C. 
 
Many peaks corresponding to the normal anions composition in urine are depicted in Figure 
87 A. No EtS has been detected as it is shown in Figure 87 B. A small peak of EtG appears in the 
urine sample in Figure 87 C. The signal of this peak corresponds approximately to the three RSD 
of noise, and thus to limit of detection of EtG, although two relatively high peaks of noise 
migrating before EtG disturb the electropherogram. For the experiments with spiked urine, I 
added standards of EtS and EtG in concentrations 10, 5 and 1 µg/ml to 50 times diluted urine to 
reduce the peak area of EtG occurring in urine. Following Figure 88 shows the base peak 
electropherogram of urine spiked with 5 µg/ml EtS and EtG together with extracted ion 
electropherograms of both analytes of interest. 
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Figure 88: Base Peak Electropherogram of EtS and EtG standard samples (5 µg/ml) added to 
human urine 50 times diluted in water, injection 5 s - A. Extracted Ion Electropherograms of EtS 
- B and EtG - C. 
 
The electropherogram of spiked urine in Figure 88 A shows, that both analytes migrate 
separately from the other peaks and also no peaks from the urine disturb the extracted ion 
electropherograms as it is presented in Figure 88 B and C. In Table 13, variations of limits of 
detection, migration times and peak areas are expressed as RSDs evaluated from analyses of 
spiked complex biological matrices.  
 
Table 13: Repeatability of EtS and EtG separation. 
 EtS EtG 
Limit of detection (µg/ml) 0.15 ± 0.07 (53%) 0.50 ± 0.24 (48%)  
 Migration time (min) 1.47 ± 0.03 (2%) 2.56 ± 0.04 (1.4%) 
Peak Area 35620 ± 7133 (20%) 67690 ± 14713 (22%) 
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The limits of detection evaluated from the spiked urine analysis differ a lot from LODs evaluated 
from the analysis standard samples. The LOD value for EtS for separation of standard samples is 
6.4 ng/ml, the LOD for EtS from spiked urine is much higher (150 ng/ml). The same situation is 
with EtG, the LOD for the standards was 65 ng/ml and now it is 500 ng/ml. Although these 
values of LOD in complex biological matrixes are very high, they are comparable with the limits 
of detection published in the literature using CE with indirect UV detection, where the selection 
of BGE is not limited by MS compatibility. High relative standard deviations of LODs represent 
another problem, caused by high RSD values of peak heights. Therefore, in such a case, the 
quantization of analytes is usually made with the internal standard migrating with the analytes in 
the same separation. However, I plotted the dependences of peak areas on the spiking 
concentrations of both analytes to quantify the analytes without internal standards (Figures 89, 
90). The linear regression equations together with correlation coefficients are calculated.  
 
 
  
Figure 89: Calibration curve of Ethylsulphate with linear regression and correlation coefficient. 
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Figure 90: Calibration curve of Ethylglucuronide with linear regression and correlation 
coefficient. 
 
Although the RSDs of the peak areas were around 20 % the correlation factors of linear 
regressions for both analytes were higher than 0.99 as it is shown in Figure 89 and 90. I used 
linear regression equations for calculation of amount of EtS and EtG in human urine after 
consumption of definite quantity of alcohol.  
4.4.1.4 Analysis of human urine after alcohol consumption  
The urine of healthy volunteer after definite amount of alcohol consumption was collected after 
approximately 8 hours from the beginning of alcohol intake, diluted 10 times and directly 
injected to the separation capillary. The amount of EtS and EtG was evaluated from the linear 
regression equations. Table 14 shows the amount of alcohol per kg of body mass together with 
calculated concentration of both metabolites found in urine. 
 
Table 14: Amount of analytes 8 hours after alcohol consumption. 
volume of consumed wine (l)  pure ethanol intake (g/kg) 
c (µg/ml) 
EtS EtG 
0.4  0.59 1.32 0.23 
0.7  1.03 1.23 9.63 
1.5  2.21 2.39 64.93 
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As it is presented in Table 14, the amount of EtS in urine does not correspond to the increasing 
quantity of alcohol intake. Probably, EtS is metabolized faster than EtG and after 8 hours, the 
amount of EtS in urine is already low. Thus, the measurement error affects the results 
significantly. On the other hand, the concentration of EtG corresponds to the amount of 
consumed alcohol. Although the first value is under the limit of detection calculated in the 
previous paragraph and the last value is much higher than the highest value in the calibration 
curve, it seems that this metabolite is related more precisely to the ethanol intake 8 hours after 
the consumption. The example of base peak and extracted ion electropherograms of diluted urine 
after alcohol intake is presented in Figure 91. 
 
 
Figure 91: Base Peak Electropherogram of 10 times diluted urine after alcohol consumption 
(0.4 l of wine), injection 5 s - A. Extracted Ion Electropherograms of EtS - B and EtG - C. 
 
As it is shown in Figure 91 A, no peaks of EtS and EtG are visible at base peak 
electropherogram, because other compounds from urine has much higher intensity. Nevertheless, 
both Figures 91 B and C show relatively clear extracted ion electropherograms of analytes of 
interest. Generally, the analysis of ethanol metabolites is not useful for the determination of 
amount of consumed alcohol, because the concentrations of metabolite do not show, when the 
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person drunk and how much. There is no difference in EtG and EtS concentration, whether the 
person drunk three or even more than eight hours ago. Since the ethanol metabolism is very 
individual, the measurement of a relation between consumed ethanol and amount of metabolites 
in urine is problematic. Thus, this type of analysis can be implemented in practice mainly in the 
detection of complete abstinence of alcohol abusers.  
 
4.4.1.5 Separation of ethanol metabolites in uncoated capillary 
Since the reproducibility of analyses in the coated capillary was bead, the uncoated capillaries 
were tested as well. In coated capillaries, however, the consecutive extension of migration times 
after the analyses of urine samples became an issue. I could not wash the capillary with anything 
else except of distilled water and this washing proved not to be sufficient. For the analyses in 
uncoated capillary, at first, I used the same conditions as in coated one; 15 cm long capillary 
with 75 µm i.d. and 30 mmol/l ammonium acetate at pH = 9. I started the analysis at positive 
mode of CE. Thus the positive voltage inserted at the injection end of the separation capillary 
and its outlet at liquid junction chamber is grounded. In this setting, electroosmotic flow moves 
positively and also negatively charged analytes toward MS orifice. Unfortunately, in this setting 
no signal was detected. Therefore I diluted the BGE in order to increase electroosmotic flow 
velocity. Following experiments were performed with UV detection and dimethyl sulfoxide 
(DMSO) as a marker of EOF. The increase of EOF velocity with decreasing BGE concentration 
is plotted in Figure 92. 
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Figure 92: Dependence of the electroosmotic flow mobility on the BGE concentration. 
 
As it is evident from Figure 92, the mobility of electroosmotic flow was approximately 42 · 10-9 
m2/(V·s) in 30 mmol/l ammonium acetate. This value, however, is not sufficient for the analysis 
of EtS, which has higher effective mobility. EtG should move to the detector by such EOF 
velocity. Nevertheless, I did not detect it in previous MS experiments. By decreasing the 
concentration of BGE, the EOF mobility increases to 51 · 10-9 or 56 · 10-9 m2/(V·s) in 5 and 3 
mmol/l ammonium acetate, respectively. I chose a compromise and followed the analysis in 10 
mmol/l ammonium acetate, pH = 9, because the current was too low in 3 or 5 mmol/l ammonium 
acetate. The separation of both metabolites together with glucose, as an EOF marker for negative 
ion mode MS [240], is presented in Figure 93.  
 
 
Figure 93: Separation of ethylglucuronide and ethylsulphate in uncoated capillary, BGE: 
10 mmol/l ammonium acetate, pH = 9, SL: 50 % isopropanol, 1% NH3. 
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As shown in Figure 93, a complete separation was finished in less than two minutes. The 
concentration of both analytes in this experiment was 100 µg/ml. The EOF marker glucose with 
m/z = 179.0 migrates in 0.75 minute and thus the electroosmotic flow mobility is 50 · 10-9 
m2/(V·s). Effective electrophoretic mobilities together with limits of detection for both 
metabolites are listed in Table 15. 
 
Table 15: Measured effective mobility (for 10 mmol/l ammonium acetate, pH = 9) 
 and LODs of EtS and EtG. 
 EOF marker - glucose Ethylglucuronide Ethylsulphate 
mobility (m2/V.s) 50 · 10-9 15.9 · 10-9 25 · 10-9 
LOD (µg/ml) - 1.57 ± 0.26 (17%) 0.22 ± 0.10 (45%) 
 
The LODs are relatively high according to the analysis of spiked urine in coated capillary 
(0.15 µg/ml for EtS and 0.5 µg/ml for EtG). It can be speculated that the decrease of LODs 
observed using uncoated capillary can be caused by the fact, that EOF moved the volume of 
separation capillary to the liquid junction chamber and thus BGE displaced the spray liquid. 
Thus analytes are not sprayed from 50 % isopropanol, but from BGE. I verified this hypothesis 
by simple infusion of standard samples at concentration 10 µg/ml dissolved in spray liquid (50 % 
isopropanol and 1 % NH3) or in BGE (10 mmol/l ammonium acetate). The results are presented 
in following Figure 94.  
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Figure 94:  Electrospray ionization efficiency in different solvents. The comparison of  total ion 
electropherograms - A; m/z spectra of 10 µg/ml EtS and EtG dissolved in spray liquid - B and 
m/z spectra of the same sample dissolved in BGE - C. 
 
Figure 94 A shows two total ion electropherograms of infused samples. A huge difference at 
signal intensity is evident from these two records. Intensity more than 3 · 106 was observed, 
when the sample was dissolved in 50 % isopropanol with ammonia and the intensity around 
1.5 · 105 was measured, when the sample was dissolved in 10 mmol/l ammonium acetate.  Figure 
94 B and C show the m/z spectra of sample dissolved in spray liquid and in BGE, respectively. 
The big difference in intensities is evident from these two spectra as well.  
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Since the previous experiment proved the hypothesis that analytes are ionized poorly from BGE, 
I compared the ratios of volumes of BGE and spray liquid, which flow from the separation and 
spray capillary, respectively. I calculated the volume that flows from both capillaries in one 
minute. Hagen - Poiseuille equation (section 4.3.1.2) was used for the evaluation of flow volume 
of spray capillary. Both values were calculated for all available capillary diameters. The results 
are presented in the left part of following Table 16. Then I compared all possible combination of 
separation and spray capillaries and calculated the volume ratio. The results are listed in right 
part of Table 16. 
 
Table 16: The comparison of volumes that goes from separation and spray capillaries 
separation capillary diameter (µm) flow (nl/min) separation/spray capillary volume ratio 
50 294 50/10 4.1 
75 662 50/25 1.1 
spray capillary diameter (µm) flow (nl/min) 50/50 0.1 
10 71 75/10 9.3 
25 273 75/25 2.4 
50 2640 75/50 0.3 
 
As it is evident from the left part of Table 16, separation capillary with inner diameter 75 µm, 
that I used for the analysis exhibits 662 nl in one minute. The spray capillary with inner diameter 
of 10 µm exhibits only 71 nl per minute. Thus the volume that flowed from the separation 
capillary was approximately ten times higher than the volume used for spraying; so the worst 
possible combination of capillaries was chosen. The best combination of capillaries would be the 
separation capillary with inner diameter 50 µm or 75 µm and the spray capillary with inner 
diameter of 50 µm. The values of volume ratio of these two combinations are highlighted in red 
in the right part of Table 16.  
 
However, the 50 µm spray capillary does not provide as sensitive analyses as 10 µm capillary. 
Therefore, the isopropanol was added to BGE in amounts of 10, 20 or 30 % to improve the 
ionization efficiency. The spray liquid was changed to the same composition as newly prepared 
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BGE. The LODs evaluated from the analysis with additional isopropanol were calculated and are 
presented in Figure 95.  
 
Figure 95:  Limits of detection with different amount of isopropanol in BGE. 
 
In Figure 95, the LODs for both analytes decrease with increasing concentration of isopropanol. 
Unfortunately, with higher amount of organic phase in the BGE I observed lower EOF velocity. 
Next Table 17 shows the changes of migration time of glucose (EOF marker) and electroosmotic 
flow mobility. 
 
Table 17: EOF mobility decrease with higher amount of isopropanol in BGE. 
 no ISO 10% ISO 20% ISO 30% ISO 
migration time of EOF marker 
(min) 
0.75 1 1.35 1.7 
EOF mobility (m2/(V·s)) 50.0 × 10-9 37.5 × 10-9 27.8 × 10-9 22.1 × 10-9 
 
As it is presented in Table 17; the EOF mobility decreases from 50 × 10-9 m2/(V·s) for no 
addition of isopropanol to 22 × 10-9 m2/(V·s) for 30 % of isopropanol in the BGE. To conclude 
the experiments in uncoated capillary, I analyzed 50 times diluted urine spiked with 100 µg/ml 
of EtS and EtG. For this experiment, the composition of BGE and spray liquid was equal; 10 
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mmol/l ammonium acetate with 20 % isopropanol. With this composition I observed the best 
LODs using standard samples. The separation is shown in Figure 96.  
 
 
Figure 96:  Base peak electropherogram (in black) and extracted ion electropherograms of EtS 
and EtG (in red) of 50 times diluted urine spiked with 100 µg/ml of EtG and EtS (BGE: 
10 mmol/l ammonium acetate, pH = 9 with 20 % of isopropanol). 
 
As it is shown in Figure 96, the migration times are longer in comparison with the analysis 
without additional isopropanol. Here the analysis is longer than five minutes in comparison with 
less than two minutes in the separation of standard sample in Figure 93. This is in accordance 
with the lower EOF velocity with higher amount of isopropanol added to BGE. The LODs 
calculated from spiked urine analysis are listed in Table 18. 
 
Table 18: Limits of detection of both analytes from spiked urine.   
 Ethylglucuronide Ethylsulphate 
LOD (µg/ml) 0.92 ± 0.05 (5%) 0.63 ± 0.05 (7%) 
 
The LOD of EtG is lower in complex biological matrix than in analysis of standard samples, 
where the LOD was 1.57 µg/ml. The LOD for EtS is higher in comparison with the analysis of 
standards, where it was 0.22 µg/ml.  
The limit of detection was not satisfactory using uncoated capillaries for the separation of 
ethanol metabolites and the reproducibility was not better than with coated capillaries, although 
the washing steps were optimized. The results show that separations in coated capillaries provide 
higher sensitivity although the reproducibility was not satisfactory. The change form coated to 
uncoated capillary did not provide better reproducibility as was expected. The limits of detection 
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were worse as well. Thus the CE-MS analysis of two ethanol metabolites in coated capillaries 
provided better results in all monitored parameters.   
 
4.4.2 Comparison of pressure and EOF driven separations (Application to separation of 
cocaine metabolites) 
4.4.2.1 Cocaine and its metabolites in human body 
According to the European Monitoring Centre for Drugs and Drug Addiction, cocaine was in 
2010 the second most abused substance in Europe [241]. Cocaine, the main alkaloid of 
Erythroxylum coca, is one of the most potent central nervous system stimulants that negatively 
affect human health. Indeed, toxic effects can involve the central nervous system, cardiovascular 
and respiratory apparatus and other target organs as liver and kidney [242, 243]. The main routes 
of administration are snorting, intravenous injection and smoking.  
Cocaine (C) is metabolized by three metabolic pathways in human body. The first is enzymatic 
hydrolysis, where cocaine is metabolized to an inactive metabolite ecgonine methyl ester (E). In 
the second pathway, non-enzymatic hydrolysis, an active metabolite benzoylecgonine (BE) is 
formed. These compounds are excreted mainly into the urine and can reach up to 94 % of initial 
cocaine concentration [243, 244]. In the oxidative metabolism, cocaine is N-demethylated in the 
third metabolic pathway to hydroxycocaine, hydroxybenzoylecgonine and norcocaine. 
Norcocaine (NC) is an active metabolite as well, which represents 2 - 5 % of initial cocaine 
concentration in urine [245]. Anhydroecgonine methyl ester, a pyrolysis product, is formed when 
cocaine is smoked as crack and it is used as analytical marker for heated cocaine [246]. 
Cocaethylene (CE) is generated by transesterification of benzoylecgonine in liver with 
simultaneous consumption of ethanol and cocaine. This simultaneous consumption enhanced and 
prolonged euphoria, but causes grater toxicity [242, 243]. The structures and molecular masses 
of compounds analyzed in this work are presented in Figure 97.  
Cocaine and its metabolites have been characterized in various matrices important in forensic 
toxicology like human hair [247, 248], urine [214] or oral fluids [249]. The environmental 
science here is strongly related to forensic science, because the drugs have been determined also 
in surface and waste waters, where the amount of drugs and their metabolites matches the 
quantity of illicit drugs consumed in the specific area [250-253]. The global production of major 
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drugs is comparable to widely used pharmaceuticals. Some of the illicit drug residues are 
removed by sewage treatment plants, but there is still up to kilograms of cocaine residues occur 
daily for example in the river Po in Italy or in Zurich [252, 253]. Although the environmental 
concentration of drugs and their metabolites are low, they can cause toxic effects to aquatic 
organisms as well as to human health and wildlife.  
Several analytical methods have been developed for drugs determination like gas 
chromatography [251, 254, 255], liquid chromatography [252, 253, 256] or capillary 
electrochromatography [214] usually coupled with mass spectrometry detection. GC-MS shows 
a great sensitivity but presents the disadvantage to require a derivatization procedure that brings 
another variability and complexity to the sample matrix [255]. On the other hand, HPLC coupled 
to MS offers a good separation selectivity and sensitivity without the need of derivatization [256, 
257]. 
Recently, CE- MS became the method of choice in forensic toxicology. The high separation 
efficiency, rapid analysis time, minimum sample and reagent consumption make CE-MS an 
attractive methodology [247, 258-260]. Only a few papers, concerning the separation of cocaine 
and metabolites by using electrophoretic techniques, have been reported. Hsiu-Li et al. have 
developed a sweeping-MEKC method to determine these compounds in sample urine. Cocaine 
and benzoylecgonine were analyzed together with other illicit drugs by means of CE and CEC 
coupled to MS in different biological samples (hair, urine, and blood) [214, 247, 261]. To my 
knowledge, only one application of CE-MS concerning the analysis of cocaine and its 
metabolites has been published. This study was performed in acidic conditions, where the 
analyzed drugs were discriminated only with the MS detection. Indeed, at pH 3, all the 
compounds migrated more or less at the same analysis time [262].  
The aim of this work is the simultaneous determination of cocaine and its four metabolites in 
urine sample using CE hyphenated with MS detector via pressurized liquid junction interface.  
 
Structures and m/z values of all the metabolites analyzed in this work are described in Figure 97. 
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Figure 97: Molecular structures, abbreviations and molecular ions of analyzed compounds. 
 
Cocaine has very similar structure to norcocaine and cocaethylene that differs from cocaine just 
in position of one methyl group in the case of norcocaine and in the presence of ethyl instead of 
methyl group in cocaethylene. Benzoylecgonine is zwitterionic compound due to the presence of 
a carboxylic group. Ecgonine methylester is the smallest molecule among the others, because it 
does not contain aromatic group in its structure. Following Table 19 shows the pKa and ionic 
mobility values of all analyzed compounds found in the literature.  
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Table 19: pKa and ionic mobility values of cocaine and metabolites according to the literature. 
 pKa1 pKa2 references µ (m
2/(V·s)) 
benzoylecgonine 
2.15 ± 0.01 
3.15 ± 0.60 
11.41 ± 0.01 
10.14 ± 0.40 
[263] 
[264] 
n.a. 
cocaine - 8.72 ± 0.60 [264] 24·10-9  [136] 
cocaethylene - 8.80 ± 0.60 [264] n.a. 
ecgonine  
methyl ester 
9.3 14.2 [256] n.a. 
norcocaine - 9.02 ± 0.60 [265] n.a. 
 
As it is shown in Table 19, two different values for both charged groups of benzoylecgonine 
were found. The values highlighted in bold were used for following calculations and simulations. 
According to the data presented in Table 20, the pKa values of cocaine, cocaethylene and 
norcocaine are very close to each other. These compounds are positively charged approximately 
at pH = 7 and higher. They have very similar structure that differs from cocaine just in position 
of one methyl group in norcocaine structure and in the presence of ethyl instead of methyl group 
in cocaethylene. The secondary or tertiary amine group on the cyclic structure is the position, 
where these compounds can carry the positive charge. Other two metabolites, ecgonine methyl 
ester and benzoylecgonine, are zwitterionic compounds in wide range of pH. Ecgonine methyl 
ester is positively charged up to pH = 10, but benzoylecgonine just up to pH = 4 and then it 
carries both charges up to pH = 8. At higher pH, benzoylecgonine is negatively charged. Both 
zwitterionic analytes carry their positive charge at tertiary amino group in the cyclic structure as 
well. The negative charge is positioned at carboxylic group in benzoylecgonine molecule and 
hydroxyl group in ecgonine methyl ester molecule. Regarding the ionic mobility I was able to 
find only the value for cocaine in the literature. 
To find the optimum pH value for a separation of previously mentioned five analytes, I 
calculated their dissociation curves by software Medusa [266] according to the theoretical pKa 
values obtained from the literature (Table 19). The dissociation curves of all compounds in the 
pH range from 0 to 14 are in Figure 98. 
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Figure 98: Dissociation curves of cocaine and its metabolites according to the pKa values in the 
table 19 made by software Medusa. 
 
The highlighted area in Figure 98 shows the pH range from 8.5 to 10, in which the optimum pH 
value for separation can be expected. In this area, cocaine, cocaethylene, norcocaine and 
ecgonine methyl ester are partially dissociated and carry positive charge. Benzoylecgonine is 
either neutral or slightly negatively charged. The neutrality of benzoylecgonine is a reason for 
the use of uncoated capillaries with elevated electroosmotic flows to transport it to the detector 
and separate all five compounds in a single electrophoretic run. 
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4.4.2.2 Simulation of analysis in Peak Master 5.2. 
Prior to experiments the separation was simulated in PeakMaster 5.2 [135]. According to the 
highlighted area in Figure 98, I chose three different pH values 8.5, 9 and 9.5 of 30 mmol/l 
ammonium formate that serves as a BGE. The pKa values were set according to the data in 
Table 19. Since only the value of ionic mobility for cocaine was found, this value was used for 
all analytes. Other conditions are described in section 3.4.1.1. The simulated separations are 
shown in Figure 99 A - C. 
Figure 99: Simulation of separation of cocaine and metabolites in uncoated capillary by Peak 
Master 5.2 in different pH. 
 
In the first simulation shown in Figure 99 A (pH 8.5), cocaine and cocaethylene are not fully 
separated and the benzoylecgonine peak is extremely wide. In the second simulation (Figure 
99 B, pH 9), cocaine and cocaethylene are separated well to the baseline and the nearly neutral 
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benzoylecgonine migrated at a velocity close to EOF with an asymmetric peak shape that is 
narrower than in the previous separation. The third simulation (Figure 99 C, pH 9.5) shows not 
fully resolved peaks of cocaine and cocaethylene. The simulation program showed that the 
optimum pH value for complete resolution of all five analytes is pH = 9 
 
4.4.2.3 EOF driven separation of cocaine and metabolites 
According to the results obtained from the simulations, I chose the uncoated capillary and basic 
pH value of BGE for CE-MS analysis. The separation was performed with liquid junction 
interface device described in details in section 4.3.1.1 according to the protocol in section 
3.4.1.3. I run the separations at the pH range from 8.5 to 10 of 30 mmol/l ammonium formate 
that serves as BGE and I achieved the fully separation of all five analytes in pH = 9.5 as it is 
shown in following Figure 100. 
 
Figure 100: Extracted ion electropherograms of standard compounds (cocaine and metabolites) 
separated in uncoated capillary at pH = 9.5. 
 
As can be seen from Figure 100, the full separation of all five metabolites was accomplished in 
less than 8 minutes. The migration order of analytes was different according the the order 
obtained from the simulations. The position of norcocaine was changed, probably because the 
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pKa and ionic mobility value set to the Peak Master simulation program differ from the real 
values. At pH = 9, found as an optimum value in simulations, cocaine and cocaethylene were not 
fully separated. Table 20 shows the limits of detection for all analytes calculated as three fold of 
the RSDs of the noise. 
 
Table 20: Limits of detection of separated standard compounds in uncoated capillary. 
 
The LODs for ecgonine, cocaethylene, cocaine and norcocaine are in the range between 1.4 and 
3.2 ng/ml with various RSDs. On the other hand, LOD for benzoylecgonine is pretty high, more 
than 80 ng/ml. This high value could be caused by the spray instability that appears when 
electroosmotic flow reaches the MS detector. The benzoylecgonine peak shape was than 
negatively influence by the spray instability and thus the signal to noise ratio was lower in 
comparison with other peaks. In uncoated capillaries, I also observed a peak tailing of tested 
compounds, mainly cocaine, norcocaine and benzoylecgonine probably due to interactions of the 
analytes with the capillary wall. Thus I moved the analysis to coated capillaries. 
 
4.4.2.4 Separation of analytes in coated capillary with additional forward pressure 
The separation in PVA coated capillaries was realized on a different instrument that enables the 
application of forward pressure to the analysis. Without the applied inlet pressure the separation 
of cocaine and its metabolites at pH 9.5 cannot be reached in a single run, because of the neutral 
or negative character of benzoylecgonine. The CE instrument was connected to MS using a 
different type of laboratory-made liquid junction interface with hydrostatic pressure control, 
which was described in section 3.4.1.4. I used the same type of BGE as for analysis in uncoated 
capillary, ammonium formate, only the concentration was twice lower (15 mmol/l) to decrease 
the current influencing negatively the spray stability in the type of MS instrument used for the 
detection in these experiments. The CE-MS separation of all standard compounds in PVA coated 
capillary is shown in Figure 101. 
 
 ecgonine cocaethylene cocaine norcocaine benzoylecgonine 
LOD (ng/ml) 2.09 ± 0.34 1.39 ± 0.42 3.19 ± 0.97 1.57 ± 0.01 80.12 ± 11.48 
RSD (%) 16.48 30.47 30.43 0.62 14.33 
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Figure 101: Base peak electropherogram of standard compounds (cocaine and metabolites) 
separated in PVA coated capillary. 
 
The full separation was achieved within 15 minutes as it is depicted in Figure 103. Although the 
peaks widths are much higher in comparison with the analysis in uncoated capillary, the method 
enables the baseline separation of all the compounds and thus their precise quantification. The 
limits of detection calculated from Extracted Ion Electropherograms achieved in PVA coated 
capillary are listed in Table 21.  
 
Table 21: Limits of detection of separated standard compounds in PVA coated capillary. 
 
The lowest LOD was achieved for cocaethylene – 7.21 ng/ml, other analytes have LODs in tens 
of ng/ml as it is evident from the Table 21. In all cases, I still achieved better limits of detection 
that have already been published [262]. The RSDs of LODs are in some cases relatively high, 
e.g., more than 50 % for benzoylecgonine. This could be caused by a partial charge of 
compounds with a small change of conditions causing the changes of peak heights. 
 ecgonine cocaethylene cocaine norcocaine benzoylecgonine 
LOD (ng/ml) 42.22 ± 
7.88 
7.21 ± 0.90 
31.53 ± 
13.32 
21.95 ± 5.07 37.56 ± 18.99 
RSD (%) 18.66 42.25 12.48 23.10 50.56 
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4.4.2.5 Theoretical contribution of hydrodynamic flow to dispersion electrophoretic zones 
To establish the main reason for the zones dispersion when using coated capillary in comparison 
with uncoated capillary, I calculated the theoretical contribution of hydrodynamic flow to the 
zone dispersion for benzoylecgonine. The theoretical contribution of hydrodynamic flow to the 
length variance of the breadth of a electrophoretic zone was expressed [133, 267] as 
12
' =	
2 ∙ ,' ∙ )' ∙ 
48	5
	,	 
where r is the capillary diameter, v velocity of the neutral component, t neutral component 
migration time and D is diffusion coefficient. The relationship between length variance and time 
variance can be expressed as 
1
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12
'
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Thus the time variance of theoretical contribution of hydrodynamic flow to the peak broadening 
was derived [133, 267] as 
1
' =	
2 ∙ ,' ∙ 
48	5
	.	 
Diffusion coefficient D is can be evaluated from the electrophoretic mobility by Einstein 
Smoluchowski equation 
5 =	
( ∙ 6 ∙ 
7
	, 
where k is the Boltzmann constant, T temperature, µ electrophoretic mobility and q elementary 
charge. The calculated diffusion coefficient value of 6.16 · 10-10 m2/s correspond to the variance 
is of 78.76 s2 and standard deviation of 8.87 s.  
 
The apparent time variance σt
2 of a concentration distribution of a zone is defined as 
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is 28.62 s2, which corresponds to the standard deviation σ of 5.35 s, for the separation in 
uncoated capillary mobilized by EOF. The standard deviation of the same compound, 
benzoylecgonine, in coated capillary with additional inlet pressure is 12.67 s. The difference 
between these two values is 7.32 s. The small difference between this experimental value (7.32 s) 
and the theoretical one (8.87 s) shows that the peak broadening in coated capillary is caused 
mainly by the additional hydrodynamic flow and the zone dispersion is acceptable for practical 
purposes. 
 
4.4.2.6 Sensitivity improvement by stacking 
Sample stacking procedure is based on the difference of conductivities between the sample 
solvent and BGE. When sample with low conductivity is injected to the capillary filled with high 
conductive BGE as a long plug, the strong electric field is established in the sample zone after 
the voltage application. The analytes migrates quickly to the BGE boundary and creates a narrow 
zone. When the conductivity in whole capillary is adjusted, analytes are separated normally 
according to their electrophoretic mobilities. Sensitivity improvement in several orders of 
magnitude can be achieved using this method. 
To improve the LODs in the analysis in coated capillary, at first, the the injection time was 
increased. Previously, I compared both types of injection, electrokinetic and hydrodynamic. The 
results show that the electrokinetic injection gave better LODs. I have also found out that the 
presence of low amount of formic acid in sample solvent, enable the injection of amphoteric 
benzoylecgonine that is positive in low pH. Then, I tested the injection time in the range from 10 
to 100 s by applying 10 kV. The examples of analyses are shown in Figure 102. 
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Figure 102: Examples of cocaine and its metabolites separations (with different injection times). 
 
As it is depicted in Figure 102 the peak broadening appears when the injection time was 60 or 
100 s especially for the last peak belonging to benzoylecgonine. The improvement of limits of 
detection was evaluated and the results are shown in following Figure 103. 
 
 Figure 103: LOD dependence on injection time. 
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The limits of detection for E, CE and NC decrease with longer injection times. LODs of BE 
decrease just to the injection for 30 s and LOD of cocaine to the injection of 60 s. 
As a compromise between peak broadening and signal improvement, the injection time of 60 s 
was chosen for the next experiments. The samples were then diluted ten times using various 
solvents with lower conductivity. At first I dissolved the samples in different amount of 
methanol; LODs are shown in Figure 104. The amount of 0.1 % formic acid as a sample solvent 
remained constant in all of the experiments. 
 
Figure 104:  LOD dependence on different amount of methanol in the sample. 
 
As it is evident from Figure 104, some amount of methanol in the sample is useful, because LOD 
of benzoylecgonine in the sample without any methanol addition was pretty high. Unfortunately 
a distorted peak shape for benzoylecgonine was observed in both solvents with 10 % or 20 % of 
methanol. Thus methanol was replaced with acetonitrile, where the amount between 20 and 50 % 
of acetonitrile was investigated. The electropherograms are depicted in following Figure 105. 
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Figure 105: Extracted ion electropherograms of cocaine and metabolites dissolved in different 
amounts of acetonitrile. 
 
As it is shown in Figure 105, the benzoylecgonine peak shape in 20 % of acetonitrile was still 
pretty broad, but when the amount of acetonitrile in the solvent was increased to 50 %, the peak 
shape was already acceptable. The limits of detection of all samples are listed in Table 22. 
 
Table 22: Limits of detection of standard compounds dissolved in 50 % acetonitrile. 
 ecgonine cocaethylene cocaine norcocaine benzoylecgonine 
LOD (ng/ml) 3.19 ± 0.55 0.44 ± 0.09 0.90 ± 0.30 0.56 ± 0.13 1.28 ± 0.36 
RSD (%) 17.21 20.65 32.92 23.69 28.40 
 
With the lower injection time and different sample solvent, an improvement of LODs in the 
range from 13 to 39 times was achieved. Thus, the optimized sample solvent (50 % acetonitrile 
with 0.1 % of formic acid) together with an optimized electrokinetic injection (10 kV for 60 s) 
were used for the analysis of fortified urine. 
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4.4.2.7 Method validation 
The developed method was verified also for quantitative analysis by testing not only limits of 
detection, but also linearity, intra-day and inter-day precision. The precision within the same day 
was calculated for six consecutive runs at the sample concentrations 5 µg/ml for ecgonine, 
0.5 µg/ml for cocaine, cocaethylene and norcocaine and 2 µg/ml for benzoylecgonine. The inter-
day precision was realized in three days by six runs accomplished each day. In Table 23, intra 
and inter-day precision, data concerning retention time and peak areas precision, linear 
regression equations together with the relative standard deviations in percentage (RSD %) are 
listed for each analyte. 
 
Table 23: Method precision and linearity. 
 
Intra-day precision  
(n = 6) RSD % 
Inter-day precision 
(n = 18) RSD % 
Linear regression 
equations 
Correlation 
coefficient r2 
tm Peak area tm Peak area 
cocaine 1.36 5.88 1.87 7.82 y = 0.189 x + 0.011 0.9932 
cocaethylene 1.31 6.24 1.95 9.57 y = 0.413 x - 0.098 0.9941 
norcocaine 1.29 7.10 2.05 10.12 y = 0.285 x + 0.056 0.9913 
ecgonine 1.54 5.24 2.13 6.88 y = 0.346 x + 0.013 0.9976 
benzoylecgonine 1.32 12.15 2.54 18.34 y = 0.015 x - 0.006 0.9668 
 
As it is presented in Table 23, the RSD for retention time is below 2.6 % for both intra and inter-
day experiments. Acceptable results were also achieved for peak areas with RSD in the range of 
5.2 to 7.1 % and 6.9 to 10.1 % for intra-day and inter-day precision, respectively, except for 
benzoylecgonine (12.2 % and 20.4 %), due to its very low charge, which is probably less suitable 
for stacking. Linearity was investigated in the concentration range of 5 - 250 ng/ml for cocaine, 
cocaethylene and norcocaine, 10 - 500 ng/ml and 20 - 500 ng/ml for ecgonine and 
benzoylecgonine, respectively. For linearity, six concentration levels in duplicate runs for each 
analyte were tested. The equations and correlation coefficients of linear regression are listed in 
Table 23 as well. The linearity was evaluated by plotting of the peak areas (y) on the analyte 
concentrations (x). The correlation coefficients ranging from 0.9668 for benzoylecgonine to 
0.9976 for ecgonine confirm a good linearity. 
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4.4.2.8 Human urine extraction and analysis 
The CE-MS method was applied also to the quantitative analysis of all five compounds in human 
urine. In order to reduce or eliminate matrix effects, urine samples were subjected to SPE 
procedure by testing two different sorbents, Oasis HLB (hydrophilic - lipophilic balance) 
cartridges from Waters and Supelclean LC-SCX SPE from Supelco. Oasis HLB columns contain 
macroporous copolymer as a sorbent made from two monomers: lipophilic divinylbenzene and 
hydrophilic N-vinylpyrrolidone. The producer ensures the ability to retain both polar and non-
polar compounds [213]. For cocaine and its metabolites extraction from serum, Waters company 
promises at least 93 % recovery [268]. The results of extraction from human urine performed 
according to the protocol of producer presented in section 3.4.1.5 are shown in Figure 106. 
 
 
Figure 108: Base peak and extracted ion electropherograms of spiked urine after Solid Phase 
Extraction in Oasis HLB columns. 
 
As it is evident from Figure 168, no ecgonine was detected using OASIS cartridges. The 
recovery ranging between 50 and 60 % for other compounds was not satisfactory as well. I also 
observed impurity in extracted ion electropherograms with same molecular mass as BE 
migrating before 16th minute. Thus for the next experiment, I used Supelclean LC-SCX SPE 
cartridges from Supelco. These strong cation exchange columns with aliphatic sulfonic acid on 
the sorbent were successfully used for various drug extractions from human urine [269, 270]. 
The results are shown in Figure 107.  
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Figure 107: Base peak and extracted ion electropherograms of spiked urine after Solid Phase 
Extraction in SCX Supelclean columns. 
 
With SCX cartridges, all metabolites were eluted and the recoveries were 79.8% for ecgonine, 
93.2 % for cocaine, 84.9 % for cocaethylene, 94.1 % for norcocaine, and 96.2 % 
benzoylecgonine with RSD values ranged between 6.32 % and 11.96 % for all the analytes 
calculated from the three replicate analyses. For the further optimization, Supelclean LC-SCX 
SPE cartridges from Supelco were used. 
Since some impurities were presented in extracted ion electropherograms of blank urine, two 
methods of sample treatment were tested prior to SPE process. Since proteins are common 
impurities in urine samples, the acidic and basic treatment was performed for the proteins 
precipitation [271, 272]. Acidic treatment was induced by addition of 100 µl H3PO4 (100 
mmol/l) to 1 ml of diluted urine (1:1, with water) and centrifugated for 10 min. Basic treatment 
was made using the same procedure, but with the addition of 30 µl of NH3 solution. The acidic 
treatment provided results with cleaner electropherograms, thus it was used for next experiments, 
but some impurities were still detectable. As a further optimization step, the centrifugation time 
was prolonged from 10 to 30 min. The results of these experiments are shown in Figure 108. 
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Figure 108: Extracted ion electropherograms of blank and spiked human urine. 
 
 
In Figure 108, the extracted ion electropherograms of a blank urine sample and blank urine 
fortified with the cocaine and its metabolites are depicted. The intensity of electropherogram of 
blank urine was set to the same intensity as spiked urine electropherogram. No matrix 
interferences have been detected and the separation efficiency of the compounds was similar to 
that achieved with the standard mixture.  
The presented CE-MS method for the separation of cocaine and its four main metabolites 
provides high sensitivity, selectivity, precision and accuracy. The combination of pressurized 
liquid junction interface, nanoelectrospray ionization and online stacking increased the method 
sensitivity allowing the applicability to the analysis of cocaine and its metabolites in complex 
biological matrices as human urine.  
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5. CONCLUSIONS 
Selective luminescent molecular probes for localization of targeted proteins including membrane 
proteins and specific molecules, ovalbumin, CD3, FADD, FAS and fosfatidylserine were 
developed and synthesized via conjugation of quantum dots with antibodies or other specific 
ligands.  
First, water soluble CdTe quantum dots with mercaptopropionic acid attached to their surface 
were prepared in the size range from 2.5 nm to 5 nm and characterized. Their size-dependent 
luminescent properties, broad excitation spectra from 300 to 550 nm, emission spectra in the 
range from 500 nm to 750 nm as narrow as 58 nm at the half height of the maximum intensity 
and luminescence lifetimes varying from 3.6 ns to 43.5 ns proved to be convenient for high-
sensitivity analyses (Figures 24 and 26, Table 3). The size of the QDs and their crystal structure 
(cubic face-centered lattice with 8 atoms in every cube) were confirmed by HRTEM and 
emission spectra. Thus, the mass of individual QDs with 3.5 nm in diameter was evaluated to be 
approximately 79 kDa (660 atoms of Cd and Te) with average of 12 negative charges of 
mercaptopropionic acid molecules on the surface [218].  
 
The highly luminescent QDs were functionalized by conjugation to antibodies or other specific 
ligands using zero-length cross-linkers. It was essential to add cross-linkers, EDC and 
sulfo-NHS, to the solvent in a solid state to avoid the QDs precipitation. The reaction run at 
room temperature at pH = 7.4 in phosphate buffer. The successful conjugation between QDs and 
anti-ovalbumin was proved by analysis of reaction products by CE-LIF. After the addition of 
ovalbumin to the labeled anti-ovalbumin, three zones were detected: broad zone of free QDs, 
wide peak of labeled anti-ovalbumin and narrow zone of immunocomplex (Figure 35) [273].  
Another type of conjugation reaction via oxidized glycans was optimized to avoid the linkage of 
QD directly to the antigen binding site of antibody. This oriented conjugation method was 
proved by the following experiment. Anti-ovalbumin conjugated with magnetic particles via 
oxidized glycans was mixed with ovalbumin conjugated to QDs using EDC/sulfo-NHS method. 
Then, the movement of luminescent immunocomplex in magnetic field was observed under 
microscope (Figures 42 and 43). 
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Imaging of cellular proteins by synthesized luminescence probes based on QDs was tested on 
human lymphocytes. The specific antibodies to membrane proteins, anti-FAS, anti-FADD and 
anti-CD3 were conjugated to QDs via EDC/sulfo-NHS method. All of these proteins, involved in 
the process of cellular apoptosis were detected on membranes of human lymphocytes (Figures 
52, 53 and 54). Another example of the successful application of molecular probes based on QDs 
is the imaging of externalized molecules of phosphatidylserine on membranes of apoptotic cells 
in mouse duodenum tissue. In this case, annexin V conjugated to QDs played the role of a 
specific ligand (Figure 55). 
 
The combination of off-line 2D electrophoresis with on-line LC-ESI-MS or CE-ESI-MS for the 
identification of protein changes in carotenogenic yeast Rhodotorula glutinis cultivated under 
normal or stressed conditions was tested. This yeast was cultivated in the media containing 2 % 
NaCl. As a result, 19 proteins from 79 down - regulated and 9 proteins from 89 up - regulated 
were identified according to the homology with proteins of different organisms (Tables 4 and 5). 
Since the substitution of LC by CE did not provide a sufficient sensitivity for the identification of 
any proteins, following processes were investigated: sample preparation, transient 
isotachophoretic stacking before CE and instrumentation of CE-MS interface. The 20 times 
improvement in limits of detection in standard sample of Cytochrome C tryptic peptides was 
achieved with solid phase microextraction of samples prior to the analyses using commercially 
available ZipTips with C-18 as a stationary phase. The LOD of 7.74 × 10-9 mol/l for the most 
intensive peptide was obtained after treatment instead of 1.59 ×10-7 mol/l before ZipTip 
treatment (Figure 70). Simulation software Simul 5.0 was used for searching optimum conditions 
for transient isotachophoresis as an online concentration method before CE. Although a 20 fold 
increase in concentration of model amino acids was achieved in simulated analysis, this result 
was not confirmed in real systems. A remarkable improvement of LOD was reached by the 
implementation of a miniaturized liquid junction interface for combination of CE and ESI-MS. 
With the spray tip of a diameter of 10 µm the LOD of the tryptic peptides from Cytochome C 
was evaluated to be 3.87 × 10-9 mol/l, which represents approximately 83 fold improvement, 
when compared with sheath flow interface (Figure 83). In summary, the sensitivity of CE-MS 
could be improved by 4 orders of magnitude by the combination of all these items for the 
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analysis of the model sample. These improvements in the methodology and instrumentation, 
however, have not been tested with yeast proteins anymore.  
 
The newly developed instrumentation of liquid junction interface was tested also for CE-MS 
separation of small molecules of clinically important metabolites. Ethanol as well as cocaine 
metabolites were analysed in complex matrices of human urine. The analysis method of specific 
markers of ethanol users, ethylglucuronide (EtG) and ethylsulphate (EtS) was optimized. 
Although the reproducibility of analysis in coated capillaries was not perfect, the limits of 
detection achieved in diluted human urine were 0.15 and 0.5 µg/ml for EtS and EtG, respectively 
(Figure 88). 
Four cocaine metabolites together with cocaine itself were analysed by CE-MS using two types 
of liquid junction interface. The CE-MS separation provided very good limits of detection in the 
range from 0.4 to 3.2 ng/ml. The validated method was applied to the analysis of spiked human 
urine after extraction (Figure 108). The development of the high sensitivity instrumentation and 
methodology demonstrated in the thesis can potentially have an impact on the environmental 
analysis.  
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8. LIST OF ABBREVIATIONS 
CE    capillary electrophoresis 
CE-LIF  capillary electrophoresis with laser induced fluorescence detection 
CE-MS  capillary electrophoresis with mass spectrometry detection 
PMF   peptide mass fingerprinting 
ESI   electrospray ionization 
MALDI  matrix-assisted laser desorption ionization 
HPLC   high performance liquid chromatography 
SCX   strong cation exchange 
UV   ultraviolet 
QD   quantum dot 
MPA   mercaptopropionic acid  
TGA   thioglycolic acid 
TEM   transmission electron microscopy 
SGE   slab gel electrophoresis 
PAGE   polyacrylamide gel electrophoresis 
SDS-PAGE  sodium dodecyl sulphate polyacrylamide gel electrophoresis 
2D electrophoresis two-dimensional electrophoresis 
IgG   immunoglobulin 
DTT   dithiotreitol 
MEA   mercaptoethylamine 
EDC   1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride  
sulfo-NHS   N-Hydroxysulfosuccinimide  
CDI   N, N´- carbonyldiimidazol 
CEIA   capillary electrophoresis immunoassay 
TIRF   total internal reflection fluorescence microscope  
TRIS   Tris(hydroxymethyl)aminomethane 
TAPS   N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid 
ID   inner diameter 
LOD   limit of detection 
194 
 
SPE   solid phase extraction 
SPME    solid phase microextraction 
BGE   background electrolyte 
LE   leading electrolyte 
TE   terminating electrolyte 
EOF   electroosmotic flow 
tITP   transient isotachophoresis 
Ab   antibody 
Ag   antigen 
OVA   ovalbumin 
anti-OVA  antiovalbumin 
EtS   ethylsulphate 
EtG   ethylglucuronide 
E   ecgonine 
C   cocaine 
NC   norcocaine 
CE   cocaethylene 
BE   benzoylecgonine 
PVA   polyvinyl alcohol 
ACN   acetonitrile 
MeOH   methanol 
ISO   isopropanol 
 
 
 
